JJuunnee 1188,, 22001188
BBooaarrdd ooff DDiirreeccttoorrss 9:15 am
FFiinnaannccee SSuubbccoommmmiitttteeee 8:30 am
HR Training Room
Munson Road
Agenda and Materials
June 18, 2018
FINANCE SUBCOMMITTEE
Board of Directors
Time: 8:30 a.m.
Location: HR Training Room, Munson Road Page
1 . Public Comment 1
2 . Chair’s Remarks 2.1 Welcome 2.2 Approval of Minutes 32
2.2.1 May 22, 2018
3 . Financial Reports and Updates
3.1 Results of Operations as of April 30, 2018 - J. Geoghegan 18
4 . Items Needing Approval:
Contracts/PO’s/Amendments $1 million – J. Geoghegan
4.1 Contracts > $1,000,000 [F] 13 4.1.1 CT Natural Gas Corporation 4.1.2 Eversource (CL&P) 4.1.3 Johnson & Johnson 4.1.4 Medtronic USA, Inc. 4.1.5 Owens & Minor 4.1.6 J. Morrissey & Company, Inc. 4.1.7 The Jackson Laboratory 4.1.8 Anthrex, Inc. 4.1.9 Howmedica Osteonics 4.1.10 Medtronic Sofamor Danek 4.1.11 Nuvasive 4.1.12 Connecticut Chilldren’s Medical Center 4.1.13 Hartford Hospital 4.1.14 Saint Francis hospital and Medical Center 4.1.15 The Hospital of Central Connecticut 4.1.16 HealthWide Solutions, LLC 4.1.17 Olympus America, Inc. 4.1.18 GE healthcare 4.1.19 Cardinal Health, 110 LLC 4.1.20 McKesson Corporation 4.1.21 Optum 360, LLC and its affiliate, Optuminsight, Inc.
FINANCE SUBCOMMITTEE
Agenda and Materials
June 18, 2018
UConn Health
4.2 Leases [F] 14 4.2.1 Instrumentation Laboratory 4.2.2 Universal Hospital Services 4.2.3 Advisory Board 4.2.4 Hartford Healthcare Medical Group
4.3 Project Budgets [F] 15 4.3.1 Project Budget for the UConn Health Main Accumulation Building
(Revised Final: $4,050,000)
5 . Updates and Informational Items:
6. Other Reports6.1 Personnel List 36
Next Regularly Scheduled Meeting:
Monday, September 19, 2018
8:30 a.m.
HR Training Room
PAGE
1 PUBLIC COMMENT 1
2 CHAIR’S REMARKS
2.1 Welcome 2.1.1 Recognition of R. Lamont MacNeil, D.D.S., M. Dent. Sc. 2 2.1.2 Faculty Recognition Award, Dr. Douglas Peterson 3
2.2 Approvals [vote]
2.2.1 Meeting minutes - March 12, 2018 5 2.2.2 Conflict of Interest Committee Resolution 11
3 CONSENT ITEM
3.1 Contracts > $1,000,000 [F] 13 3.1.1 CT Natural Gas Corporation 3.1.2 Eversource (CL&P) 3.1.3 Johnson & Johnson 3.1.4 Medtronic USA, Inc. 3.1.5 Owens & Minor 3.1.6 J. Morrissey & Company, Inc. 3.1.7 The Jackson Laboratory 3.1.8 Anthrex, Inc. 3.1.9 Howmedica Osteonics 3.1.10 Medtronic Sofamor Danek 3.1.11 Nuvasive 3.1.12 Connecticut Chilldren’s Medical Center 3.1.13 Hartford Hospital 3.1.14 Saint Francis hospital and Medical Center 3.1.15 The Hospital of Central Connecticut 3.1.16 HealthWide Solutions, LLC 3.1.17 Olympus America, Inc. 3.1.18 GE healthcare 3.1.19 Cardinal Health, 110 LLC 3.1.20 McKesson Corporation 3.1.21 Optum 360, LLC and its affiliate, Optuminsight, Inc.
Board of Directors
Agenda and Materials June 18, 2018
8:30 am – Finance Subcommittee
9:15 am – BoD Public Session BoD Executive Session to follow
Munson Road Training Room 16 Munson Road Farmington, CT
3.2 Leases [F] 14 3.2.1 The Jackson Laboratory 3.2.2 Eagleville Partner, LLC 3.2.3 Eagleville Partner, LLC 3.2.4 Blackthorn Holdings, LLC 3.2.5 Connecticut Children’s Medical Center
3.3 Project Budgets [F] 15
3.3.1 Project Budget for the UConn Health Main Accumulation Building
(Revised Final: $4,050,000)
4 CEO/EVP REPORT – A. Agwunobi
4.1 UConn Foundation Health Sciences Fundraising Report – J. Grey
[A] Academic Affairs Subcmte [C] Clinical Affairs Subcmte [F] Finance Subcmte
5 MAIN BUSINESS
5.1 2019 Consolidated Operating Budget/Spending plan – J. Geoghegan 5.2 Current Services Requests for Fiscal Years 2020 and 2021 – J. Geoghegan (walk in item) 5.3 UConn Health One (EMR) update – B. Metz 5.4 Dean, School of Medicine Update – B. Liang
5.4.1 Health Disparities - Dr. Wizdom Powell, Dir. Health Disparities Institute 5.5 Dean, School of Dental Medicine Update – M. MacNeil 5.6 Clinical Update –
5.6.1 JDH - A. Agwunobi 5.6.2 UMG – A. Horbatuck 30
6 FINANCIAL AFFAIRS COMMITTEE REPORT -T. Holt 6.1 Chair’s Remarks 6.2 Informational Items
6.2.1 Minutes: March 12, 2017 32 6.2.2 Contracts to $999,999 35 6.2.3 Personnel List 36
7 BUILDING AND GROUNDS COMMITTEE REPORT – R. Carbray
7.1 Chair’s Remarks 7.2 Informational items
7.2.1 Minutes – November 28, 2017 43 7.2.2 Bioscience Connecticut Monthly Capital Projects Report 45
8 ACADEMIC AFFAIRS COMMITTEE REPORT - F. Archambault
8.1 Chair’s Remarks 8.2 Informational Items
8.2.1 Minutes: May 21, 2018 70
9 CLINICAL AFFAIRS COMMITTEE REPORT - C. Chase
9.1 Chair’s Remarks 9.2 Informational Items
9.2.1 Minutes: February 22, 2018 75 9.2.2 Minutes: Peer Review Session – February 22, 2018 80 9.2.3 Summary of Key Indicators 81
10 OTHER REPORTS
10.1 JACC Update – T. Holt
11 EXECUTIVE SESSION
Preliminary notes and drafts that the Health Center has determined that the public interest in withholding such documents and discussions clearly outweighs the public interest in disclosure.
NEXT REGULARLY SCHEDULED MEETING September 17, 2018
Munson Road Training Room 16 Munson Road
Public Participation at UCHC Board of Directors Meetings
University of Connecticut Health Center Board of Directors starts its agenda with Public
Comments. The BOD shall hear brief oral presentations from members of the public who
wish to express their views on issues pending before the BOD or on other issues of
concern to the University of Connecticut Health Center. The agenda for each regular
public meeting of the BOD shall allot up to thirty minutes for this purpose:
a. Requests to address the BOD shall be made to the Chair’s designee at least one day
prior to the meeting and may begin to be made the day following the last BOD meeting.
The actual person who intends to speak must make the request.
b. The Chair of the BOD shall recognize each speaker in the order of signing up, shall
request the speaker identify himself/herself, and shall ensure adherence to time limits as
will permit the orderly progress of the BOD through its agenda. Each speaker will be
allotted a time period of three minutes to speak.
c. At a special meeting of the BOD, comment by members of the public shall be limited
specifically to the subject described in the call of the special meeting.
The BOD would like to give each constituency an opportunity to speak. Therefore,
groups are encouraged to appoint a single spokesperson to present their point of view.
The purpose of Public Participation is to allow the BOD to hear the views of the public.
BOD will neither ask nor answer questions nor make comments during this portion of the
agenda.
The Chair appoints the following person as his designee to receive requests to speak in
the Public Comments portion of BOD meetings:
Scott L. Wetstone, M.D.
Director, Health Affairs Policy Planning
Phone: (860) 679-4440
Fax: (860) 679-1255
Email: [email protected]
University of Connecticut Health Center
263 Farmington Avenue
Farmington, CT 06030-1920
1
R. Lamont (Monty) MacNeil
2007 - 2018
WHEREAS, R. Lamont MacNeil has served the people of the State of Connecticut and
the University of Connecticut as the Dean of the School of Dental Medicine for the past
eleven years as well as being a UConn Health faculty member for twenty years; and
WHEREAS, During his period of leadership the School of Dental Medicine has excelled
academically in terms of its innovative curriculum, quality of teaching, and number of
students & residents and the research it provides, and clinically in terms of quality of care
and increasing volume of care, especially to underserved populations; and
WHEREAS, Dr. MacNeil’s has navigated the School through very fiscally challenging
times and still achieved success and growth including the planning and implementation of
new clinical facilities under the BioScience Connecticut program; and
WHEREAS, Dr. MacNeil has been an outstanding partner on joint efforts with the
School of Medicine, UConn Health clinical programs, and UConn including but not
limited to the new Biomedical Engineering Department and M-Delta Curriculum; and
WHEREAS, Through his deanship, Dr. MacNeil has been an active and productive
leader in national dental education organizations including service as the Chair of the
Board of the American Dental Education Association; and
WHEREAS, Throughout his tenure, Dr. MacNeil has been a colleague and had an
exemplary working relationship with the members of the Board of Directors; and Dr.
MacNeil leaves his deanship with the gratitude, respect and affection of the members of
the Board of Directors, and their best wishes for the future;
THEREFORE BE IT RESOLVED That the UConn Health Board of Directors records
its deep appreciation to R. Lamont MacNeil for exemplary service to the Board and to the
University.
BE IT FURTHER RESOLVED That this resolution be spread upon the minutes of the
Board of Directors, with copies sent to UConn Board of Trustees and to Dr. MacNeil.
Sanford Cloud, Jr., Chairperson
June 18, 2018
2
To: Members of the UConn Health Board of Directors
From: Dr. R. Lamont MacNeil, Dean, School of Dental Medicine
Date: June 18, 2018
Subject: Recognition of Dr. Douglas Peterson as the Recipient of the 2018 UCH Board of
Directors Faculty Recognition Award
______________________________________________________________________________
Dr. Douglas Peterson is the recipient of the 2018 Board of Directors Faculty Recognition Award.
This award celebrates and rewards demonstrated academic, administrative and/or excellence of
Health Center faculty. The award was conveyed at the 2018 UCH Commencement Exercises on
May 7, 2018.
Douglas Peterson
Dr. Peterson began his faculty career in 1976 in the Cancer Center and the Dental School of the
University of Maryland, with continuation through 1989. He served as Visiting Scholar at the
Fred Hutchinson Cancer Research Center in 1983, following which time he co-published with Dr.
E. Donnall Thomas, 1990 Nobel Laureate in Physiology or Medicine. Dr. Peterson was
Consultant in Oral Medicine to the National Institutes of Health (NIH) from 1988-1994. Dr.
Peterson was also an Associate Medical Staff member at The Johns Hopkins Hospital and
Oncology Center from 1988-1991. He served as Professor and Head, Department of Oral
Diagnosis, Univ. of Connecticut School of Dental Medicine between 1989-2005, and again as
Interim Department Head 2006-2007. Dr. Peterson served as Chair of the School of Dental
Medicine Faculty Senate from 2009-2015.
Dr. Peterson’s primary academic responsibilities throughout his career have been directed to oral
management of the medically complex patient, with emphasis on oral complications in cancer
patients. He has contributed to development of interprofessional models for patient care,
research, and health professional education in this context for more than 40 years. He has
lectured extensively at the regional, national, and international levels throughout this time.
Dr. Peterson is author of approximately 165 peer-reviewed publications and 150 abstracts, and is
editor of 2 books and co-editor of a Monograph for the Journal of the National Institute. He has
been involved in translational and clinical trial research in the oncology setting throughout his
career, including serving as Principal Investigator on two multi-center, international clinical trials
involving drug development for oral mucositis in cancer patients. He has also served as Principal
Investigator on National Institutes of Health (NIH) grants including R01's and R13's, as well as
primary mentor via the NIH K Award program. Dr. Peterson has also been a reviewer of grant
applications for the NIH on a frequent basis during the past 30 years, including study section
chair for several panels.
Dr. Peterson is a Special Government Employee for the United States Food & Drug
Administration for mucositis clinical trials, having been initially appointed 13 years ago. Dr.
Peterson has also served as lead writer for the NCI’s PDQ® website Oral Complications of
3
Chemotherapy and Head/Neck Radiation for the past 13 years, with strategic updates to be
completed in 2018 via his leadership.
Dr. Peterson chaired the NIH-funded Conference Oral Complications of Emerging Cancer
Therapies in April 2009. He also chaired an American Society of Clinical Oncology (ASCO)
Education Session in June 2012 titled Mucosal Injury in Patients with Cancer: Targeting the
Biology. Dr. Peterson is Co-chair of ASCO’s Supportive Care Guideline Advisory Group, and is
a member of ASCO's Clinical Practice Guidelines Committee as well as its Methodology
Subcommittee. These ASCO committees are responsible for development of high quality,
evidence-based guidelines for the national and international oncology community, including the
role of dental medicine in cancer patient care. He is currently contributing a leadership role in
developing first-in-kind joint oral oncology guidelines in collaboration with ASCO and the
International Society of Oral Oncology. Dr. Peterson has been a frequent contributor to
CancerCare for many years, and received CancerCare’s Physician-of-The-Year award in 2006.
He has also served as lead writer for mucositis guidelines for the European Society of Medical
Oncology from 2007-2016.
Dr. Peterson has contributed to the World Workshop on Oral Medicine series beginning in the
1990’s, with leadership roles from 2004-present. Dr. Peterson is currently Associate Editor for
Dentistry and Medicine for the Journal of the American Dental Association, and is President and
Diplomate of the American Board of Oral Medicine. He is Region 6 Advisor for the European
Association of Oral Medicine, having been elected in 2013. Dr. Peterson also serves as a
reviewer for the Cochrane Oral Health portfolio, based in Univ. of Manchester, U.K.
In recognition of his career contributions, Dr. Peterson received the FDS RCSEd without
Examination from the Royal College of Surgeons/Edinburgh in 2011. He was appointed in
March 2015 to the Faculty of Examiners for the Conjoint FDS Examination in Oral Medicine,
and as Regional Dental Advisor for the Royal College effective April 2015.
Current UConn Health leadership responsibilities include serving as:
Chair of Oral Medicine, Dept. of Oral Health & Diagnostic Sciences
Chair of Scientific Review Committee, UConn Health Institutional Review Board
Co-Chair of UConn Health Conflict of Interest Committee
Vice President/Secretary of Medical Staff, UConn Health (re-elected to 2nd term Nov
2017)
School of Dental Medicine representative to the predoctoral biomedical curriculum
reform committee Vertical Teams Aligned in Learning & Scholarship.
In this role Dr. Peterson is one of two Co-chairs for interprofessional education, in
which Univ. of Connecticut students from multiple health professions, including
dental medicine, medicine, nursing, and pharmacy, are taught management of
medically complex patients via a team-based model.
For these remarkable contributions to education, research, administration and service, Dr.
Peterson is this year’s recipient for the Board of Directors Faculty Recognition Award.
4
Sanford Cloud, Chairman, called the meeting to order at 9:35 a.m.
1. Public CommentRikel Lightner gave public comment on the transition of Correctional Managed Health Carefrom UConn Health to DOC. Stating that many feel, as she does, that there is a highprobability of nonunionized managerial staff will not be selected to crossover to the DOCleaving them without a job; while unionized managerial staff, such as herself, included in thecrossover, may be laid off or put back on the floor at a lower grade level. Combined with this isthe fact that all seniority will be lost and not carried over to the DOC and UConn Health beingthe preferred place of employment may not have suitable positions available for those beingaffected by this change. In closing, Ms. Lightner publically thanked Gail Johnson for hercontinued work through this transitional process.
2. Chair’s Remarks2.1 Mr. Cloud welcomed everyone to the meeting. Chairman Cloud recognized the work of
Mr. Lawrence McHugh and his work with the Board of Directors.
2.1.1 Recognition of Lawrence McHugh
The Board of Directors unanimously approved the resolution honoring the service of Lawrence McHugh.
2.2 Minutes – 2.2.1 December 4, 2017 - Regular meeting
The Board of Directors unanimously approved the minutes of the meetings of the UConn Health Board of Directors held on December 4, 2017.
3. Consent Items (items 3.1 – 3.4 were voted on in the Finance Subcommittee meeting heldearlier in the day)
3.1 Contracts > $1,000,000 [F] 3.1.1 Novo Nordisk, Inc. 3.1.2 Capital Area Health Consortium 3.1.3 Capital Area Health Consortium 3.1.4 Concentra 3.1.5 Edwards Lifescience 3.1.6 GE Healthcare 3.1.7 Jackson & Coker Holdings, LLC, dba Jackson & Coker Locum Tenens, LLC 3.1.8 Locum Tenens Holdings, LLC, dba Locum Tenens.com, LLC 3.1.9 MDA Holdings, Inc., dba Medical Doctor Associates, LLC 3.1.10 Medestar 3.1.11 Quest Healthcare Solutions, LLC 3.1.12 Tusk Enterprises, LLC, dba Rhino Medical and Hospitalists Plus
March 12, 2018 Meeting minutes
Draft
Board of Directors
5
The Board of Directors unanimously approved agenda item 3.1 described in detail in the board materials on page 9.
3 CEO/EVP Report – A. Agwunobi Dr. Agwunobi briefly highlighted the financial report highlighting the positive margins. At this time we are about $7.5 million ahead of budget. He added some comments regarding the correctional managed health care transition. There are approximately sixteen different groups working collaboratively with the Department of Correction to ensure a smooth transition while the staff is working tirelessly to guarantee that exceptional care continues to be given to all of our prisoners. The UConn Health One, the electronic medical records project is slated to go live on April 28. There will be a go-live readiness time, where we will determine whether the program is ready to go-live. If it is necessary, Dr. Agwunobi will delay the date to go-live. At this time, it appears that we are ready for April 28th. The final item Dr. Agwunobi discussed is the preparation for the Joint Commission. The two recent mock surveys brought to light a few areas that needed attention, manly in the area of Environment of Care. Since then there has been a great deal of focus on these areas in preparation for the Joint Commission’s visit. Jennifer Grey announced that fundraising overall for UConn Health is at $6.5 million, about $2 million over last year at this time and continues to track well. She continued by sharing some initiatives that the Foundation is working on including: - New focuses on naming opportunities for UConn Health. This would include some smaller
areas such as a classroom or hospital room - $25,000, waiting rooms at $100,000, and the Academic Rotunda is $1,000,000.
- A new initiative coming up in April which is #UConn Gives, which a university wide initiative. This will be our first ever school wide giving day.
- In 2015 the Foundation committed to raising $6 million dollars toward the Bioscience CT project. To date they have raised. $4.6 million. Gifts of over $100,000 will get recognized on the donor wall.
5 Main Business
5.1 Fiscal Year 2018 Results of Operations as of January 31, 2018 – J. Geoghegan The full report of the results of operations was reviewed in detail at the Finance Subcommittee meeting earlier and can be found in the board materials beginning on page 11. Mr. Geoghegan reinforced that currently UConn Health has a positive bottom line of $2.9 million, comparable to our budget (loss $4.6 million). All programs are favorable. The driver is overall positive volume, JDH is positive on discharges and outpatient activity; while UMG is positive in RVU production and the providers RVU’s are up year over year. There is additional information in the board materials.
5.2 Optum360 LLC and its affiliate, Optuminsight, Inc. – A. Agwunobi This report was presented in the Finance Subcommittee meeting earlier the same day. We continue to look for more ways to save funds for UConn Health. One of those cost saving approaches would be through revenue cycle. By outsourcing our revenue cycle management. This will improve the finances with additional revenue capture, improve billing function at UConn Health, and improve our readiness for launching the electronic medical records system. An RFP was issued last fall and interviewed 4 out of the 5 that responded. Jeff Geoghegan led the task of interviews and investigating. Dr. Agwunobi did clarify that he did not participate in the interview or selection process. He explained that although he does not have a direct conflict of interest, Dr. Agwunobi sits on the board of a large hospital system in California. That organization owns about 20% of Optum. Once it was determined that Optum was a respondent, Dr. Agwunobi
6
immediately recused himself from the process. Optum360, a national revenue cycle management firm, with favorable overall costs compared to the other RFP’s; was selected. This firm indicated they serve 4 out of every 5 health care facilities across the US. This firm is part of the same firm that purchased ProHealth Physicians,
Optum did a small assessment prior to the contract stage so we would understand the potential financial benefit of them managing our revenue cycle would be and also to understand the full agreement. Their assessment was that conservatively we have about $8 million of opportunity with best practice being up to $14.5 million over the next twelve months. UConn Health has chosen a target of $10 million.
Dr. Agwunobi discussed the various breakdown costs of the contract and the separate portions of the agreement, including interim staffing and the HealthOne EPIC consulting. The request to the board is net funds of $2.6 million. A resolution was handed out to each board members in a total amount not to exceed $2.6 million.
The Board of Directors unanimously approved agenda item 5.2, The Resolution for a contract with Optum360, LLC and its affiliate, Optuminsight, Inc. in a total amount not to exceed $2.000,000.
5.3 UConn Health One update – Bruce Metz
Mr. Metz reported that considerable progress has been made toward the April 26 go-live
date for the UConn Health EPIC project. Major project areas have been improved and
strengthened including the overall approach to the implementation, project management
governance, testing, training, reporting and an a range of technical activities. The
emphasis of the project team has shifted. The focus now is getting the organization
ready for Health One. To this end a very extensive communication campaign is moving
forward to inform and engage not only our end users but also our patients. In addition
comprehensive clinical, revenue cycle and EPIC directive assessments are being
completed. As a result of these assessments over 100 critical go-lives risks have been
identified with mediation plans developed. A vendor has been selected to serve as
UConn Health’s activation partner and activation planning is well underway.
5.4 Dean, School of Medicine – B. Liang
Dr. Liang reported on the LCME full survey that occurred the week prior to the board
meeting. LCME stands for Liaison Committee on Medical Education, which is the
accrediting board for all United States Medical Schools. Dr. Liang reported that the
survey went well. The survey team reported that although the final LCME report will not
lists strengths of the school, the team recognized that the investment in facilities,
strategy and success of the debt management system, the recently introduced
innovative curriculum, and the wellness concept woven throughout the curriculum are
admirable. There are several areas believed to be mostly compliant but with a need to
monitor; they will need follow ups.
The new curriculum in collaboration with the School of Dental Medicine has successfully
completed Stage 1, the pre-clerkship forum and is now moving to Stage 2 which is the
required clerkship forum.
7
In addition, Dr. Liang reported that there have two chairs that been recruited and are
now in place. Dr. Riqiang Yan is the new chair of the Neuroscience Department. Dr. Yan
comes to us from the Cleveland Clinic and is the world’s expert on Alzheimer ’s disease.
Also, Dr. Brenton Graveley will now assume the position of permanent chair of the
Department of Genetics and Genome Sciences. Dr. Graveley has recently been
awarded a $9,000,000 grant from the National Institute of Health.
5.4 Dean, School of Dental Medicine update – M. MacNeil
Dr. MacNeil gave an overview of the school’s highlights including the school’s academic
outcomes continue to be very strong reflected in our acceptance rate this year. This year
the school had an unusually high response to the first round of offers which speaks to
the reputation of the school nationally as well as locally. Starting to see Part 1 National
Board results for students who are completing the shared curriculum with medicine and
the results look very good. The match results were very strong this year.
Mr. Geoghegan gave the clinical report earlier. Dr. MacNeil wanted it noted that these
results are being achieved while an onsite clinical renovation and expansion project is
going on. The project should be completed in 12-14 months.
5.5 Clinical update – A. Agwunobi
UConn John Dempsey Hospital has just opened a new state of the art Epilepsy Unit
under the leadership of Dr. John Greenfield. Dr. Ketan Bulsara recently performed JDH’s
first Mechanical Thrombectomy on an advanced stroke patient. The volume at JDH has
been running 70% - 74% occupancy over the last few months. The surgeries are
increasing generally across the board, with several days when the operating rooms were
completely full. The new hybrid operating room will open in May. Overall John Dempsey
is growing.
UMG encounters are 5% ahead of the prior year, and productivity is 7% ahead of last
year. That is due to some great work by Anne Horbatuck and Denis Lafreniere; adding
patients, core physicians, and working with them to ensure they are supported. This has
driven UMG to be favorable to budget, which has not occurred in recent prior years.
Some of the new providers include physicians hired by UMG but who will also benefit the
hospital. In addition Dr. Agwunobi stressed that he and Dr. Liang are working diligently
to retain our current physicians.
As our finances start to improve we must take note that the staff on the front line,
particularly the nursing staff, take the brunt of the increased volume; and we run the
danger of losing nurses. Working with the unions it was decided to pay a stipend to
nurses to enable us to retain and recruit.
6. Financial Affairs – Tim Holt
The Finance Subcommittee met just prior to the full board meeting. The group reviewed and recommended contracts over $1,000,000, which were presented at the board meeting. In additional there was a detailed report on the FY 18 through January and the 2017 audited financial statements. There are informational items beginning on page 26 of the board materials.
8
7. Building and Grounds – Richard Carbray
The building and grounds committee did not formally meeting this quarter. However, Mr. Carbray and Dr. Archambault attended the joint Building and Grounds committee which met in Storrs on February 14th. At which time Tom Trutter provided an update which highlighted the completion of the Academic building addition as well as the main building and lab renovations. Currently the clinic building renovations are 70% complete.
8. Academic Affairs – Fran Archambault
Academic Affairs met on January 29th and approved recommendations for appointments, sabbatical leaves, and promotions for the medical and dental schools. The group heard a report from the medical oversight committee on department reviews. We are currently in good shape with department reviews which is an improvement over past years. Dr. Steve Angus gave a report on the graduate medical education annual institutional review. Dr. Archambault made a motion that the board approve two recommendations for appointments to endowed chairs. The first was to Dr. Brenton Graveley, for the Health Net, Inc. Chair in Genetics and Developmental Biology. And the second to Dr. David McFadden, for the Murray-Heilig Chair in Surgery.
The Board of Directors unanimously approved the recommendations for appointments to Endowed Chairs for Dr. Brenton Graveley, for the Health Net, Inc. Chair in Genetics and Developmental Biology. And the second to Dr. David McFadden, for the Murray-Heilig Chair in Surgery. 9. Clinical Affairs – A. Agwunobi
Dr. Agwunobi reported for Chair Cheryl Chase. The Clinical Affairs Subcommittee met on February 22nd. Dr. Scott Allen was appointed as Chief Quality Officer for John Dempsey Hospital. The finances were also presented and it was announced that a Vice President of Patient Experience will be hired. This will be someone to lead the effort across the organization to further improve the patient experience in our system and make it more consistent. The nurse stipend (mentioned earlier) was also discussed. The surveys for patient satisfaction were reviewed showing that nurse communication has improved. There is additional work to do in the area of staff responsiveness and doctor communication. Some hospital goals were tentatively approved and an additional goal is being added for central line infections because of the challenges expected with the Leapfrog Safety grade. Our CMS star rating is 3 out of 5 which is where we have been and is equal to or better than most hospitals in the state.
10. Other Reports– Tim Holt
The JACC met twice since the last Board of Directors meeting; once on December 19, 2017 and once on March 12, 2018. Over that period of time the group reviewed six audits, one specific to UConn Health. Action plans are in place to address all recommendations that were a result of the audits. There was an audit of the John Dempsey Hospital Deaf and Hard of Hearing Voluntary Resolution Agreement which was a good report and in compliance with the Department of Justice. There was also a report on the Health One Electronic Medical Records. Two audits were presented on the financial statements for 2017 which were presented earlier in this meeting. Marcum, the outside auditor, issued unqualified opinions and did not identify any deficiencies in internal control. Likewise, the auditors of pubic accounts presented UConn and UConn Health financial statements for 2017 and issued an unqualified opinion and did not identify any issues.
9
Executive Session
At 10:31 a.m. a motion was made and unanimously approved to enter into executive session in order to discuss:
Preliminary notes and drafts that the Health Center has determined that the public interest in withholding such documents and discussions clearly outweighs the public interest in disclosure; and trade secrets that derive independent economic value, actual or potential, from not being generally known, and not being readily ascertainable by proper means by other persons who can obtain economic value from their disclosure of use, and are the subject of efforts that are reasonable under the circumstances to maintain secrecy.
Executive Session Attendees: K. Alleyne, F. Archambault, R. Barry, K. Bragherol, R. Carbray,
S. Cloud, J. Droney, S. Herbst, T. Holt, R. Pino, W. Rawlins (phone), T. Ressel (phone), and K.
Woods
Guests: A. Agwunobi, L. Danville, J. Geoghegan, C. Hyers, A. Keilty, S. Jordan (phone), R. Rubin, J. Teitelbaum (phone), B. White
With no further business the meeting was adjourned at 11:28 am.
Respectfully submitted,
Andrew Agwunobi, MD, MBA Chief Executive Officer, UConn Health Executive Vice President for Health Affairs
Attendees : K. Alleyne, F. Archambault, R. Barry, K. Bragherol, R. Carbray, S. Cloud, J. Droney,
S. Herbst, T. Holt, R. Pino, W. Rawlins (phone), T. Ressel (phone), and K. Woods
10
TO: Members, Board of Directors
FROM: Andrew Agwunobi, MD, MBA
Executive Vice President for Health Affairs
DATE: June 18, 2018
SUBJECT: Conflict of Interest
RECOMMENDATION
That the Conflict of Interest Subcommittee submit the following advice to Chairman Cloud to support
his decision making regarding instituting Conflict of Interest management plans for selected Board of
Directors members:
BACKGROUND
The committee unanimously approved submitting the following advice to Chairman Cloud to support
his decision making regarding instituting Conflict of Interest management plans for selected Board of
Directors members:
Richard Barry – The chair of each BoD subcommittee should be made aware that Mr. Barry is
the Chief Risk Officer for Key Bank which provides various services to public institutions like
UConn. Mr. Barry should be instructed from voicing his opinions or making comments to other
Board members on any matter that could benefit Key Bank. Mr. Barry should also be recused
from voting on any such matters in his capacity as a Board member.
Andy Bessette – The chair of each BoD subcommittee should be made aware that Mr. Bessette
is an officer at the Travelers. Mr. Bessette should be instructed to refrain from voicing his
opinions or making comments to other Board members on any matter that could benefit the
Travelers, such as rate setting for UCHC contracts with the Travelers. Mr. Bessette should also
be recused from voting on any such matters in his capacity as a Board member.
Robert Dakers - The chair of each BoD subcommittee should be made aware that Mr. Dakers
serves as the Executive Financial Officer for the State Office of Policy and Management. Mr.
Dakers should be instructed to refrain from voicing his opinions or making comments to other
Board members on any regulatory matter in which the Department of Policy and Management
11
is transacting with UCHC. Mr. Dakers should also be recused from voting on any such matters in
his capacity as a Board member.
Joel Freedman - The chair of each BoD subcommittee should be made aware that Mr.
Freedman’s wife, Susan, is a partner in the law firm of Shipman and Goodwin. Mr. Freedman
should be instructed to refrain from voicing his opinions or making comments to other Board
members on any matter that could benefit Shipman and Goodwin. Mr. Freedman should also be
recused from voting on any such matters in his capacity as a Board member.
Wayne Rawlins – The chair of each BoD subcommittee should be made aware that Dr. Rawlins is
the medical director at Connecticare and is a member of the Boards of Trustees for the
Connecticut Science Center. Dr. Rawlins should be instructed to refrain from voicing his
opinions or making comments to other Board members on any matter that could benefit
Connecticare or the Connecticut Science Center. Dr. Rawlins should also be recused from voting
on any such matters in his capacity as a Board member.
12
No
.C
on
tra
cto
rP
R,
PO
, B
id o
r
Co
ntr
ac
t N
um
be
rC
on
tra
ct
Typ
e
Pre
vio
us C
on
tra
ct
Am
ou
nt
(if
ap
pli
ca
ble
)A
pp
rova
l A
mo
un
tT
erm
Fu
nd
So
urc
eD
ep
t./In
div
idu
al S
po
nso
r (B
usin
ess
Ow
ne
r)
Ex
pe
nse
(E)
Re
ve
nu
e
(R)
De
sc
rip
tio
nS
ou
rcin
g
1C
T N
atu
ral G
as C
orp
ora
tio
n
Mu
ltip
le P
urc
ha
se
Ord
ers
Mu
ltip
le P
Os
$2
,90
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
17
fo
r
FY
18
sp
en
d)
$2
,90
0,0
00
7/1
/18
- 6
/30
/19
Mu
ltip
le S
ou
rce
sC
liff
Ash
ton
, A
sso
cia
te V
ice
Pre
sid
en
t
Fa
cili
tie
s M
an
ag
em
en
t A
dm
inis
tra
tio
nE
Pu
rch
ase
of
na
tura
l g
as f
or
he
at
for
all
bu
ildin
gs o
n t
he
Fa
rmin
gto
n c
am
pu
s f
or
FY
19
. A
ctu
al
sp
en
d d
urin
g F
Y1
8 (
ye
ar
to d
ate
) is
ap
pro
xim
ate
ly $
1,5
70
,00
0.
No
n-c
om
pe
titive
(Utilit
y)
2E
ve
rso
urc
e (
CL
&P
)M
ultip
le P
urc
ha
se
Ord
ers
Mu
ltip
le P
Os
$1
2,6
00
,00
0
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
17
fo
r
FY
18
sp
en
d)
$1
2,6
00
,00
07
/1/1
8 -
6/3
0/1
9O
pe
ratin
g F
un
ds
Clif
f A
sh
ton
, A
sso
cia
te V
ice
Pre
sid
en
t
Fa
cili
tie
s M
an
ag
em
en
t A
dm
inis
tra
tio
nE
Ele
ctr
icity c
osts
fo
r th
e F
arm
ing
ton
ca
mp
us f
or
FY
19
. A
ctu
al sp
en
d d
urin
g F
Y1
8 (
ye
ar
to
da
te)
is a
pp
roxim
ate
ly $
8,7
00
,00
0.
No
n-c
om
pe
titive
(Utilit
y)
3Jo
hn
so
n &
Jo
hn
so
nM
ultip
le P
urc
ha
se
Ord
ers
Mu
ltip
le P
Os
$1
,90
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
17
fo
r
FY
18
sp
en
d)
$1
,90
0,0
00
7/1
/18
- 6
/30
/19
Op
era
tin
g F
un
ds-
Clin
ica
l
Lin
da
Ma
nze
lli,
Dire
cto
r
Ca
lho
un
Ca
rdio
log
y C
en
ter
E
Pu
rch
ase
of
me
dic
al d
evic
es a
nd
ca
rdio
va
scu
lar
pro
du
cts
fo
r F
Y1
9,
so
me
of
wh
ich
are
acce
sse
d t
hro
ug
h G
PO
ag
ree
me
nts
. A
ctu
al sp
en
d d
urin
g F
Y1
8 (
ye
ar
to d
ate
) is
ap
pro
xim
ate
ly $
81
5,0
00
.
So
le S
ou
rce
4M
ed
tro
nic
US
A,
Inc
Mu
ltip
le P
urc
ha
se
Ord
ers
Mu
ltip
le P
Os
$2
,00
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
17
fo
r
FY
18
sp
en
d)
$2
,00
0,0
00
7/1
/18
- 6
/30
/19
Op
era
tin
g F
un
ds-
Clin
ica
l
Au
gu
stu
s M
azzo
cca
, M
D,
Dire
cto
r,
Ort
ho
pa
ed
ic S
urg
ery
E
Pu
rch
ase
of
sp
ina
l m
ed
ica
l su
pp
lies f
or
FY
19
, so
me
of
wh
ich
are
acce
sse
d t
hro
ug
h G
PO
ag
ree
me
nts
. A
ctu
al sp
en
d d
urin
g
FY
18
(ye
ar
to d
ate
) is
ap
pro
xim
ate
ly $
1,2
00
,00
0.
GP
O/C
on
so
rtiu
m
5O
we
ns &
Min
or
Mu
ltip
le P
urc
ha
se
Ord
ers
Mu
ltip
le P
Os
$1
3,0
00
,00
0
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
17
fo
r
FY
18
sp
en
d)
$1
3,0
00
,00
07
/1/1
8 -
6/3
0/1
9O
pe
ratin
g F
un
ds-
Clin
ica
l
Lo
ri A
co
mb
, D
ire
cto
r
Pro
cu
rem
en
t &
Su
pp
ly C
ha
in O
pe
ratio
ns
EM
ed
ica
l a
nd
su
rgic
al su
pp
lies f
or
FY
19
fro
m o
ur
prim
ary
dis
trib
uto
r fo
r th
is c
om
mo
dity.
Actu
al
sp
en
d d
urin
g F
Y1
8 (
ye
ar
to d
ate
) is
ap
pro
xim
ate
ly $
8,4
00
,00
0.
GP
O/C
on
so
rtiu
m
6J M
orr
isse
y &
Co
mp
an
y In
cU
CH
C2
-35
51
90
72
Am
en
dm
en
t
$4
,30
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
Se
pte
mb
er
20
16
)
$5
,00
0,0
00
(in
clu
de
s a
n a
dd
itio
na
l $
70
0,0
00
)3
/1/1
3 -
11
/30
/18
Mu
ltip
le S
ou
rce
sL
ori A
co
mb
, D
ire
cto
r
Pro
cu
rem
en
t &
Su
pp
ly C
ha
in O
pe
ratio
ns
EO
n C
all
Pro
fessio
na
l T
em
po
rary
Se
rvic
es
Bid
7T
he
Ja
ckso
n L
ab
ora
tory
UC
HC
2-6
95
81
40
8A
me
nd
me
nt
$9
00
,00
0$
5,0
40
,00
0
(in
clu
de
s a
n a
dd
itio
na
l $
4,1
40
,00
0)
3/8
/16
- 2
/2/2
2O
pe
ratin
g F
un
ds-
Re
se
arc
h
Ju
lie S
ch
wa
ge
r, A
ssis
tan
t V
ice
Pre
sid
en
t
Re
se
arc
h F
ina
nce
E
Co
llab
ora
tive
re
se
arc
h a
gre
em
en
t w
he
re U
Co
nn
He
alth
will
pro
vid
e f
un
din
g t
o J
AX
to
su
pp
ort
the
eq
uiv
ale
nt
of
10
fu
ll-tim
e f
acu
lty p
ositio
ns.
Jo
int
facu
lty w
ill b
e e
mp
loye
es o
f U
Co
nn
He
alth
with
de
dic
ate
d r
ese
arc
h s
pa
ce
at
JA
X.
So
le S
ou
rce
8A
rth
rex,
Inc.
UC
HC
FC
1-1
02
67
18
15
Ne
w
$1
,50
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
Se
pte
mb
er
20
12
fo
r 8
/1/1
3 -
7/3
0/1
8)
$1
,50
0,0
00
8/1
/18
- 7
/31
/23
Op
era
tin
g F
un
ds-
Clin
ica
l
Ro
be
rt A
rcie
ro,
M.D
., P
rofe
sso
r/C
linic
al
Ort
ho
pe
dic
Su
rge
ryE
Re
pla
ce
me
nt/
up
gra
de
of
cu
rre
nt
su
rgic
al vid
eo
art
hro
sco
py e
qu
ipm
en
t. C
on
tra
ct
va
lue
inclu
de
s c
ost
of
lea
se
d e
qu
ipm
en
t a
nd
re
pa
ir/r
ep
lace
me
nt
se
rvic
e a
gre
em
en
t.S
ole
So
urc
e
9H
ow
me
dic
a O
ste
on
ics
UC
HC
FC
1-8
54
08
75
3A
me
nd
me
nt
$9
00
,00
0$
1,8
00
,00
0
(in
clu
de
s a
n a
dd
itio
na
l $
90
0,0
00
)4
/1/1
7 -
3/3
1/1
9O
pe
ratin
g F
un
ds-
Clin
ica
l
Ka
ren
Cu
rle
y,
Dire
cto
r
Nu
rsin
g A
dm
inis
tra
tio
nE
Sp
ine
Im
pla
nts
S
ole
So
urc
e
10
Me
dtr
on
ic S
ofa
mo
r D
an
ek
UC
HC
FC
1-8
54
15
23
8A
me
nd
me
nt
$7
00
,00
0$
1,0
50
,00
0
(in
clu
de
s a
n a
dd
itio
na
l $
35
0,0
00
)4
/1/1
7 -
3/3
1/1
9O
pe
ratin
g F
un
ds-
Clin
ica
l
Ka
ren
Cu
rle
y,
Dire
cto
r
Nu
rsin
g A
dm
inis
tra
tio
nE
Sp
ine
Im
pla
nts
S
ole
So
urc
e
11
Nu
va
siv
eU
CH
CF
C1
-85
40
62
09
Am
en
dm
en
t$
95
0,0
00
$1
,90
0,0
00
(in
clu
de
s a
n a
dd
itio
na
l $
95
0,0
00
)4
/1/1
7 -
3/3
1/1
9O
pe
ratin
g F
un
ds-
Clin
ica
l
Ka
ren
Cu
rle
y,
Dire
cto
r
Nu
rsin
g A
dm
inis
tra
tio
nE
Sp
ine
Im
pla
nts
S
ole
So
urc
e
12
Co
nn
ecticu
t C
hild
ren
's M
ed
ica
l
Ce
nte
rU
CH
CF
C-9
98
32
59
6N
ew
$3
1,6
16
,76
6
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
15
fo
r
7/1
/15
- 6
/30
/18
)
$3
5,8
75
,72
97
/1/1
8 -
6/3
0/2
1R
eve
nu
e
Ge
ne
ratin
g
Ma
rk S
ira
co
, D
ire
cto
r
Fin
an
ce
-Gra
du
ate
Me
dic
al E
du
ca
tio
nR
CC
MC
ag
ree
s t
o r
eim
bu
rse
UC
on
n H
ea
lth
fo
r th
e s
ala
rie
s a
nd
frin
ge
be
ne
fits
of
all
UC
on
n
He
alth
re
sid
en
ts a
ssig
ne
d b
y t
he
Sch
oo
l o
f M
ed
icin
e t
o t
he
CC
MC
's s
ite
fo
r ro
tatio
ns.
In
ad
ditio
n,
CC
MC
sh
all
pa
y its
pro
po
rtio
na
l sh
are
of
UC
on
n H
ea
lth
’s a
dm
inis
tra
tive
exp
en
se
s in
su
pp
ort
of
Gra
du
ate
Me
dic
al E
du
ca
tio
n.
N/A
- R
eve
nu
e
13
Ha
rtfo
rd H
osp
ita
lU
CH
CF
C-9
98
32
88
9N
ew
$8
1,4
75
,80
8
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
15
fo
r
7/1
/15
- 6
/30
/18
)
$9
3,4
99
,07
87
/1/1
8 -
6/3
0/2
1R
eve
nu
e
Ge
ne
ratin
g
Ma
rk S
ira
co
, D
ire
cto
r
Fin
an
ce
-Gra
du
ate
Me
dic
al E
du
ca
tio
nR
HH
ag
ree
s t
o r
eim
bu
rse
UC
on
n H
ea
lth
fo
r th
e s
ala
rie
s a
nd
frin
ge
be
ne
fits
of
all
UC
on
n
He
alth
re
sid
en
ts a
ssig
ne
d b
y t
he
Sch
oo
l o
f M
ed
icin
e t
o H
art
ford
Ho
sp
ita
l's s
ite
fo
r ro
tatio
ns.
In a
dd
itio
n,
HH
sh
all
pa
y its
pro
po
rtio
na
l sh
are
of
UC
on
n H
ea
lth
’s a
dm
inis
tra
tive
exp
en
se
s in
su
pp
ort
of
Gra
du
ate
Me
dic
al E
du
ca
tio
n.
N/A
- R
eve
nu
e
14
Sa
int
Fra
ncis
Ho
sp
ita
l a
nd
Me
dic
al C
en
ter
UC
HC
FC
-10
03
35
71
3N
ew
$5
2,7
75
,92
2
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
15
fo
r
7/1
/15
- 6
/30
/18
)
$6
0,6
80
,03
47
/1/1
8 -
6/3
0/2
1R
eve
nu
e
Ge
ne
ratin
g
Ma
rk S
ira
co
, D
ire
cto
r
Fin
an
ce
-Gra
du
ate
Me
dic
al E
du
ca
tio
nR
Sa
int
Fra
ncis
ag
ree
s t
o r
eim
bu
rse
UC
on
n H
ea
lth
fo
r th
e s
ala
rie
s a
nd
frin
ge
be
ne
fits
of
all
UC
on
n H
ea
lth
re
sid
en
ts a
ssig
ne
d b
y t
he
Sch
oo
l o
f M
ed
icin
e t
o S
ain
t F
ran
cis
's s
ite
fo
r
rota
tio
ns.
In a
dd
itio
n,
Sa
int
Fra
ncis
sh
all
pa
y its
pro
po
rtio
na
l sh
are
of
UC
on
n H
ea
lth
’s
ad
min
istr
ative
exp
en
se
s in
su
pp
ort
of
Gra
du
ate
Me
dic
al E
du
ca
tio
n.
N/A
- R
eve
nu
e
15
Th
e H
osp
ita
l o
f C
en
tra
l
Co
nn
ecticu
tU
CH
CF
C-9
98
32
90
1N
ew
$1
9,9
33
,43
3
(ap
pro
ve
d b
y B
oa
rd in
Ju
ne
20
15
fo
r
7/1
/15
- 6
/30
/18
)
$2
0,9
15
,36
97
/1/1
8 -
6/3
0/2
1R
eve
nu
e
Ge
ne
ratin
g
Ma
rk S
ira
co
, D
ire
cto
r
Fin
an
ce
-Gra
du
ate
Me
dic
al E
du
ca
tio
nR
TH
OC
C a
gre
es t
o r
eim
bu
rse
UC
on
n H
ea
lth
fo
r th
e s
ala
rie
s a
nd
frin
ge
be
ne
fits
of
all
UC
on
n
He
alth
re
sid
en
ts a
ssig
ne
d b
y t
he
Sch
oo
l o
f M
ed
icin
e t
o T
HO
CC
's s
ite
fo
r ro
tatio
ns.
In
ad
ditio
n,
TH
OC
C s
ha
ll p
ay its
pro
po
rtio
na
l sh
are
of
UC
on
n H
ea
lth
’s a
dm
inis
tra
tive
exp
en
se
s
in s
up
po
rt o
f G
rad
ua
te M
ed
ica
l E
du
ca
tio
n.
N/A
- R
eve
nu
e
16
He
alth
Wid
e S
olu
tio
ns,
LL
CU
CH
CF
C1
-90
86
41
89
A
me
nd
me
nt
$1
,50
0,0
00
(ap
pro
ve
d b
y B
oa
rd in
De
ce
mb
er
20
17
)
$2
,00
0,0
00
(in
clu
de
s a
n a
dd
itio
na
l $
50
0,0
00
)7
/31
/17
- 1
2/3
1/1
8O
pe
ratin
g F
un
ds-
Clin
ica
l
Je
ffre
y G
eo
gh
eg
an
,
Ch
ief
Fin
an
cia
l O
ffic
er
EC
on
tin
ua
tio
n o
f re
ve
nu
e c
ycle
ma
na
ge
me
nt
co
nsu
ltin
g s
erv
ice
s f
or
bo
th t
he
Ep
ic
imp
lem
en
tatio
n p
roje
ct
an
d in
terim
re
ve
nu
e c
ycle
le
ad
ers
hip
.E
me
rge
ncy
17
Oly
mp
us A
me
rica
, In
c.
UC
HC
FC
1-1
00
31
18
13
&
UC
HC
FC
4-1
00
33
00
68
Ne
w$
97
5,0
00
(fo
r 1
/18
/15
- 1
/17
/18
)$
1,5
00
,00
06
/25
/18
- 6
/24
/21
Op
era
tin
g F
un
ds-
Clin
ica
l
Ka
ren
Cu
rle
y,
Dire
cto
r
Nu
rsin
g A
dm
inis
tra
tio
nE
En
do
sco
py e
qu
ipm
en
t (s
co
pe
s,
ca
me
ra,
mo
nito
rs a
nd
re
late
d a
cce
sso
rie
s)
an
d s
erv
ice
ag
ree
me
nt
for
UC
on
n H
ea
lth
Ga
str
oe
nte
rolo
gy D
ep
art
me
nt.
So
le S
ou
rce
18
GE
He
alth
ca
reM
ultip
le,
inclu
din
g P
R
10
33
95
59
3N
ew
/ M
ultip
le P
Os
N/A
$2
,50
0,0
00
7/1
/18
- 6
/30
/19
Mu
ltip
le S
ou
rce
sM
org
an
Hill
s,
Se
nio
r D
ire
cto
r
Ho
sp
ita
l O
pe
ratio
ns
EP
urc
ha
se
of
fou
r x-r
ay m
ach
ine
s,
fou
r u
ltra
so
un
d m
ach
ine
s a
nd
on
e C
-arm
, p
lus
co
nstr
uctio
n/r
en
ova
tio
n o
f ro
om
s f
or
the
pla
ce
me
nt
of
the
ne
w e
qu
ipm
en
t.
So
le S
ou
rce
19
Ca
rdin
al H
ea
lth
11
0 L
LC
Mu
ltip
le,
inclu
din
g
UC
HC
FC
1-7
24
35
57
6M
ultip
le C
on
tra
cts
/ P
Os
$3
,00
0,0
00
(ap
pro
xim
ate
FY
18
sp
en
d w
ith
bo
th
Ca
rdin
al H
ea
lth
11
0 L
LC
an
d
McK
esso
n C
orp
ora
tio
n f
or
34
0b
rep
len
ish
me
nts
)
$5
,00
0,0
00
7/1
/18
- 6
/30
/19
Op
era
tin
g F
un
ds-
Clin
ica
l
Kim
be
rly M
etc
alf,
Se
nio
r D
ire
cto
r
Ho
sp
ita
l O
pe
ratio
ns
EP
urc
ha
se
of
ph
arm
ace
utica
ls t
o r
ep
len
ish
sto
ck o
f re
tail
ph
arm
acie
s t
ha
t a
re p
art
icip
atin
g in
the
Jo
hn
De
mp
se
y H
osp
ita
l P
ha
rma
cy's
34
0b
pro
gra
m.
So
le S
ou
rce
20
McK
esso
n C
orp
ora
tio
nM
ultip
le,
inclu
din
g
UC
HC
FC
1-5
34
93
44
3M
ultip
le C
on
tra
cts
/ P
Os
$3
,00
0,0
00
(ap
pro
xim
ate
FY
18
sp
en
d w
ith
bo
th
Ca
rdin
al H
ea
lth
11
0 L
LC
an
d
McK
esso
n C
orp
ora
tio
n f
or
34
0b
rep
len
ish
me
nts
)
$5
,00
0,0
00
7/1
/18
- 6
/30
/19
Op
era
tin
g F
un
ds-
Clin
ica
l
Kim
be
rly M
etc
alf,
Se
nio
r D
ire
cto
r
Ho
sp
ita
l O
pe
ratio
ns
EP
urc
ha
se
of
ph
arm
ace
utica
ls t
o r
ep
len
ish
sto
ck o
f re
tail
ph
arm
acie
s t
ha
t a
re p
art
icip
atin
g in
the
Jo
hn
De
mp
se
y H
osp
ita
l P
ha
rma
cy's
34
0b
pro
gra
m.
So
le S
ou
rce
21
Op
tum
36
0,
LL
C a
nd
its
aff
ilia
te,
Op
tum
Insig
ht,
In
c.
UC
HC
FC
-5-2
08
7A
me
nd
me
nt
$2
,00
0,0
00
$
2,3
00
,00
0
(in
clu
de
s a
n a
dd
itio
na
l $
30
0,0
00
)4
/1/1
8 -
6/3
0/1
9O
pe
ratin
g F
un
ds-
Clin
ica
l
Je
ffre
y G
eo
gh
eg
an
,
Ch
ief
Fin
an
cia
l O
ffic
er
E
Clin
ica
l re
ve
nu
e c
ycle
ma
na
ge
me
nt
se
rvic
es in
su
pp
ort
of
UC
on
n H
ea
lth
's c
linic
al e
nte
rprise
.
Th
e a
me
nd
me
nt
co
ve
r a
dd
itio
na
l se
rvic
es r
ela
ted
to
th
e im
ple
me
nta
tio
n o
f H
ea
lth
On
e a
nd
He
alth
In
form
atio
n M
an
ag
em
en
t re
vie
ws.
Bid
Fin
an
ce
Su
bco
mm
itte
e J
un
e 1
8, 2018
CO
NT
RA
CT
S (
OT
HE
R T
HA
N R
EA
L E
ST
AT
E L
EA
SE
S)
AN
D P
UR
CH
AS
E O
RD
ER
S O
F $
1,0
00,0
00 O
R M
OR
EF
OR
UC
ON
N H
EA
LT
H B
OA
RD
OF
DIR
EC
TO
RS
AP
PR
OV
AL
ON
JU
NE
18, 2018
Fin
an
ce
Co
rpo
rati
on
Page 1
of
1
13
No
.L
es
se
eA
nn
ua
l A
mo
un
t
Re
ce
iva
ble
Pri
ce
Pe
r S
q. F
t.T
erm
Ye
arl
y In
cre
as
e
Typ
e o
f L
ea
se
:
Tri
ple
Ne
t o
r
Gro
ss
Le
as
e
If a
ny C
AM
, ta
xe
s,
Ins
ura
nc
e f
or
1s
t ye
ar
Fu
nd
So
urc
eP
rog
ram
Dir
ec
tor
Pu
rpo
se
1T
he
Ja
ckso
n L
ab
ora
tory
$2
20
,25
0/y
ea
r$
25
.32
7/1
/18
- 6
/30
/29
2.5
%G
ross
N/A
Re
ve
nu
e G
en
era
tin
g
Th
om
as T
rutte
r, A
sso
cia
te V
ice
Pre
sid
en
t
Ca
mp
us P
lan
nin
g
UC
on
n H
ea
lth
will
le
ase
8,7
00
sq
ua
re f
ee
t o
f o
ffic
e s
pa
ce
lo
ca
ted
on
the
th
ird
flo
or
of
the
Ad
min
istr
ative
Se
rvic
es B
uild
ing
(A
SB
) to
Th
e
Ja
ckso
n L
ab
ora
tory
,
No
.L
es
so
rA
nn
ua
l A
mo
un
t
Pa
ya
ble
Pri
ce
Pe
r S
q. F
t.T
erm
Ye
arl
y In
cre
as
e
Typ
e o
f L
ea
se
:
Tri
ple
Ne
t o
r
Gro
ss
Le
as
e
If a
ny C
AM
, ta
xe
s,
Ins
ura
nc
e f
or
1s
t ye
ar
Fu
nd
So
urc
eP
rog
ram
Dir
ec
tor
Pu
rpo
se
1E
ag
levill
e P
art
ne
r, L
LC
$2
1,6
00
/ye
ar
$1
.64
7/1
/18
- 6
/30
/19
No
ne
Gro
ss
N/A
Op
era
tin
g F
un
ds-C
linic
al
Do
nn
a M
cK
en
ty, S
en
ior
Dir
ecto
r
De
an
's O
ffic
e M
ed
ica
l
Re
sid
en
tia
l le
ase
of
pro
pe
rty a
t 6
6 In
dia
n S
pri
ng
Ro
ad
, W
oo
dsto
ck, C
T.
Th
e p
rop
ert
y w
ill h
ou
se
up
to
th
ree
3rd
-ye
ar
me
dic
al stu
de
nts
at a
tim
e
wh
ile th
ey a
re c
om
ple
tin
g th
eir
6-w
ee
k c
linic
al ro
tatio
ns in
th
e to
wn
s o
f
Pu
tna
m, T
ho
mp
so
n a
nd
Na
tch
au
g, C
T.
2E
ag
levill
e P
art
ne
r, L
LC
$2
1,6
00
/ye
ar
$1
.95
7/1
/19
- 6
/30
/19
No
ne
Gro
ss
N/A
Op
era
tin
g F
un
ds-C
linic
al
Do
nn
a M
cK
en
ty, S
en
ior
Dir
ecto
r
De
an
's O
ffic
e M
ed
ica
l
Re
sid
en
tia
l le
ase
of
pro
pe
rty a
t 3
3 H
iaw
ath
a H
eig
hts
, W
oo
dsto
ck
Va
lley, C
T. T
he
pro
pe
rty w
ill h
ou
se
up
to
th
ree
3rd
-ye
ar
me
dic
al
stu
de
nts
at a
tim
e w
hile
th
ey a
re c
om
ple
tin
g th
eir
6-w
ee
k c
linic
al
rota
tio
ns in
th
e to
wn
s o
f P
utn
am
, T
ho
mp
so
n a
nd
Na
tch
au
g, C
T.
3B
lackth
orn
Ho
ldin
gs L
LC
$4
68
,41
6/y
ea
r$
13
.00
9/1
/18
- 8
/31
/23
$0
.50
psf
incre
ase
in
ye
ars
2 a
nd
4
Tri
ple
Ne
tT
en
an
t is
re
sp
on
sib
le f
or
CA
M, ta
xe
s &
in
su
ran
ce
Op
era
tin
g F
un
ds-C
linic
al
An
ne
Ho
rba
tuck, V
ice
Pre
sid
en
t
UM
G A
dm
inis
tra
tio
n
5-y
ea
r le
ase
re
ne
wa
l fo
r U
MG
of
36
,03
2 s
qu
are
fe
et lo
ca
ted
at 6
5 K
an
e
Str
ee
t, W
est H
art
ford
.
4C
on
ne
cticu
t C
hild
ren
's M
ed
ica
l
Ce
nte
r $
84
,81
0/y
ea
r$
28
.27
7/1
/18
- 6
/30
/19
n/a
Gro
ss
N/A
Op
era
tin
g F
un
ds-C
linic
al
Jo
hn
Bri
ga
da
, D
ire
cto
r
De
an
's O
ffic
e D
en
tal
Th
e D
en
tal C
linic
s o
f th
e S
ch
oo
l o
f D
en
tal M
ed
icin
e p
rovid
e s
erv
ice
s o
n-
site
at C
on
ne
cticu
t C
hild
ren
’s M
ed
ica
l C
en
ter.
UC
on
n H
ea
lth
pu
rch
ase
s
facili
tie
s, se
rvic
es, a
nd
sta
ff tim
e in
su
pp
ort
of
the
De
nta
l C
linic
's
pe
dia
tric
de
ntistr
y p
ractice
s. T
his
re
qu
est is
fo
r th
e c
ost o
f th
e f
acili
tie
s
on
ly (
3,0
00
sq
ft.).
UN
IVE
RS
ITY
AS
LE
SS
OR
P
RO
PE
RT
Y L
EA
SE
AG
RE
EM
EN
TS
UN
IVE
RS
ITY
AS
LE
SS
EE
Fin
an
ce S
ub
co
mm
itte
e J
un
e 1
8, 2018
RE
AL
ES
TA
TE
/SP
AC
E L
EA
SE
SF
OR
UC
ON
N H
EA
LT
H B
OA
RD
OF
DIR
EC
TO
RS
AN
D U
CO
NN
BO
AR
D O
F T
RU
ST
EE
S A
PP
RO
VA
L
P
RO
PE
RT
Y L
EA
SE
AG
RE
EM
EN
TS
14
TO: Members, UConn Health Board of Directors
FROM: Carolle T. Andrews
Chief Administrative Officer
Thomas P. Trutter, AIA
Associate Vice President, Campus Planning Design & Construction
DATE: June 18, 2018
SUBJECT: Project Budget for the UConn Health Main Accumulation Building (Revised Final:
$4,050,000)
RECOMMENDATION:
That the Board of Directors approve the Revised Final Budget in the amount of $4,050,000 for
the UConn Health (UCH) Main Accumulation Building project
BACKGROUND:
UConn Health’s building for the collection, consolidation, and shipping of hazardous waste
materials from research and clinical activities was demolished in late 2012 as part of the site
preparation for the Jackson Laboratory for Genomic Medicine. Since that time the waste materials
have been handled in temporary areas in the Main Building lab area. The temporary area is
undersized and does not provide sufficient storage areas, resulting in less than optimal operating
conditions including more frequent shipping and thus increased operating expenses. This project
will construct a new 2,500 sf building to establish a new permanent location for the waste
handling and shipping activities.
The Revised Final budget is based upon the estimated cost to complete the project. The proposed
increase of $200,000 is due to complications with the underground water line relocation and
winter weather impacts.
With your approval, the budget will be presented to the Board of Trustees at their June 27, 2018
meeting for their approval.
Attachment
15
MAIN ACCUMULATION BUILDING RENDERING
CONSTRUCTION PROGRESS: 5-17-2018
16
TYPE BUDGET:
PROJECT NAME:
APPROVED APPROVED APPROVED PROPOSED PROPOSED
PLANNING DESIGN FINAL REVISED FINAL REVISED FINAL
BUDGETED EXPENDITURES 12/7/2016 3/29/2017 6/28/2017 9/27/2017 6/27/2018
CONSTRUCTION 2,080,000$ 3,600,000$ 3,600,000$ 3,070,000$ 3,280,000$
DESIGN SERVICES 305,000 305,000 305,000 352,000 406,000
TELECOMMUNICATIONS 25,000 25,000 25,000 25,000 25,000
FURNITURE, FIXTURES AND EQUIPMENT 35,000 35,000 35,000 35,000 35,000
CONSTRUCTION ADMINISTRATION - - - - -
OTHER AE SERVICES (including Project Management) 45,000 45,000 45,000 28,000 15,000
ART - - - - -
RELOCATION 5,000 5,000 5,000 5,000 5,000
ENVIRONMENTAL 10,000 10,000 10,000 - -
INSURANCE AND LEGAL 10,000 10,000 10,000 - -
MISCELLANEOUS 10,000 10,000 10,000 10,000 10,000
SUBTOTAL 2,525,000$ 4,045,000$ 4,045,000$ 3,525,000$ 3,776,000$
PROJECT CONTINGENCY 255,000 355,000 355,000 325,000 274,000
TOTAL BUDGETED EXPENDITURES 2,780,000$ 4,400,000$ 4,400,000$ 3,850,000$ 4,050,000$
SOURCE(S) OF FUNDING
UCONN HEALTH FUNDS 2,780,000$ 4,400,000$ 4,400,000$ 1,850,000$ 2,050,000$
UCONN 2000 FUNDS - - - 2,000,000 2,000,000
TOTAL BUDGETED FUNDING 2,780,000$ 4,400,000$ 4,400,000$ 3,850,000$ 4,050,000$
BOT 6.27.18
CAPITAL PROJECT BUDGET REPORTING FORM
REVISED FINAL
UCONN HEALTH - MAIN ACCUMULATION BUILDING
17-007
17
Fisc
al Y
ear
2018
R
esul
ts o
f Ope
ratio
ns
As o
f Apr
il 30
, 201
8
18
Con
solid
ated
Fin
anci
al R
epor
ts
Fina
ncia
l Upd
ate
& H
ighl
ight
s TO
:Mem
bers, B
oard of D
irectors
FROM:
Jeffrey P. G
eoghegan, Chief Financial Officer
DAT
E:
May 16, 201
8 SU
BJEC
T:
Una
udite
d FY
201
8 Fina
ncial R
esults fo
r the
ten mon
ths en
ded Ap
ril 30, 201
8.
Intr
oduc
tion:
Th
e fo
llow
ing
prov
ides
hig
hlig
hts f
or th
e ye
ar to
dat
e re
sults
thro
ugh
Apr
il 30
, 201
8:
The
YTD
loss
for t
he p
erio
d en
ding
Apr
il 30
, 201
8, w
as $
3.1
mill
ion
as c
ompa
red
to a
bud
gete
d lo
ss o
f $11
.3 m
illio
n fo
r a fa
vora
ble
varia
nce
of $
8.2
mill
ion.
K
ey d
river
s of b
udge
t var
ianc
es a
re o
utlin
ed b
elow
.
Edu
catio
n, R
esea
rch
& In
stitu
tiona
l Sup
port
Th
e re
sult
of o
pera
tions
for E
duca
tion,
Res
earc
h &
Inst
itutio
nal S
uppo
rt is
favo
rabl
e to
the
budg
et b
y $3
.1 m
illio
n. T
he v
aria
nce
is a
ttrib
uted
to th
e fa
vora
ble
varia
nces
in th
e Sc
hool
of M
edic
ine,
Sch
ool o
f Den
tal M
edic
ine,
Res
earc
h an
d In
stitu
tiona
l Sup
port.
Yea
r to
date
sign
ifica
nt h
ighl
ight
s inc
lude
:
Sc
hool
of M
e dic
ine
resu
lts o
f ope
ratio
ns w
ere
favo
rabl
e to
bud
get b
y $1
.1 m
illio
n. T
here
wer
e fa
vora
ble
varia
nces
in P
erso
nnel
Ser
vice
s, Fr
inge
Ben
efits
and
Out
side
and
Oth
er P
urch
ase
Serv
ices
.
Scho
ol o
f Den
tal M
edic
ine
resu
lts o
f ope
ratio
ns w
ere
favo
rabl
e to
bud
get b
y $2
.0 m
illio
n. T
here
wer
e fa
vora
ble
varia
nces
in P
erso
nnel
Ser
vice
s and
Frin
ge B
enef
its.
R
esea
rch
resu
lts o
f ope
ratio
ns w
ere
favo
rabl
e to
bud
get $
1.1
mill
ion.
Unf
avor
able
var
ianc
es in
Fed
eral
Gra
nt R
even
ue w
ere
offs
et b
y fa
vora
ble
varia
nces
in F
eder
al e
xpen
ditu
res.
Aux
iliar
y an
d In
vest
men
t rev
enue
s wer
e bo
th fa
vora
ble
to b
udge
t.
Clin
ical
Th
e cl
inic
al o
pera
tions
had
a c
o mbi
ned
loss
of $
31.7
mill
ion
com
pare
d to
a b
udge
t los
s of $
36.8
mill
ion.
Sum
mar
y an
alys
is o
f rev
enue
s and
exp
ense
s is p
rese
nted
in
the
follo
win
g pa
ges.
19
Key
Fin
anci
al R
esul
tsFo
r th
e pe
riod
end
ing
Apr
il 30
, 201
8
Y
ear
- to
- Dat
eC
ateg
ory
Act
ual
Bud
get
Var
ianc
ePe
rcen
tPr
ior
Yea
rV
aria
nce
Perc
ent
Tota
l UC
HC
Exc
ess/
(Def
icie
ncy)
($3,
053)
($11
,316
)$8
,263
73.0
%($
18,1
44)
$15,
091
83.2
%
Educ
atio
n, R
esea
rch
& In
stitu
tiona
l Sup
port-
Exce
ss/(D
efic
ienc
y)($
150,
004)
($15
3,11
9)$3
,115
2.0%
($14
9,42
8)($
576)
-0.4
%
Tota
l Clin
ical
(JD
H/U
MG
)($
31,6
90)
($36
,838
)$5
,148
14.0
%($
52,8
53)
$21,
163
40.0
%
CM
HC
- Ex
cess
/(Def
icie
ncy)
$0$0
$0
$0$0
Stat
e A
ppro
pria
tion-
Blo
ck G
rant
$90,
620
$90,
620
$00.
0%$1
01,2
52($
10,6
32)
-10.
5%Fr
inge
Ben
efits
& O
ther
Adj
ustm
ents
$88,
021
$88,
021
$00.
0%$8
2,88
5$5
,136
6.2%
Tota
l Sta
te S
uppo
rt$1
78,6
41$1
78,6
41$0
0.0%
$184
,137
($5,
496)
-3.0
%
To
tal R
even
ues (
000'
s)$7
64,0
92$7
54,3
19$9
,773
1.3%
$726
,460
$37,
632
5.2%
Tota
l Exp
ense
s (00
0's)
$945
,786
$944
,276
$1,5
100.
2%$9
28,7
41$1
7,04
51.
8%
Res
earc
h R
even
ue R
ecog
nitio
n in
Fin
anci
al S
tate
men
ts$6
5,38
9$7
0,37
3($
4,98
4)-7
.1%
$71,
895
($6,
506)
-9.0
%
1,05
4 2,02
2
1,11
5
(1,076
)
5,14
8
‐‐
8,26
3
Scho
ol of M
edicine
Scho
ol of D
ental M
edicine
Research
Institu
tiona
l Sup
port
Clinical
Correctio
nal M
anaged
Health
Care
State Supp
ort
Total U
CHC
Budget Variance by
Program
‐Year To
Date
(in 000's)
20
Con
solid
ated
Sta
tem
ent o
f Rev
enue
s and
Exp
ense
s (w
ithou
t Elim
inat
ions
)
Perc
ent
Perc
ent
Act
ual
Bud
get
Var
ianc
eV
aria
nce
Act
ual
Var
ianc
eV
aria
nce
Rev
enue
s:Tu
ition
20,1
22,4
10$
20
,357
,438
$
(235
,028
)$
-1
.2%
19,2
87,4
99$
83
4,91
1$
4.
3%R
esea
rch
Gra
nts a
nd C
ontra
cts
65,3
88,6
8270
,373
,316
(4,9
84,6
33)
-7.1
%71
,894
,779
(6,5
06,0
97)
-9.0
%A
uxili
ary
Ente
rpris
es15
,267
,114
14,2
58,5
051,
008,
608
7.1%
14,2
62,4
201,
004,
694
7.0%
Inte
rnal
Inco
me
81,1
14,2
3881
,539
,085
(424
,847
)-0
.5%
89,8
04,6
39(8
,690
,401
)-9
.7%
Inte
rns a
nd R
esid
ents
55,7
52,0
2256
,189
,424
(437
,402
)-0
.8%
52,0
29,2
683,
722,
754
7.2%
Net
Pat
ient
Car
e41
0,80
0,17
039
9,09
7,34
311
,702
,827
2.9%
375,
414,
769
35,3
85,4
029.
4%C
orre
ctio
nal M
anag
ed H
ealth
Car
e68
,548
,539
67,2
75,9
371,
272,
601
1.9%
69,6
92,9
41(1
,144
,402
)-1
.6%
Gift
s & E
ndow
men
t Inc
ome
4,29
6,71
65,
121,
942
(825
,226
)-1
6.1%
4,62
3,28
4(3
26,5
68)
-7.1
%In
vest
men
t Inc
ome
479,
811
130,
300
349,
511
268.
2%10
0,53
337
9,27
837
7.3%
Oth
er In
com
e42
,322
,718
39,9
75,6
292,
347,
089
5.9%
29,3
49,7
3712
,972
,980
44.2
%
Tot
al R
even
ues
764,
092,
418
$
754,
318,
919
$
9,
773,
499
$
1.3%
726,
459,
868
$
37
,632
,550
$
5.
2%
Exp
ense
s:
Pers
onne
l Ser
vice
s32
2,34
6,23
6$
32
2,37
4,62
8$
(28,
392)
$
0.
0%32
0,19
1,62
9$
2,15
4,60
7$
0.7%
Frin
ge B
enef
its17
7,82
8,07
218
0,01
2,45
2(2
,184
,380
)-1
.2%
171,
451,
048
6,37
7,02
43.
7%M
edic
al C
ontra
ctua
l Sup
port
13,7
79,6
2713
,943
,370
(163
,743
)-1
.2%
12,9
29,9
4384
9,68
46.
6%In
tern
al C
ontra
ctua
l Sup
port
80,6
17,3
8481
,131
,305
(513
,921
)-0
.6%
89,0
87,2
59(8
,469
,875
)-9
.5%
Med
ical
/Den
tal H
ouse
Sta
ff44
,409
,936
44,9
36,5
88(5
26,6
52)
-1.2
%43
,845
,799
564,
137
1.3%
Cor
rect
iona
l Man
aged
Hea
lthca
re68
,548
,539
67,2
75,9
37
1,
272,
601
1.9%
69,6
92,9
41
(1
,144
,402
)-1
.6%
Out
side
Age
ncy
Per D
iem
s3,
154,
672
2,99
8,21
815
6,45
45.
2%2,
546,
960
607,
712
23.9
%D
rugs
32,5
81,8
8931
,909
,892
671,
998
2.1%
27,1
98,0
015,
383,
889
19.8
%M
edic
al S
uppl
ies
44,3
21,3
1842
,948
,353
1,37
2,96
43.
2%41
,587
,881
2,73
3,43
66.
6%U
tiliti
es10
,695
,950
11,2
56,1
17(5
60,1
68)
-5.0
%10
,950
,711
(254
,762
)-2
.3%
Out
side
& O
ther
Pur
chas
ed S
ervi
ces
68,2
13,1
0368
,499
,132
(286
,028
)-0
.4%
61,1
78,8
337,
034,
271
11.5
%In
sura
nce
4,18
1,80
22,
946,
939
1,23
4,86
341
.9%
3,76
4,90
041
6,90
311
.1%
Rep
airs
& M
aint
enan
ce12
,369
,064
12,1
00,1
5826
8,90
62.
2%11
,021
,646
1,34
7,41
812
.2%
Deb
t Ser
vice
8,29
9,08
88,
305,
571
(6,4
83)
-0.1
%8,
541,
748
(242
,661
)-2
.8%
Oth
er E
xpen
ses
24,3
23,0
7523
,785
,409
537,
667
2.3%
22,7
45,8
181,
577,
257
6.9%
Dep
reci
atio
n30
,116
,018
29,8
51,9
4326
4,07
60.
9%32
,005
,783
(1,8
89,7
65)
-5.9
%
Tot
al E
xpen
ses
945,
785,
774
$
944,
276,
011
$
1,
509,
763
$
0.2%
928,
740,
901
$
17
,044
,873
$
1.
8%
Exc
ess/
(Def
icie
ncy)
of R
even
ues
ove
r E
xpen
ses P
rior
to S
tate
App
ropr
iatio
ns(1
81,6
93,3
56)
$
(1
89,9
57,0
92)
$
8,
263,
736
$
4.4%
(202
,281
,033
)$
20,5
87,6
77$
10.2
%
Stat
e A
ppro
pria
tion-
Blo
ck G
rant
90,6
19,9
81$
90
,619
,981
$
(0)
$
0.0%
101,
252,
152
$
(1
0,63
2,17
1)$
-1
0.5%
Wor
kers
Com
pens
atio
n N
et o
f App
ropr
iatio
ns0
(721
,350
)(1
,049
,521
)St
ate
Supp
orte
d Fr
inge
Ben
efits
and
Oth
er
Adj
ustm
ents
88,0
20,7
6388
,020
,763
(0)
0.0%
83,6
06,2
624,
414,
501
5.3%
Exc
ess/
(Def
icie
ncy)
(3
,052
,612
)$
(11,
316,
347)
$
8,26
3,73
5$
73
.0%
(18,
143,
969)
$
15,0
91,3
57$
83.2
%
YT
D A
pril
2017
Con
solid
ated
UC
onn
Hea
lth
YT
D A
pril
2018
Con
solid
ated
UC
onn
Hea
lth
21
Perc
ent
Act
ual '
18B
udge
t '18
Var
ianc
eV
aria
nce
Act
ual '
17
Rev
enue
s:
Net
Pat
ient
Car
e32
7,37
1,55
7$
31
7,69
5,12
8$
9,
676,
429
$
3.
0%30
1,10
3,68
8$
O
ther
Inco
me
34,1
27,4
01
31
,932
,036
2,19
5,36
5
6.9%
23,9
51,3
93
Tot
al R
even
ues
361,
498,
958
$
349,
627,
164
$
11,8
71,7
94$
3.
4%32
5,05
5,08
1$
Exp
ense
s:
Pers
onne
l Ser
vice
s11
4,57
7,18
7$
11
3,08
8,23
9$
1,
488,
948
$
1.
3%99
,045
,664
$
Frin
ge B
enef
its72
,324
,788
71,9
92,7
24
33
2,06
4
0.
5%58
,725
,224
Med
ical
Con
tract
ual S
uppo
rt20
5,33
2
19
8,30
2
7,
030
3.
5%16
7,20
4
In
tern
al C
ontra
ctua
l Sup
port
41,5
62,1
05
41
,364
,565
197,
540
0.5%
61,4
11,5
68
M
edic
al/D
enta
l Hou
se S
taff
1,86
8,64
5
2,30
8,33
3
(439
,688
)
-19.
0%2,
596,
170
O
utsi
de A
genc
y Pe
r Die
ms
2,77
5,79
8
2,63
8,61
2
137,
186
5.2%
2,26
6,66
0
Dru
gs28
,889
,012
28,4
05,2
33
48
3,77
9
1.
7%23
,750
,788
Med
ical
Sup
plie
s34
,807
,275
32,8
39,3
24
1,
967,
951
6.
0%31
,607
,778
Util
ities
2,78
3,19
8
2,79
3,89
9
(10,
701)
-0.4
%2,
886,
566
O
utsi
de &
Oth
er P
urch
ased
Ser
vice
s26
,224
,623
24,6
85,4
15
1,
539,
208
6.
2%24
,951
,497
Insu
ranc
e2,
602,
227
2,
117,
165
48
5,06
2
22
.9%
2,83
3,19
0
Rep
airs
& M
aint
enan
ce6,
484,
970
6,
179,
673
30
5,29
7
4.
9%5,
675,
173
O
ther
Exp
ense
s1,
813,
588
1,
586,
433
22
7,15
5
14
.3%
1,57
4,37
1
Inte
rest
Exp
ense
31,9
73
38,4
57
(6,4
84)
-1
6.9%
22,3
11
Dep
reci
atio
n6,
526,
332
6,
145,
609
38
0,72
3
6.
2%7,
384,
728
Tot
al E
xpen
ses
343,
477,
053
$
336,
381,
983
$
7,09
5,07
0$
2.1%
324,
898,
892
$
Exce
ss/(D
efic
ienc
y) o
f Rev
enue
s ov
er E
xpen
ses P
rior t
o St
ate
App
ropr
iatio
ns18
,021
,905
$
13,2
45,1
81$
4,
776,
724
$
36
.1%
156,
189
$
Yea
r-to
-Dat
e A
pril
John
Dem
psey
Hos
pita
lC
onso
lidat
ed S
tate
men
t of R
even
ues a
nd E
xpen
ses
Apr
il 30
, 201
8
22
John
Dem
psey
Hospital
Res
ults
of O
pera
tions
Th
e Y
TD g
ain
for t
he p
erio
d en
ding
Apr
il 30
, 201
8, w
as $
18.0
mill
ion
com
pare
d to
a b
udge
ted
gain
of $
13.2
mill
ion,
for a
favo
rabl
e va
rianc
e of
$4.
8 m
illio
n.
Tota
l rev
enue
s wer
e fa
vora
ble
by $
11.9
mill
ion.
R
even
ue v
aria
nces
wer
e dr
iven
by
favo
rabl
e ne
t pat
ient
reve
nue
of $
9.7
mill
ion,
alo
ng w
ith o
ther
ope
ratin
g in
com
e. T
otal
exp
ense
s wer
e un
favo
rabl
e $7
.1 m
illio
n an
d w
ere
driv
en b
y in
crea
sed
patie
nt c
are
expe
nses
in D
rugs
and
Med
ical
Sup
plie
s as w
ell a
s Out
side
and
ot
her p
urch
ase
serv
ices
. Th
e ga
in fo
r the
sam
e pe
riod
in th
e pr
ior y
ear w
as $
156,
000
for a
favo
rabl
e va
rianc
e of
$17
.9 m
illio
n.
Yea
r - t
o - D
ate
Cat
egor
yA
ctua
lB
udge
tV
aria
nce
Perc
ent
Prio
r Y
ear
Var
ianc
ePe
rcen
tJo
hn D
emps
ey H
ospi
tal (
in th
ousa
nds)
JDH
Exc
ess/
(Def
icie
ncy)
of R
even
ues o
ver E
xpen
ses
$18,
022
$13,
245
$4,7
7736
.1%
$156
$17,
866
1145
2.6%
JDH
Ope
ratin
g M
argi
n5.
0%3.
8%1.
2%31
.6%
0.0%
4.9%
1027
5.3%
Inpa
tient
Dis
char
ges
8,35
87,
947
411
5.2%
7,66
469
49.
1%O
utpa
tient
Equ
ival
ents
14,9
0414
,946
(42)
-0.3
%14
,191
713
5.0%
Ave
rage
Len
gth
of S
tay
4.2
4.2
0.0
0.0%
4.2
0.0
0.0%
Net
Rev
enue
per
Adj
uste
d D
isch
arge
$14,
073
$13,
877
$196
1.4%
$13,
777
$296
2.1%
Cos
t per
Adj
uste
d D
isch
arge
$14,
766
$14,
694
$72
0.5%
$14,
866
($10
0)-0
.7%
Day
s Rev
enue
in A
ccou
nts R
ecei
vabl
e46
415
12.2
%45
12.
2%C
ase
Mix
Inde
x 1.
5670
1.53
840.
0286
1.9%
1.52
96
0.03
742.
4%
Net
Rev
enue
: Yea
r to
Dat
e To
tal n
et p
atie
nt re
venu
e w
as fa
vora
ble
to th
e bu
dget
pla
n by
$9.
7 m
illio
n (3
.0%
) and
favo
rabl
e to
prio
r yea
r by
$26.
3 m
illio
n (8
.7%
). In
patie
nt d
isch
arge
s of
8,35
8 ar
e ab
ove
budg
et b
y 41
1 (5
.2%
) and
repr
esen
t an
9.1%
incr
ease
from
prio
r yea
r. O
utpa
tient
vol
ume,
repr
esen
ted
by O
utpa
tient
Equ
ival
ents
of 1
4,90
4, w
as
unfa
vora
ble
to b
udge
t by
42 (.
3%) a
nd a
bove
prio
r yea
r by
713
(5.0
%).
The
key
driv
ers f
or n
et re
venu
e ar
e:
Com
pare
d to
Bud
get J
DH
had
the
follo
win
g Pr
ice/
Vol
ume
varia
nces
on
Adj
uste
d D
isch
arge
s
o V
olum
e va
rianc
e: A
djus
ted
disc
harg
es w
ere
favo
rabl
e to
bud
get b
y 36
9 a
varia
nce
valu
ed a
t $5.
1 m
illio
n.
o P
rice
varia
nce:
Net
Rev
enue
per
adj
uste
d di
scha
rge
was
$19
6 ab
ove
budg
et, a
favo
rabl
e va
rianc
e va
lued
at $
4.6
mill
ion.
Cas
e m
ix in
dex
is 1
.567
0 co
mpa
red
to a
bud
get o
f 1.5
384
and
a pr
ior y
ear a
ctua
l of 1
.529
6.
23
E
xpen
ses
Ex
pens
es w
ere
unfa
vora
ble
to th
e bu
dget
by
$7.1
mill
ion.
Si
gnifi
cant
unf
avor
able
var
ianc
es in
clud
ed O
utsi
de a
nd O
ther
Pur
chas
e Se
rvic
es a
nd In
sura
nce
Expe
nses
. D
rug
expe
nses
, whi
ch e
xcee
d bu
dget
, are
off
set b
y hi
gher
pha
rmac
y re
venu
e. M
edic
al S
uppl
ies,
whi
ch w
as a
lso
over
bud
get,
is th
e re
sult
of
high
er su
rgic
al v
olum
e.
Tot
al c
ost p
er a
djus
ted
disc
harg
e w
as $
14,7
66 c
ompa
red
to a
bud
get o
f $14
,694
for a
n un
favo
rabl
e va
rianc
e of
$72
(.5%
). T
otal
cos
t per
adj
uste
d di
scha
rge
was
unf
avor
able
to p
rior y
ear b
y $1
00 (.
7%).
24
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Prio
r Yea
r1,
236
1,42
91,
496
1,37
61,
286
1,40
31,
481
1,40
31,
525
1,55
51,
545
1,70
9Bu
dget
1,47
71,
507
1,47
81,
593
1,37
61,
605
1,47
31,
398
1,51
61,
523
1,42
51,
577
FY 2
018
1,37
21,
682
1,49
81,
552
1,61
91,
417
1,49
41,
367
1,36
11,
542
1,0
00
1,1
00
1,2
00
1,3
00
1,4
00
1,5
00
1,6
00
1,7
00
1,8
00
OP Equivilants
JDH Ou
tpatient Equ
ivilants
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Prio
r Yea
r38
042
742
141
845
043
346
336
551
047
749
145
8Bu
dget
412
440
443
440
463
446
476
376
510
491
480
455
Act
ual
371
548
449
550
544
478
514
506
460
486
325
375
425
475
525
575
Cases
Outpatie
nt Surgery Cen
ter C
ases
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Prio
r Yea
r74
979
273
274
775
079
382
472
078
077
778
679
0B
udge
t82
081
176
779
077
581
683
375
279
678
7FY
201
879
487
282
978
984
781
285
579
587
489
1
600
650
700
750
800
850
900
950
Discharges
JDH Discharges by
Mon
th
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Prio
r Yea
r10
6.110
4.610
2.310
4.010
6.810
5.911
6.610
5.910
2.010
1.610
5.099
.3Bu
dget
108.9
108.4
108.3
108.3
109.5
108.4
111.1
107.8
108.7
108.6
FY 20
1810
8.310
9.010
9.510
8.811
1.610
9.512
2.212
0.513
1.111
6.6
90.0
95.0
100.0
105.0
110.0
115.0
120.0
125.0
130.0
135.0
Census
JDH Av
erage D
aily C
ensus B
y Mon
th
25
Yea
r-to
-Dat
e A
pril
Perc
ent
Act
ual '
18B
udge
t '18
Var
ianc
eV
aria
nce
Act
ual '
17
Rev
enue
s:
Net
Pat
ient
Car
e74
,253
,295
$
72
,564
,198
$
1,
689,
097
$
2.
3%66
,310
,630
$
Oth
er In
com
e18
,193
,115
18
,497
,588
(3
04,4
73)
-1
.6%
17,5
74,3
49
Tot
al R
even
ues
92,4
46,4
10$
91,0
61,7
86$
1,38
4,62
4$
1.5%
83,8
84,9
79$
Exp
ense
s:
Pers
onne
l Ser
vice
s71
,303
,311
$
70
,685
,783
$
61
7,52
8$
0.
9%69
,634
,369
$
Frin
ge B
enef
its34
,518
,722
34
,400
,207
11
8,51
5
0.
3%31
,996
,451
Med
ical
Con
tract
ual S
uppo
rt5,
731,
724
5,84
2,28
7
(110
,563
)
-1.9
%5,
443,
019
In
tern
al C
ontra
ctua
l Sup
port
11,9
98,9
62
12,0
90,8
04
(91,
842)
-0.8
%12
,015
,096
Out
side
Age
ncy
Per D
iem
s35
0,66
9
308,
469
42,2
00
13.7
%22
4,29
6
D
rugs
3,63
3,57
7
3,
461,
498
17
2,07
9
5.
0%3,
414,
403
M
edic
al S
uppl
ies
1,49
6,59
3
1,
391,
560
10
5,03
3
7.
5%1,
303,
486
U
tiliti
es20
3,98
9
206,
649
(2,6
60)
-1
.3%
174,
029
Out
side
& O
ther
Pur
chas
ed S
ervi
ces
6,91
1,81
4
6,
694,
024
21
7,79
0
3.
3%6,
552,
230
In
sura
nce
195,
666
19
7,23
1
(1
,565
)
-0.8
%24
3,72
7
R
epai
rs &
Mai
nten
ance
753,
379
77
5,18
4
(2
1,80
5)
-2
.8%
617,
054
Oth
er E
xpen
ses
373,
763
40
2,94
5
(2
9,18
2)
-7
.2%
420,
671
Dep
reci
atio
n4,
686,
682
4,68
8,35
8
(1,6
76)
0.
0%4,
855,
206
Tot
al E
xpen
ses
142,
158,
851
$
141,
144,
999
$
1,01
3,85
2$
0.7%
136,
894,
037
$
Exce
ss/(D
efic
ienc
y) o
f Rev
enue
s ov
er E
xpen
ses P
rior t
o St
ate
App
ropr
iatio
ns(4
9,71
2,44
1)$
(5
0,08
3,21
3)$
37
0,77
2$
0.
7%(5
3,00
9,05
8)$
UC
onn
Med
ical
Gro
upC
onso
lidat
ed S
tate
men
t of R
even
ues a
nd E
xpen
ses
Apr
il 30
, 201
8
26
UCo
nn M
edical Group
R
esul
ts o
f Ope
ratio
ns
The
YTD
def
icit
for t
he p
erio
d en
ding
Apr
il 30
, 201
8, is
$49
.7 m
illio
n co
mpa
red
to a
bud
gete
d de
ficit
of $
50.1
mill
ion,
for a
favo
rabl
e va
rianc
e of
$37
1,00
0. T
he
defic
it in
the
prio
r yea
r was
$53
.0 m
illio
n fo
r a fa
vora
ble
varia
nce
of $
3.3
mill
ion.
Oth
er si
gnifi
cant
hig
hlig
hts i
nclu
de:
Y
ear
- to
- Dat
eC
ateg
ory
Act
ual
Bud
get
Var
ianc
ePe
rcen
tPr
ior
Yea
rV
aria
nce
Perc
ent
Uni
vers
ity M
edic
al G
roup
(in
thou
sand
s)(D
efic
ienc
y)/E
xces
s of R
even
ues o
ver E
xpen
ses
($49
,712
)($
50,0
83)
$371
0.7%
($53
,009
)$3
,297
6.2%
Ope
ratin
g M
argi
n-5
3.8%
-55.
0%1.
2%2.
2%-6
3.2%
9.42
%14
.9%
RV
U's
948,
672
940,
061
8,61
10.
9%86
1,24
287
,430
10.2
%N
et R
even
ue P
er R
VU
$78.
27$7
7.19
$1.0
81.
4%$7
6.99
$1.2
81.
7%C
ost p
er R
VU
(w.o
. Ane
sthe
sia)
$138
.96
$139
.39
($0.
43)
-0.3
%$1
47.6
0($
8.64
)-5
.9%
Ave
rage
Pro
vide
r FTE
190
188
10.
8%19
0(1
)
-0.3
%A
vera
ge M
onth
ly R
VU
Per
Pro
vide
r50
050
01
0.1%
453
48
10.5
%D
ays R
even
ue in
Acc
ount
s Rec
eiva
ble
4442
24.
8%43
1
2.3%
Net
Rev
enue
: Yea
r to
Dat
e N
et p
atie
nt re
venu
e is
favo
rabl
e to
the
budg
et p
lan
by $
1.7
mill
ion
and
is fa
vora
ble
to p
rior
year
by
$7.9
mill
ion
(12.
0%).
The
key
driv
ers f
or n
et re
venu
e ar
e:
R
VU
’s a
re a
head
of b
udge
t 8,6
11 u
nits
(.9%
) – a
favo
rabl
e vo
lum
e va
rianc
e of
$6
65,0
00.
C
ompa
red
to B
udge
t –Th
e ne
t rev
enue
per
uni
t was
$1.
08 fa
vora
ble
to b
udge
t – a
fa
vora
ble
pric
e va
rianc
e of
$1.
0 m
illio
n.
Exp
ense
s: Y
ear-
to-d
ate
To
tal e
xpen
ses a
re u
nfav
orab
le to
the
budg
et b
y $1
.0 m
illio
n or
.7%
. N
otab
le
favo
rabl
e va
rianc
es w
ere
in P
erso
nnel
Ser
vice
s and
Out
side
and
oth
er p
urch
ase
serv
ices
.
‐0.75%
‐1.36%
2.59%
‐0.35%‐0.16%
‐0.09%
‐2.00%
‐1.50%
‐1.00%
‐0.50%
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%M
EDICAID
MED
ICAR
E
MED
ICAR
E MC
HMO
WORKER
'S COMP
SELFPA
Y
UMG Payer Shifts: 201
8 vs. 201
7
27
July
Aug
Sept
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
June
Prio
r Yea
r RV
U's
79,2
9989
,168
85,6
3785
,847
89,8
8785
,753
90,0
3379
,668
91,7
9884
,152
98,0
2695
,263
FY 2
018
budg
eted
RV
U's
90,9
4086
,795
90,1
8198
,185
97,1
0891
,555
95,4
6887
,429
101,
599
100,
801
83,2
9497
,879
FY 2
018
RV
U's
83,5
2895
,085
86,5
3197
,664
96,6
2591
,280
100,
012
96,5
7997
,892
103,
476
FY 2
018
Tot
al M
onth
ly R
even
ue$8
,300
,395
$8,7
77,8
60$8
,870
,600
$9,5
61,8
61$9
,288
,733
$8,7
13,6
47$9
,291
,485
$8,8
88,4
30$9
,895
,081
$10,
858,
319
Prio
r Yea
r Tot
al M
onth
ly R
even
ue$7
,611
,808
$8,6
16,2
30$8
,217
,392
$8,4
23,6
27$8
,501
,024
$8,4
27,5
07$8
,972
,253
$7,7
34,0
13$8
,928
,076
$8,4
53,0
49$9
,260
,295
$9,6
53,1
66
$-
$2,0
00
,00
0
$4,0
00
,00
0
$6,0
00
,00
0
$8,0
00
,00
0
$10
,00
0,0
00
$12
,00
0,0
00
45,0
00
55,0
00
65,0
00
75,0
00
85,0
00
95,0
00
105
,00
0
115
,00
0
Revenue
RVU's
Un
ive
rsit
y M
ed
ica
l G
rou
pC
om
pa
ris
on
of
Ac
tua
l, B
ud
ge
ted
, an
d P
rio
r Y
ea
r R
VU
's A
ga
ins
t M
on
thly
To
tal R
ev
en
ue
s
28
FROM: Jeffrey P. Geoghegan
Chief Financial Officer
DATE: June 18, 2018
RE: Proposed Spending Plan for Fiscal Year 2019 for UConn Health
RECOMMENDATION:
The UCH Board of Directors endorse and recommend to the University Board of Trustees
approval of the spending plan for Fiscal Year 2018 of $1,047.6 million for UConn Health.
BACKGROUND:
The Fiscal Year 2019 Spending Plan includes $1,047.6 million of revenue, including state
funding of $238.8 million, to cover $1,047.6 million in expenses.
29
TO: UCONN Health Board of Directors
FROM: Anne Horbatuck, RN, BSN, MBA
Vice President, Ambulatory Operations
Denis Lafreniere, MD, FACS
Medical Director, UConn Medical Group, Professor and Chief, Division of Otolaryngology,
Head and Neck Surgery, Associate Dean of Clinical Affairs
DATE: June 18, 2018
SUBJECT: UConn Medical Group (UMG) Operations Report
PROGRESS ON AMBULATORY ORGANIZATIONAL GOALS and INITIATIVES
Brief highlights for the third quarter of FY18 include:
Service
Substantial work to prepare for the HealthOne go-live continued in Q3, efforts this quarter focused on
Workflow planning; Provider preferences; Provider scheduling and productivity standards; Scheduling
set-up; along with coordination and the completion of Epic certified trainer and user trainings
In addition, 199 Medical Assistants were certified or registered in preparation for HealthOne
Quality
YTD UMG collected $442,000 in MU incentive payments, $136,000 received in Q3 for providers
meeting MU.
Population Health efforts have continued with the expansion of the Chronic Care Management Program.
Finance
As of April, encounters are 5% ahead of prior year actual, with RVU's are 10% ahead of prior year actual.
YTD Encounters are 1.54% ahead of budget with RVU's are slightly ahead budget by just under 1%
30
In Q3, UMG received $60,000 from United Medicare Advantage for work done to close gaps in care for
attributed lives under this contract.
Providers meeting or exceeding the 55th percentile: As of the end of the third quarter, 161 providers
(40.0%) are meeting or exceeding the 55th percentile. This quarter, UMG has experienced a slight
decrease compared to the baseline, where in March 2017, 130 of 315 providers had met the 55th
percentile, which equated to 41.4% of all providers meeting or exceeding the target.
Distribution of providers based on percentage of the 55th percentile target
As of March (YTD) Less than
59.9%
60 to
69.9%
70 to
79.9%
80 to
89.9%
90 to
99.9%
>99.9% Grand
Total
Count of Provider Name 79 28 39 43 52 161 402
% of Providers 19.7% 7.0% 9.7% 10.7% 12.9% 40.0% 100%
Provider Productivity Summary (compared to Budget wRVUs): As of the end of the third quarter, 170
providers (42.5%) are meeting or exceeding budgeted wRVUs.
Distribution of providers based on percentage of the budget (wRVUs)
As of March (YTD) Less than
59.9%
60 to
69.9%
70 to
79.9%
80 to
89.9%
90 to
99.9%
>99.9% Grand
Total
Count of Provider Name 51 23 31 59 66 170 400
% of Providers 12.8% 5.8% 7.8% 14.8% 16.5% 42.5% 100.0%
31
Meeting Minutes
March 12, 2018
DRAFT
FINANCE SUBCOMMITTEE
Board of Directors
Location: HR Training Room, Munson Road
Present (Voting): R. Carbray; R. Dakers; T. Holt; K. Woods
Chairman Tim Holt called the meeting to order at 8:32 am
1. Public CommentThere was no public comment.
2. Chair’s Remarks
2.1 Chair Tim Holt welcomed the group.2.2 Approval of Minutes
2.2.1 December 4, 2017
In a motion duly made and seconded, the Committee approved the minutes of December 4, 2017
3. Fiscal Reports and Updates
Mr. Geoghegan reported that at the end of January, 2018 UConn Health had a favorable varianceto budget of $7.4 million. The forecast for the rest of the year is for the next five months there are anumber of items that are coming up against the budget including a reduction in our Medicarepayments and a reduction in our payments for pharmaceuticals related to 340b which will result inless revenue. Mr. Geoghegan reminded the board that we are still budgeted for the implementationof the EPIC project for May and June.
Mr. Geoghegan showed a slide of the budget variance to the group depicting all business unitswere favorable to the overall budget. Clinical is about $5 million favorable, Institutional Support,Research, both the School of Medicine and the School of Dental Medicine are also favorable.Overall salaries and fringe benefits are under as we still continue to monitor all of the hiring throughthe entity. In the School of Dental Medicine, as they are still ramping up and utilizing their newdental clinics, they continue to be favorable to budget.
John Dempsey Hospital has seen excellent volume overall. Hospital discharges are about 3.3%greater than expectations; which is 7.7% greater than the prior year. Outpatient equivalents are1.1% greater than budget, and 9.3% greater than the prior year. Showing the hospital is makinggreat strides overall. Another main driver for our overall hospital progress is our surgeries. Themain OR in University Tower as well as the Outpatient Surgery Center both continue to befavorable to budget with significant growth. Another area for this year for volume is our emergencyroom which continues to track over budget. This year we have seen double the number of flupatients over past years.
UMG: The Physician RVU’s have been tracking about 1% greater than budgeted. The averageprovider FTE’s is currently over budget about 3 indicating we have highered about 3 providers morethan the number of providers that have left. The average monthly RVU’s is almost exactly right onthe budged target which is 39 RVU’s over last year’s productivity. The Medicare managed careplans are resulting in a slight increase in the revenue over prior year.
32
FINANCE SUBCOMMITTEE
March 12, 2018
The question was asked about new hire physicians for specialties. Dr. Agwunobi answered our increase in faculty in one of the drivers our recent volume, especially in the area of specialties such neurosurgery and neurology. The State of Connecticut budget: The Governor did release a proposed budget for next year (fiscal 2019). That budget basically rolls forward our state appropriations from this year into next year. There was a slight increase which has been reduced due to cuts made by the state which were rolled to 2019. This was an expected occurrence. Otherwise there is not significant change in the budget to date. In May Mr. Geoghegan expects to have a special meeting of the Finance Subcommittee to discuss where we feel the proposed budget will land and to prepare a 2019 budget plan. There were estimated retirement contribution rates released from the Comptroller’s office. All of the rates regardless of the plan have an increase. The state retirement plan increased 11%. The contribution for this is now a 67.6% proposal. This is not an increase or a change in the employees’ contributions, those changes were made last year. This is the amount charged to UConn Health for the plan. Overall for all the plans it is expected we will see a $13.1 million increase with the new rates. Approximately $5.6 million of that could be covered by the block grant, but the remaining $7.5 million will need to be covered by additional revenues. The question was asked how our fringe rate costs compare with other Connecticut Hospitals. Mr. Geoghegan answered: Connecticut Hospital Association does an analysis of fringe costs state wide. That has been tracking an overall rate around 28-30% rate. UConn does have an alternate plan here that is at about 15%. When we do our combination our overall rate is in the mid 60’s. Mr. Geoghegan noted that there were handouts of the state auditors’ report distributed to each board member. That information can be found with the Board of Directors meeting materials at https://health.uconn.edu/finance/accounting/overview/financial-reports/
4. Items Needing Approval
In preparation of the approval of the contracts, Dr. Agwunobi reviewed the Optum360 revenue cycle
management RFP. The decision was made to outsource our revenue cycle management which will
cause additional financial capture. The selection process ran from September to December, 2017.
Mr. Geoghegan led the selection committee process to choose a firm. Dr. Agwunobi pointed out
that because he is on the board of a large hospital group in California which owns 20% of one of the
firms that applied he recused himself from the selection process. The firm that was selected is
Optum360, which is a national revenue cycle firm that had favorable overall costs. Optum states
that it serves 4 out of every five hospital centers across the United States with revenue cycle
solutions and has over 7,700 revenue cycle experts. This company is part of the same firm that has
purchased ProHealth, however a different arm of the same corporation. Optum was asked to do a
thirty day assessment of UConn Health to evaluate the opportunities and help us determine what
the contract would look like. The results showed a low opportunity of $8 million and the aggressive
opportunity of $13 million. The actual revenue cycle improvement cost will be $1.8 million. In
addition Optum will be supplying us with some short term staffing, and some EPIC consulting help
(EPIC work will be offset by EPIC budgeted funds). The total contract is $2.6 million, however
$730,000 is being offset by vacant position salaries. The total requested operating funds is $2.3
million.
33
FINANCE SUBCOMMITTEE
March 12, 2018
4.1 Contracts/PO’s/Amendments $1million+
4.1.1 Novo Nordisk, Inc.
4.1.2 Capital Area Health Consortium
4.1.3 Capital Area Health Consortium
4.1.4 Concentra
4.1.5 Edwards Lifescience
4.1.6 GE Healthcare
4.1.7 Optum360, LLC and its affiliate, Optuminsight, Inc
4.1.8 Jackson & Coker Holdings, LLC, dba Jackson & Coker Locum Tenens, LLC
4.1.9 Locum Tenens Holdings, LLC, dba Locum Tenens.com, LLC
4.1.10 MDA Holdings, Inc., dba Medical Doctor Associates, LLC
4.1.11 Medestar
4.1.12 Quest Healthcare Solutions, LLC
4.1.13 Tusk Enterprises, LLC, dba Rhino Medical and Hospitalists Plus
4.2 Leases
There were no leases presented to the group
4.4 Project Budgets There were no project budgets presented to the group
In a motion duly made and seconded, the Committee approved agenda item 4.1 as described in detail in the board materials on pages 9.
5. Updates and Informational Items 5.1 Contracts to $999,999
5.1.1 Health Sciences North Research Institute 5.1.2 Institute for Community Research 5.1.3 Khmer Health Advocates, Inc. 5.1.4 Regents of the University of California, Davis 5.1.5 Yale University 5.1.6 Agilent Technologies 5.1.7 Edge pharmacy Services, LLC 5.1.8 Tomotherapy, Inc.
6. Other Reports
6.1 Personnel List
With no further business, the Finance Subcommittee meeting was adjourned at 9:22 am
Respectfully submitted,
Jeffrey Geoghegan
Chief Financial Officer
The Next Regularly Scheduled Meeting
Monday, June 18, 2018 at 8:30 am
34
No
.C
on
tracto
rP
O/C
on
tract
Nu
mb
er
Co
ntr
act
Typ
e
To
tal A
mo
un
tT
erm
Fu
nd
So
urc
eD
ep
t./In
div
idu
al S
po
nso
r (B
usin
ess
Ow
ner)
Exp
en
se (
E)
Reven
ue (
R)
Descri
pti
on
So
urc
ing
1In
str
um
enta
tion L
abora
tory
UC
HC
FC
1-3
4769263
Am
endm
ent
$950,0
00
7/9
/13 -
7/8
/18
Opera
ting F
unds-
Clin
ical
Kim
berl
y M
etc
alf, S
enio
r D
irecto
r
Hospital O
pera
tions
E
JD
H u
ses Instr
um
enta
tion L
abora
tory
for
all
coagula
tion testing
inclu
din
g f
acto
rs &
specia
lty
coagula
tion a
ssays
. T
his
agre
em
ent
for
equip
ment, s
erv
ice a
nd c
onsum
able
s f
or
coagula
tion testing
inclu
des tra
nsitio
n to n
ew
er
equip
ment, s
erv
ice inclu
din
g labor,
travel, p
art
s a
nd r
eagents
Sole
Sourc
e
2U
niv
ers
al H
ospital S
erv
ices
UC
HC
FC
4-9
9096293
New
$750,0
00
4/2
/18 -
4/1
/21
Opera
ting F
unds-
Clin
ical
Kim
berl
y M
etc
alf, S
enio
r D
irecto
r
Hospital O
pera
tions
EU
niv
ers
ity
Hospital S
erv
ices (
UH
S)
pro
vid
es a
n A
sset3
60
medic
al equip
ment m
anagem
ent pro
gra
m.
Sole
Sourc
e
3A
dvis
ory
Board
U
CH
CF
C2-6
0164960-C
CC
Am
endm
ent
$580,0
00
3/3
1/1
5 -
3/3
0/2
0O
pera
ting F
unds-
Clin
ical
Jam
es T
hib
eault, D
irecto
r
Str
ate
gic
Pla
nnin
gE
Annual m
em
bers
hip
to C
rim
son C
ontinuum
of
Care
, a p
ropri
eta
ry
soft
ware
pro
duct th
at allo
ws u
s to a
naly
ze p
hys
icia
n e
conom
ic
and q
ualit
y perf
orm
ance a
nd c
om
pare
perf
orm
ance m
etr
ics to
cohort
data
bases.
Sole
Sourc
e
4H
art
ford
Healthcare
Medic
al G
roup
UC
HC
FC
1-F
usco 2
018
New
$560,0
00
7/1
/18 -
6/3
0/1
9O
pera
ting F
unds-
Clin
ical
Lin
da M
anzelli
, D
irecto
r
Calh
oun C
ard
iolo
gy
Cente
rE
HH
CM
G p
rovid
es the s
erv
ices o
f D
r. D
anie
l F
usco f
or
clin
ical,
call
covera
ge a
nd h
ospital ro
undin
g. U
Conn H
ealth b
ills a
nd
colle
cts
for
serv
ices.
Sole
Sourc
e
Fin
an
ce
Su
bc
om
mit
tee
Ju
ne
18
, 2
01
8C
ON
TR
AC
TS
(O
TH
ER
TH
AN
RE
AL
ES
TA
TE
LE
AS
ES
) A
ND
PU
RC
HA
SE
OR
DE
RS
OF
$5
00
K T
O $
99
9,9
99
INF
OR
MA
TIO
NA
L IT
EM
S
Pa
ge
1 o
f 1
35
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
JUNE 2018
ACTIONS FOR INFORMATION
What follows is a list of actions taken by the Executive Vice-President for Health Affairs
under the authority delegated to him by the Board for the period January 20, 2018 through
May 10, 2018. This list is presented to the Members of the UCH Board of Directors FOR
INFORMATION at the meeting of June 18, 2018.
Leaves of Absence
1. Aguila, Hector L., Associate Professor/Basic Sciences, Department of Immunology,
medical leave with pay for the period April 6, 2018 through May 18, 2018.
2. Appleby, Lesley, Physical Therapist 2 - UHP, Rehabilitation Services - Outpatient,
medical leave with pay for the period February 23, 2018 through May 6, 2018,
medical leave without pay for the period May 7, 2018 through May 17, 2018,
maternity leave without pay for the period May 18 through May 30 and family
leave without pay for the period May 31, 2018 through August 30, 2018.
3. Bartos, Megan E., Occupational Therapist 2 - UHP, Rehabilitation Services -
Inpatient, medical leave with pay for the period March 26, 2018 through April 12,
2018 and medical leave with pay for the period April 14, 2018 through April 15,
2018.
4. Bath, Roopjeet K., Assistant Professor/Clinical, Gastroenterology, maternity leave
with pay for the period February 2, 2018 through March 29, 2018 and family leave
with pay for the period March 30, 2018 through April 29, 2018.
5. Brennan, Lauren E., Nurse Practitioner, UMG-Surgery - Urology, maternity leave
with pay for the period February 25, 2018 through April 6, 2018, family leave with
pay for the period April 7, 2018 through May 9, 2018 and family leave without pay
for the period May 10, 2018 through June 3, 2018.
6. Carreiro, Irene D., Application Analyst 1, UConn HealthONE, medical leave with
pay for the period February 16, 2018 through May 10, 2018.
7. Champeau, Corey A., Lead Physician Assistant, N.N.I.C.U. Unit, medical leave
with pay for the period March 12, 2018 through March 25, 2018
8. Cirullo, Lisanne M., Nurse Practitioner, UMG-Rheumatology, family leave with
pay for the period February 5, 2018 through February 25, 2018.
36
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
Leaves of Absence continued
9. Cleaveland, Karen S., Nurse Practitioner, N.N.I.C.U. Unit, medical leave with pay
for the period November 7, 2017 through November 13, 2017 and medical leave
without pay for the period November 14, 2017 through March 20, 2018.
10. Constantine, Cheryl, Clinical Research Assistant 3, Psychiatry, medical leave with
pay for the period February 23, 2018 through March 25, 2018.
11. Craven, Nancy A., Physical Therapist 2 - UHP, Rehabilitation Services -
Outpatient, medical leave with pay for the period April 9, 2018 through April 22,
2018.
12. Crosson, John, Physical Therapist 2 - UHP, Rehabilitation Services - Outpatient,
medical leave with pay for the period February 6, 2018 through May 6, 2018.
13. Desousa, Marcia T., Clinical Research Assistant 2, Calhoun Cardiology Center,
medical leave with pay for the period March 19, 2018 through April 29, 2018 and
maternity leave with pay for the period April 30, 2018 through July 8, 2018.
14. Dias, Feliciano, Clinical Lab Supervisor, Microbiology and Serology, medical leave
with pay for the period April 5, 2018 through April 15, 2018.
15. Forgue, Ken F., Technical Analyst 2, Customer Support Services, medical leave
with pay for the period February 26, 2018 through March 6, 2018.
16. Giove, Kimberly S., Administrative Program Coordinator, Oral and Maxillofacial
Surgery, medical leave with pay for the period May 3, 2018 through May 7, 2018
and medical leave without pay for the period May 8, 2018 through June 27, 2018.
17. Gomlinski, Gregg, Rehabilitation Services Supervisor, Rehabilitation Services -
Outpatient, medical leave with pay for the period February 23, 2018 through
March 5, 2018.
18. Goodwin, Kerri A., Executive Assistant, Neag Cancer Center, medical leave with
pay for the period April 5, 2018 through April 22, 2018.
19. Grala, Elizabeth M., Nurse Manager, Psychiatry 1 Unit, medical leave with pay for
the period March 5, 2018 through April 24, 2018.
20. Guarino, Carolyn A., Quality Assurance Specialist, Clinical Effectiveness
Administration, medical leave with pay for the period March 7, 2018 through
April 8, 2018.
37
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
Leaves of Absence continued
21. Hepner, Aubrey A., Nurse Practitioner, Intensive Care Unit, maternity leave with
pay for the period February 1, 2018 through April 25, 2018, family leave with pay
for the period April 26, 2018 through June 25, 2018 and family leave without pay
for the period June 26, 2018 through July 12, 2018.
22. Hong, Mi Y., Nurse Practitioner, Intermediate Unit, medical leave with pay for the
period April 4, 2018 through May 2, 2018.
23. Ives, Alissa J., Medical Technologist 2, Blood Bank – Lab Medicine, medical leave
with pay for the period February 17, 2018 through March 11, 2018
24. Johnson, Debra V., Nurse Practitioner, Psychiatric Clinic, medical leave with pay
for the period February 13, 2018 through March 13, 2018.
25. Knapik, Ursula K., Administrative Officer, Academic Affairs and Education,
medical leave with pay for the period February 13, 2018 through February 19, 2018.
26. Laborde-Lilley, Carmen, Medical Technologist 2, Core Lab, family leave with pay
for the period March 25, 2018 through March 29, 2018.
27. Leblanc, Laura B., Administrative Officer, Medicine Administration, maternity
leave with pay for the period April 10, 2018 through May 21, 2018 and family leave
with pay for the period May 22, 2018 through July 11, 2018.
28. Lepowsky, Steven M., Senior Associate Dean of Education and Patient Care,
General Dentistry, medical leave with pay for the period March 5, 2018 through
March 18, 2018.
29. Levine, Nadia, Supervisor, Clinical Case Manager, Case Management, medical
leave with pay for the period April 25, 2018 through May 16, 2018.
30. Longo, Lynn D., Radiation Therapy Technologist, Radiation Therapy, medical
leave with pay for the period May 3, 2018 through May 16, 2018.
31. Lotko, John, Application Developer 3, Enterprise Systems, medical leave with pay
for the period January 26, 2018 through April 19, 2018.
32. Manion, Jody L., Occupational Therapist 2 - UHP, Rehabilitation Services -
Outpatient, maternity leave with pay for the period March 29, 2018 through May 9,
2018 and family leave with pay for the period May 10, 2018 through July 15, 2018.
38
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
Leaves of Absence continued
33. Marshall, Kristin R., Cardio Sonographer, Cardiology, medical leave with pay for
the period February 12, 2018 through March 4, 2018 and medical leave with pay for
the period April 5, 2018 through April 17, 2018.
34. McNally, Christine E., Academic Curriculum Coordinator, Curricular Affairs,
medical leave with pay for the period February 8, 2018 through February 19, 2018
and medical leave with pay for the period February 22, 2018 through March 4,
2018.
35. Mills-Miller, Racine M., Administrative Program Coordinator, Endocrinology,
medical leave with pay for the period January 19, 2018 through January 22, 2018
and medical leave without pay for the period January 23, 2018 through February 4,
2018.
36. Morin, Arlene M., Clinical Nurse Specialist, JDH – Organization and Staff
Development, medical leave with pay for the period February 5, 2018 through
February 18, 2018.
37. Neff, Lynne D., Clinical Case Manager, Case Management, medical leave with pay
for the period April 19, 2018 through May 6, 2018.
38. Nelson, Susan M., Clinical Case Manager, Case Management, medical leave with
pay for the period February 19, 2018 through February 20, 2018 and medical leave
without pay for the period February 21, 2018 through March 4, 2018.
39. Oguro, Mayu, Assistant Professor/Basic Sciences, Cell Biology, medical leave with
pay for the period March 14, 2018 through May 7, 2018.
40. Poetzsch, Robert E., Application Developer 3, Enterprise Systems, medical leave
with pay for the period March 22, 2018 through April 8, 2018.
41. Porter, Martha A., Clinical Research Associate 1, University of Connecticut Center
on Aging, medical leave with pay for the period May 1, 2018 through June 13,
2018.
42. Schwenn, Janet H., Neonatal Specialist, Respiratory Care, N.N.I.C.U. Unit, medical
leave with pay for the period March 8, 2018 through April 8, 2018.
39
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
43. Spyros, Patricia A., Assistant Nursing Manager, UConn Health Surgery Center,
medical leave with pay for the period February 22, 2018 through March 11, 2018.
44. Sun, Lei, Application Architect, Strategic Projects and Clinical Systems, family
leave with pay for the period March 19, 2018 through March 27, 2018.
45. Urciuoli, Wendy S., Librarian 2, Library, medical leave with pay for the period
February 23, 2018 through March 28, 2018.
46. Vera-Licona, Martha, Assistant Professor/Basic Sciences, Center for Quantitative
Medicine, maternity leave with pay for the period February 28, 2018 through
April 24, 2018.
47. Vieira, Tammy L., Executive Assistant, General Surgery, medical leave with pay
for the period March 8, 2018 through March 29, 2018.
48. Weinstock, Clara G., Assistant Professor/Clinical, Internal Medicine Associates,
medical leave with pay for the period March 12, 2018 through April 1, 2018.
49. White, Bruce A., Professor/Basic Sciences, Cell Biology, medical leave with pay
for the period April 12, 2018 through May 13, 2018.
Resignations
1. Bansal, Ridhi, Assistant Professor/Clinical, Internal Medicine Associates, effective
March 1, 2018.
2. Burdick, Erica L., Clinical Case Manager, Case Management, effective March 1,
2018.
3. DeMeo, Margaret O., Associate Compliance Officer, Healthcare and Regulatory
Compliance, effective, March 2, 2018.
4. Farrell, Kimberly A., Assistant Professor/Clinical, Prosthodontics and Operative
Dentistry, effective April 30, 2018.
5. Huey, Leighton Y., Professor/Clinical, Psychiatry, effective February 28, 2018.
6. Larsen, Kevin W., Associate Vice President of Business and Ancillary Services,
Operating Room Unit, effective February 16, 2018.
40
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
Resignations continued
7. Rose, Suzanne, Senior Associate Dean, Academic Affairs and Education, effective
February 5, 2018.
8. Sylvain, Jonathan M., Rehabilitation Services Supervisor, Rehabilitation Services -
Outpatient, effective April 25, 2018.
9. Tremblay, Matthew A., Assistant Professor/Clinical, Neurology, effective April 12,
2018.
10. Trudel, Crystal L., Reimbursement Analyst 1, UMG-University Physician Patient
Accounts, effective May 1, 2018.
11. Worshoufsky, Ann M., Clinical Nurse Specialist, JDH - Organization and Staff
Development, effective April 5, 2018.
12. Zanotti, Stefano, Assistant Professor/Basic Sciences, Orthopaedic Surgery,
effective April 6, 2018.
Retirements
1. Bruinsma, Patricia E., Histotechnologist, UMG – General Dermatology, effective
February 28, 2018.
2. Collins, Roxanne, Clinical Lab Supervisor, Core Lab, effective March 31, 2018.
3. Granger, Margo C., Compensation and Classification Officer, Human Resources
Administration, effective March 31, 2018.
4. Guynn, Robert S., Pharmacist - UHP, CMHC - Pharmacy, effective February 28,
2018.
5. Haar, Maria M., Nurse Practitioner, N.N.I.C.U. Unit, effective March 31, 2018.
6. Hanlon, Mary P., Histotechnologist, UMG - General Dermatology, effective
February 28, 2018.
7. Kalagher, Nancy Anne, Nurse Practitioner, UMG – General Obstetrics, effective
March 31, 2018.
8. Kelly, Martin J., Clinical Practice Manager, Psychiatric Clinic, effective March 31,
2018.
41
UNIVERSITY OF CONNECTICUT HEALTH
PERSONNEL LIST
ACTIONS FOR INFORMATION
JUNE 2018
Retirements continued
9. Kels, Barry D., Associate Professor/Clinical, Opthalmology Surgery, effective
April 30, 2018.
10. Olson, Marianne, Administrative Program Coordinator, Curricular Affairs,
effective April 30, 2018.
11. Spracklin, Kathy D., Medical Technologist 2, Microbiology and Serology, effective
February 28, 2018.
Deceased
1. Jani-Acsadi, Agnes A., Associate Professor/Clinical, Neurology, effective May 9,
2018.
42
BOARD OF DIRECTORS
BUILDING & GROUNDS COMMITTEE NOVEMBER 28, 2017
MUNSON TRAINING ROOM
MINUTES
The meeting was convened by R. Carbray at 8:30 am. I. Public Comment:
o No public comment.
II. Chair’s Remarks: o Approval of Minutes: In a motion duly made, seconded and unanimously carried the
UCHC Building & Grounds Subcommittee approved the meeting minutes from September 7, 2017.
III. Discussion Items: o Bioscience Connecticut Capital Project Status: Mr. Trutter provided an overview
of the April 2018 Bioscience Monthly Program Report to the committee, and provided an overview of budget, scope and other issues of each of the planned construction projects. Slides were presented to provide a visual reference to the overall program update.
o Construction Updates o Academic Building: This project will move into the completed projects by our next
meeting. A tour of the completed Wellness Center was provided.
o C Building: Phase 1 is completed. Phase II is underway. Budget increase will be brought to the BOD. A group that advocates for equal access for all toured our facilities and were pleased with the improvements made to accommodate individuals with disabilities. The Jacobs group is scaling back to minimal staff through 2018.
Planning Updates
o Main Accumulation Building: Started site work. Currently, a couple of weeks behind due to water main issue with MDC having to re-route a 12: water/fire line. Once completed excavation for the foundation will begin.
o C Building Roof Replacement: Majority of work is completed.
o Parking Garage Fencing: Eagle Fence awarded fencing contract.
Presentations o George Karsanow, Director of Construction Services, provided an update on the
Capital Projects unrelated to Bioscience Connecticut. This update focused on capital renewal and infrastructure improvements projects completed in and progress, including Fire Code Deficiency Corrections which are ongoing, Elevator upgrades, H Building Sealant Replacement.
43
BOARD OF DIRECTORS
BUILDING & GROUNDS COMMITTEE NOVEMBER 28, 2017
MUNSON TRAINING ROOM
o Environment of Care (EOC) Update: Joint Commission Survey expected in 2018,
which has Dr. Agwunobi’s attention and he has implemented an action plan and appointed Kevin Higgins, Director Environment of Care. Mock Survey results suggest a conditional accreditation could occur if issue are not resolved.
At 9:48 am The Committee unanimously voted to adjourn. In attendance: F. Archambault, R. Carbray
Respectfully submitted,
Carolle Andrews Administrative Liaison to the Board
44
Data
Date
:04/2
3/1
8
Re
po
rt D
ate
:05/0
1/1
8
B
ioscie
nce C
on
necti
cu
t C
ap
ital P
roje
cts
Rep
ort
No
. 72 -
Ap
ril 2018
Pre
pa
red
by
UC
ON
N H
ealth
Ja
co
bs a
nd
Ca
mp
us P
lan
nin
g,
Desig
n a
nd C
onstr
uction
45
B
ioscie
nce
Co
nn
ecticu
t C
ap
ita
l P
roje
cts
Re
po
rt N
o. 7
2 -
Ap
ril 2
01
8
Ta
ble
of C
on
ten
ts
Pro
gra
m O
ve
rvie
w -
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
1
Ex
ec
uti
ve
Su
mm
ary
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--3
Pro
gra
m S
tatu
s -
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-7
Pro
gra
m M
etr
ics
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--8
Ja
co
bs
Pro
jec
t M
an
ag
em
en
t O
ve
rsig
ht
Ac
tivit
ies
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-9
Pro
gra
m B
ud
ge
t &
Fu
nd
ing
Su
mm
ary
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-11
Pro
jec
t R
ep
ort
sJD
H N
ew
Co
nstr
uctio
n &
Re
no
va
tio
ns (
Roll-
Up)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---13
Ph
ase
I -
S
ite
& E
ast
Pa
rkin
g G
ara
ge
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---14
Ph
ase
II -
Ne
w H
osp
ita
l T
ow
er
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
15
Ph
ase
III -
H B
ldg
Re
no
va
tio
ns--
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--- 1
6
Aca
de
mic
Bu
ildin
g A
dd
itio
ns &
Re
no
va
tions--
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---17
Clin
ica
l R
en
ova
tions -
C B
ldg -
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---18
Ma
in B
uild
ing
La
b (
L)
Re
no
vations -
Pro
ject
1 -
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-19
Ma
in B
uild
ing
La
b (
L)
Re
no
vations -
Pro
ject
2 -
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-20
Ou
tpa
tie
nt
Pa
vili
on
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-21
Incu
ba
tor
La
b A
dd
itio
n -
CG
SB
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--- 2
2
Ma
ste
r P
roje
cts
Sc
he
du
leS
um
ma
ry S
ch
ed
ule
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-23
De
taile
d S
ch
ed
ule
---
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-22
46
Pa
ge
1
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Prog
ram
Ove
rvie
w
Prog
ram
Des
crip
tion
Bios
cien
ce C
onne
ctic
ut is
inte
nded
to h
elp
Con
nect
icut
’s e
cono
my
by c
reat
ing
cons
truct
ion-
rela
ted
jobs
imm
edia
tely
and
gen
erat
ing
long
term
, sus
tain
able
eco
nom
ic
grow
th b
ased
on
bios
cien
ce re
sear
ch, i
nnov
atio
n, e
ntre
pren
eurs
hip
and
com
mer
cial
izat
ion.
The
Con
stru
ctio
n Pr
ogra
m a
t UC
onn
Hea
th in
clud
es a
ll as
pect
s of
pla
nnin
g,
cons
truct
ing,
and
act
ivat
ing
the
follo
win
g pr
ojec
ts:
N
ew H
ospi
tal t
ower
, Site
& P
arki
ng (C
ompl
ete)
: Con
stru
ctio
n of
a n
ew
384,
000
SF, 1
69 b
ed, e
leve
n flo
or h
ospi
tal t
ower
hou
sing
key
pat
ient
are
as
incl
udin
g th
e em
erge
ncy
depa
rtmen
t, su
rger
y su
ite, M
RI s
uite
, ren
al d
ialy
sis,
re
spira
tory
ther
apy,
inpa
tient
reha
b (o
rthop
edic
s, re
hab
gym
and
wor
kspa
ce),
clin
ical
sup
port,
and
pat
ient
edu
catio
n sp
ace.
The
pro
ject
incl
udes
a n
ew 4
03
spac
e pu
blic
gar
age
and
a ne
w 3
97 s
pace
sta
ff ga
rage
.
Exis
ting
Hos
pita
l Ren
ovat
ions
(On
Hol
d): R
enov
atio
n to
sev
eral
dep
artm
ents
an
d up
grad
es to
util
ity a
nd e
lect
rical
sys
tem
s.
Ac
adem
ic B
uild
ing
Addi
tion
& R
enov
atio
ns (C
ompl
ete)
: A 1
9,15
3 SF
cl
assr
oom
add
ition
and
reno
vatio
n of
exi
stin
g cl
assr
oom
s, o
ffice
, and
lab
spac
e. R
enov
atio
ns w
ill in
clud
e th
e up
grad
e of
the
mec
hani
cal,
elec
trica
l and
pl
umbi
ng in
frast
ruct
ure
and
prog
ram
exp
ansi
ons.
Clin
ical
Bui
ldin
g R
enov
atio
ns (I
n Pr
ogre
ss):
Ren
ovat
ions
will
incl
ude
the
upgr
ade
or re
plac
emen
t of t
he m
echa
nica
l, el
ectri
cal a
nd p
lum
bing
in
frast
ruct
ure
and
prog
ram
exp
ansi
ons
for t
he P
at a
nd J
im C
alho
un
Car
diol
ogy
Cen
ter a
nd th
e Sc
hool
of D
enta
l Med
icin
e.
M
ain
Build
ing
Lab
(L) R
enov
atio
ns (C
ompl
ete)
: Tw
o M
ulti-
Phas
ed re
nova
tion
proj
ects
will
reno
vate
200
,000
of t
he 2
83,0
00 s
quar
e fe
et o
f exi
stin
g re
sear
ch
lab
faci
litie
s an
d bu
ildin
g in
frast
ruct
ure.
U
Con
n H
ealth
Out
patie
nt P
avilio
n (C
ompl
ete)
: Con
stru
ctio
n of
a n
ew $
203
milli
on, 3
06,8
80 s
q. ft
. am
bula
tory
car
e fa
cilit
y w
ill be
occ
upie
d by
the
Car
ole
and
Ray
Nea
g C
ompr
ehen
sive
Can
cer C
ente
r and
oth
er o
utpa
tient
ser
vice
s.
This
pro
ject
incl
udes
a n
ew p
arki
ng g
arag
e of
app
roxi
mat
ely
1,40
0 sp
aces
.
Incu
bato
r Lab
Add
ition
(Com
plet
e): N
ew b
uild
ing
addi
tion
to th
e ex
istin
g C
ell
and
Gen
ome
Scie
nce
Build
ing
(CG
SB) t
o cr
eate
an
addi
tiona
l 28,
000
squa
re
feet
of n
ew in
cuba
tor s
pace
to fo
ster
new
bus
ines
s st
art-u
ps.
47
Page 2
Bio
scie
nce C
onnecticut
Pro
gra
m R
eport
No.
71 –
January
2018
Prog
ram
Tea
m
Ow
ner:
UC
onn
Hea
lth C
ampu
s Pl
anni
ng, D
esig
n, a
nd C
onst
ruct
ion
Proj
ect M
anag
emen
t Ove
rsig
ht:
Jaco
bs P
roje
ct M
anag
emen
t Co.
Fund
ing
The
New
Con
stru
ctio
n &
Ren
ovat
ions
for U
Con
n H
ealth
are
fund
ed in
the
amou
nt o
f $79
6 m
illion
with
$57
8 m
illion
from
UC
21. T
he b
alan
ce w
ill be
fro
m p
rivat
e fin
anci
ng a
nd U
Con
n H
ealth
fund
s (in
clud
ing
phila
nthr
opy)
.
Sche
dule
and
Bud
get
Plan
ning
& D
esig
n w
as in
itiat
ed in
Jun
e of
201
0. T
he p
rogr
am is
pla
nned
for
com
plet
ion
in e
arly
201
9. C
urre
ntly
, no
maj
or is
sues
hav
e be
en id
entif
ied
whi
ch
put t
he c
ompl
etio
n at
risk
. A
sum
mar
y sc
hedu
le is
loca
ted
on th
e la
st p
age
of
this
repo
rt.
Sum
mar
y Sc
hedu
le &
Cas
h flo
w
48
Pa
ge
3
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Exec
utiv
e Su
mm
ary:
Mile
ston
es, C
urre
nt /
Upc
omin
g C
onst
ruct
ion
Activ
ities
C
linic
Bui
ldin
g R
enov
atio
n M
ilest
ones
: o
Ph
ase
2 co
nstru
ctio
n is
com
plet
e.
o
Phas
e 3
cons
truct
ion
is u
nder
way
. o
$6
7.7M
(72%
) of f
unds
exp
ende
d.
Cur
rent
/ U
pcom
ing
Activ
ities
: o
Fr
amin
g is
und
erw
ay in
Pha
se 3
Den
tal S
urge
ry a
rea.
o
D
emol
ition
is u
nder
way
in P
hase
3 D
enta
l Exa
m a
reas
.
Hos
pita
l Tow
er –
Hyb
rid O
.R.
Mile
ston
es:
o
Hyb
rid O
.R. P
roje
ct is
com
plet
e!
o
$317
.2M
(98%
) of f
unds
exp
ende
d (e
ntire
pro
ject
)
Cur
rent
/ U
pcom
ing
Activ
ities
: o
Sc
affo
ldin
g is
bei
ng in
stal
led
in th
e pe
ntho
use.
o
Fi
nal C
O fo
r the
bui
ldin
g w
ill be
issu
ed a
fter p
erm
anen
t sca
ffold
ing
is in
stal
led
in p
enth
ouse
.
49
Pa
ge
4
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Ac
adem
ic B
uild
ing
Addi
tion
and
Ren
ovat
ion
M
ilest
ones
: o
Al
l con
tract
wor
k is
com
plet
e.
o
$35.
4M (9
6%) o
f fun
ds e
xpen
ded.
Cur
rent
/ U
pcom
ing
Activ
ities
:
o
Res
olve
min
or is
sues
to o
btai
n Fi
nal C
ertif
icat
e of
Occ
upan
cy
o
Fina
ncia
l Clo
seou
t is
unde
rway
.
M
ain
Build
ing
Lab
(L) R
enov
atio
ns –
Pro
ject
2
Mile
ston
es:
o
Fina
l Cer
tific
ate
of O
ccup
ancy
rece
ived
. o
$3
8.6M
(97%
) of f
unds
exp
ende
d.
Cur
rent
/ U
pcom
ing
Activ
ities
: o
Fi
nanc
ial c
lose
out i
s un
derw
ay.
50
Pa
ge
5
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Safe
ty
(Sta
tistic
s- c
umul
ativ
e th
roug
h M
arch
of 2
018)
Proj
ect
Wor
kers
O
rient
ed
Inci
dent
s H
ours
W
orke
d O
SHA
Inci
dent
Rat
es *
Activ
ities
& T
rain
ing
Com
plet
ed T
his
Mon
th
Firs
t Aid
R
ecor
dabl
e Lo
st T
ime
Rec
orda
ble
Lost
Tim
e
Pre-
OC
IP P
roje
cts
164
7 5
3 93
,804
10
.7
6.4
C
ompl
ete
(Wor
k pr
ior t
o O
CIP
sta
rt)
OC
IP P
roje
cts
Out
patie
nt P
avilio
n C
&S
943
12
7 1
394,
251
3.6
0.5
Com
plet
e
Out
patie
nt P
avilio
n Fi
t Out
81
0 13
5
2 29
3,37
6 3.
4 1.
4
Com
plet
e
Out
patie
nt P
avilio
n –
8 Ea
st
81
0 0
0 17
,295
0.
0 0.
0
Com
plet
e
Mai
n La
b R
enov
atio
n 66
0 19
3
3 42
8,06
7 1.
4 1.
4
Com
plet
e
Mai
n La
b –
Phas
e II
410
3 1
0 19
2,25
7 1.
0 0.
0
Com
plet
e
New
Hos
pita
l Tow
er
2,08
4 72
29
10
1,
336,
546
4.3
1.5
Com
plet
e
Incu
bato
r Lab
Add
ition
31
6 4
3 0
34,4
29
17.4
0.
0
Com
plet
e
Acad
emic
Add
ition
37
3 1
0 0
99,4
40
0.0
0.0
Com
plet
e
Clin
ic B
uild
ing
Ren
ovat
ion
360
5 4
1 25
2,93
2 3.
2 0.
8
Rei
nfor
cing
Infe
ctio
n Pr
even
tion
OC
IP T
otal
s:
6,03
7 12
9 52
17
3,
048,
593
3.4
1.1
Prog
ram
Tot
als:
6,
201
136
57
20
3,14
2,39
7 3.
6 1.
3
Prog
ram
Wid
e Ac
tiviti
es T
his
Mon
th:
Ove
rall
cont
ract
or s
afet
y pe
rform
ance
co
ntin
ues
to b
e ve
ry g
ood.
The
re h
ave
been
no
firs
t-aid
or r
ecor
dabl
e in
jurie
s fo
r the
pas
t th
ree
mon
ths.
As
the
only
rem
aini
ng w
ork
for t
he p
rogr
am is
re
nova
tion
of e
xist
ing
clin
ical
faci
litie
s, fo
cus
has
prim
arily
shi
fted
to in
fect
ion
prev
entio
n.
*Incid
ent R
ate
= (#
Inju
ry/Il
lnes
s Ca
ses
x 20
0,00
0) /
Tota
l Hou
rs w
orke
d.
3.9
2.6
3.4
1.1
012345678
Aug‐13Sep‐13Oct‐13Nov‐13Dec‐13Jan‐14Feb‐14Mar‐14Apr‐14May‐14Jun‐14Jul‐14Aug‐14Sep‐14Oct‐14Nov‐14Dec‐14Jan‐15Feb‐15Mar‐15Apr‐15May‐15Jun‐15Jul‐15Aug‐15Sep‐15Oct‐15Nov‐15Dec‐15Jan‐16Feb‐16Mar‐16Apr‐16May‐16Jun‐16Jul‐16Aug‐16Sep‐16Oct‐16Nov‐16Dec‐16Jan‐17Feb‐17Mar‐17Apr‐17May‐17Jun‐17Jul‐17Aug‐17Sep‐17Oct‐17Nov‐17Dec‐17Jan‐18Feb‐18Mar‐18
Incident Rate
UCH
Incide
nt Rate Tren
ding
(OCIP Projects Only)
Conn
ecticut Average RIR
Conn
ecticut Average LTIR
UCH
C OCIP RIR
UCH
C OCIP LTRIR
51
Pa
ge
6
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Issu
es /
Con
cern
s
C B
uild
ing:
o
Pr
evio
us R
epor
ted
Ope
n Ite
ms:
Fund
s fro
m th
e fo
unda
tion
are
requ
ired
to c
ompl
ete
the
proj
ect.
Oth
er fu
nd s
ourc
es w
ill be
requ
ired
if th
e fo
unda
tion
fund
s ar
e no
t ava
ilabl
e.
52
Page
7
Bio
scie
nce C
onnecticut
Pro
gra
m R
eport
No.
71 –
January
2018
Prog
ram
Sta
tus
No Activity
or N
A No curren
t issue
s/de
cisio
ns re
quire
dIssues need attention or re
solutio
nUnresolved issue
s are im
pacting the
project.
Proj
ect
Sco
pe
Sche
dule
Bu
dget
Ph
ase I ‐ Site
& Parking
No scop
e issue
s.
Completed
on sche
dule.
Project C
ompleted
on bu
dget.
Phase II ‐ N
ew Hospital
No Scop
e Issues.
Complete
Remaining
fund
s will be used
for H
ybrid
O.R. design
and constructio
n.
Phase III ‐ H Building Re
novatio
n
Scop
e de
pend
ent o
n future fu
nding.
Desig
n is on
hold pe
nding fund
ing.
TBD
Main Bu
ilding Lab (L) R
enovations – Project 1
No scop
e issue
s.
Project com
pleted
a fe
w weeks beh
ind sche
dule
Project com
pleted
und
er bud
get.
Main Bu
ilding Lab (L) R
enovations – Project 2
No scop
e issue
s.
Actual su
bstantial com
pletion date was M
ay 3, 2017
and moves are com
plete
Project com
pleted
und
er bud
get.
Outpa
tient Pavilion
(Including
8th floo
r East)
All add
ition
al sc
ope and changes w
ere completed
with
in
the project b
udget.
Final CO re
ceived
4/19/2017
Project com
pleted
und
er bud
get.
Acad
emic Building Ad
ditio
n & Ren
ovations
No ne
w sc
ope issue
s.
All w
ork is complete
Additio
nal Skanska staff costs were resolved
with
in
project b
udget
Clinical Building Re
novatio
ns (C
Building)
No ne
w sc
ope issue
s.
Phase II work proceeding
on sche
dule.
Curren
t projection is on
bud
get.
Incuba
tor Lab
Add
ition
(CGSB
)
No scop
e issue
s.
Final Certificate of Occup
ancy re
ceived
. Project com
pleted
und
er bud
get.
(+) o
r (‐) de
notes c
hange in status from
last m
onth
53
Page 8
Bio
scie
nce C
onnecticut
Pro
gra
m R
eport
No.
71 –
January
2018
54
Pa
ge
9
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Jaco
bs P
roje
ct M
anag
emen
t Ove
rsig
ht A
ctiv
ities
In
trodu
ctio
n Ja
cobs
is p
rovi
ding
Pro
gram
Man
agem
ent O
vers
ight
sup
port
and
staf
f aug
men
tatio
n se
rvic
es to
the
UC
onn
Hea
lth fo
r the
Bio
scie
nce
CT
cons
truct
ion
proj
ects
at t
he
Farm
ingt
on c
ampu
s. T
his
supp
ort b
egan
in e
arly
Jan
uary
201
2 an
d th
is re
port
is a
con
tract
del
iver
able
inte
nded
to p
rovi
de m
anag
emen
t inf
orm
atio
n to
sup
port
the
sign
ifica
nt p
lann
ing,
sch
edul
ing,
des
ign,
dem
oliti
on, s
ite p
repa
ratio
n, c
onst
ruct
ion
and
finan
cial
act
iviti
es.
Sum
mar
y of
Wor
k Pe
rform
ed T
his
Perio
d
Plan
ning
an
d Pr
ogra
mm
ing:
Jaco
bs
cont
inue
s to
w
ork
with
C
PDC
an
d co
nstru
ctio
n m
anag
ers
on C
onst
ruct
ion
phas
ing
and
sche
dulin
g fo
r th
e C
linic
bu
ildin
g an
d Ac
adem
ic b
uild
ing
reno
vatio
ns.
Cur
rent
focu
s is
on
plan
ning
for
C
build
ing
site
logi
stic
s an
d m
ove
plan
ning
.
Te
chno
logy
Pla
nnin
g:
Jaco
bs c
ontin
ues
to c
oord
inat
e w
ith p
roje
ct t
eam
s fo
r IT
an
d AV
des
ign
in th
e C
linic
and
Aca
dem
ic B
uild
ings
.
FF&E
: J
acob
s co
ntin
ues
to c
oord
inat
e pr
ocur
emen
t, de
liver
y an
d se
tup
of t
he
furn
iture
for t
he C
bui
ldin
g pr
ojec
t.
M
ove
and
Activ
atio
n M
anag
emen
t:
Jaco
bs is
wor
king
with
the
Clin
ic B
uild
ing
team
on
mov
e pl
anni
ng e
fforts
.
Budg
et P
lann
ing:
D
etai
led
revi
ews
of b
udge
ts a
nd r
epor
ts fo
r ea
ch B
SC p
roje
ct
with
UC
onn
Hea
lth m
gt.,
CPD
C m
gt.
& PM
s co
ntin
ue.
C
ost T
rack
ing:
R
evie
win
g co
ntra
ctor
cha
nge
orde
r req
uest
s, s
ched
ule
of v
alue
s,
and
paym
ent
appl
icat
ions
. J
acob
s co
ntin
ues
to a
ssis
t in
miti
gatio
n of
pot
entia
l cl
aim
s an
d ne
gotia
tion
of c
hang
e re
ques
ts.
Sa
fety
Ove
rsig
ht S
ervi
ces:
Ja
cobs
con
tinue
s co
ordi
natin
g ob
serv
atio
ns w
ith th
e C
onst
ruct
ion
Man
ager
s an
d ve
rifyi
ng th
eir
com
plia
nce
with
UC
onn
Hea
lth s
afet
y re
gula
tions
. Th
ey c
ontin
ue to
revi
ew S
PAs,
JH
As, c
rane
lift
plan
s, e
tc.
Pr
ojec
t Man
agem
ent C
ontro
l Sys
tem
(Del
con/
Uni
fier):
Pro
ject
con
trols
hav
e be
en
trans
ition
ed fr
om D
elco
n to
Uni
fier.
Jac
obs
cont
inue
s to
ass
ist w
ith re
conc
iliatio
n of
fina
ncia
l dat
a.
M
aste
r Pr
ogra
m S
ched
ule:
Ja
cobs
con
tinue
s to
wor
k w
ith t
he c
ontra
ctor
s to
as
sist
with
sch
edul
e m
anag
emen
t and
lead
ersh
ip.
C
omm
unic
atio
n an
d C
oord
inat
ion
of E
fforts
: At
tend
ing
OAC
mee
tings
and
BSC
O
vers
ight
com
mitt
ee,
and
othe
r m
eetin
gs a
s re
quire
d to
dis
cuss
pro
ject
and
pr
ogra
m is
sues
. P
rovi
de q
uarte
rly re
ports
.
O
CIP
: Jac
obs
cont
inue
s to
atte
nd q
uarte
rly O
CIP
adm
inis
tratio
n m
eetin
gs w
ith th
e O
CIP
adm
inis
trato
r (W
illis)
, und
erw
riter
(The
Har
tford
), an
d C
M (F
usco
)
55
Pa
ge
10
Bio
scie
nce
Co
nn
ecticu
t P
rog
ram
Re
po
rt N
o.
71
– J
an
ua
ry 2
01
8
Pr
ojec
t M
anag
emen
t:
The
Clin
ic
Build
ing
proj
ect
has
been
su
cces
sful
lytra
nsiti
oned
to U
Con
n H
ealth
PM
. Ja
cobs
con
tinue
s to
sup
port
the
proj
ect w
ith fu
lltim
e Pr
ojec
t Eng
inee
ring
sta f
f and
Par
t tim
e Ex
ecut
ive
Ove
rsig
ht.
Pr
ogra
m M
anag
emen
t: J
acob
s co
ntin
ues
to p
rovi
de c
ounc
il an
d ex
ampl
es o
f bes
tpr
actic
es fo
r la
rge
scal
e pr
ogra
m a
nd c
onst
ruct
ion
man
agem
ent t
o th
e C
ampu
sPl
anni
ng, D
esig
n, a
nd C
onst
r uct
ion
depa
rtmen
t.
Va
lue
Plus
: J
acob
s tra
cks
the
valu
e w
e br
ing
to o
ur c
lient
s in
a s
yste
m c
alle
d
Valu
e +.
Ite
ms
track
ed c
an b
e in
nova
te m
etho
ds o
r pr
oces
ses
that
red
uce
cons
truct
ion
or o
pera
ting
cost
s, v
alue
eng
inee
ring,
pro
cure
men
t im
prov
emen
ts,
nego
tiate
d re
duct
ions
in c
hang
e co
sts,
etc
. T
hese
idea
s ar
e ap
prov
ed b
y th
ecl
ient
bef
ore
they
are
logg
ed in
to th
e sy
stem
. S
ince
we
are
imbe
dded
with
the
UC
onn
Hea
lth C
ampu
s Pl
anni
ng,
Des
ign,
and
Con
stru
ctio
n de
partm
ent,
we
are
also
trac
king
thes
e ite
ms
for t
he p
roje
ct te
am.
To d
ate
UC
H h
as a
ppro
ved
Valu
ePl
us it
ems
tota
ling
$73,
295,
355.
56
Bio
scie
nce
Co
nn
ecticu
t C
ap
ita
l P
roje
cts
Re
po
rt N
o.
72
- A
pri
l 2
01
8
Pro
gra
m B
ud
ge
t &
Fu
nd
ing
Su
mm
ary
- A
nticip
ate
d C
ash
flo
w
FY
11
FY
12
FY
13
FY
14
FY
15
FY
16
FY
17
FY
18
FY
19
Fu
nd
ing
To
tal
Cu
rre
nt
Fu
nd
ing
UC
21 B
ond F
unds
35,1
42,5
13
68,7
00,0
00
83,4
60,3
29
127,2
00,0
00
96,2
65,0
00
103,0
63,8
75
57,9
90,9
06
5,5
80,0
00
-
577,4
02,6
23
OutP
atient
Pavili
on F
unds
-
-
48,2
79,2
03
125,9
20,0
90
27,9
80,7
07
-
-
-
-
202,1
80,0
00
UC
H F
unds (
inclu
din
g p
hila
nth
ropy)
-
-
-
8,5
02
1,6
20,2
68
3,8
82,7
44
3,1
78,0
45
2,9
43,8
24
3,2
87,1
20
14,9
20,5
03
TO
TA
L F
UN
DS
35,1
42,5
13
68,7
00,0
00
131,7
39,5
32
253,1
28,5
93
125,8
65,9
75
106,9
46,6
19
61,1
68,9
51
8,5
23,8
24
3,2
87,1
20
794,5
03,1
26
Pla
nn
ed
Ex
pe
nd
itu
res
JD
H N
ew
Constr
uction &
Renovations
2,5
99,7
16
13,2
99,3
23
18,0
16,8
49
48,5
83,4
26
101,0
25,0
55
102,4
58,4
48
26,8
04,1
07
12,2
29,0
77
-
325,0
16,0
00
Academ
ic B
uild
ing A
dditio
ns &
Renovations
-
-
315,0
85
1,2
36,0
19
2,0
48,4
75
14,5
38,8
71
11,6
97,8
90
6,9
58,6
60
-
36,7
95,0
00
Clin
ical R
enovations -
C B
ldg
-
-
407,3
46
2,0
68,1
62
3,0
06,5
47
4,9
20,7
03
38,4
78,6
71
24,1
60,4
19
20,3
22,7
56
93,3
64,6
04
Main
Build
ing L
ab (
L)
Renovations -
Pro
ject
1
2,3
33,6
10
741,8
53
6,4
04,4
86
32,0
44,3
65
21,2
80,4
68
10,1
23,2
21
3,8
34,9
87
582,5
13
-
77,3
45,5
03
Main
Build
ing L
ab (
L)
Renovations -
Sw
ing S
pace
-
-
476,1
12
17,7
62
98,4
74
-
-
-
-
592,3
48
Main
Build
ing L
ab (
L)
Renovations -
Pro
ject
2-
-
-
331,5
73
660,7
40
8,0
20,6
77
24,9
24,6
26
5,9
52,0
55
-
39,8
89,6
71
Outp
atient
Pavili
on
-
1,0
49,7
35
32,3
56,8
08
78,6
15,2
37
76,2
38,4
93
9,9
68,0
44
3,6
39,6
18
312,0
65
-
202,1
80,0
00
Incubato
r Lab A
dditio
n -
CG
SB
-
-
62,0
49
812,1
69
6,6
32,4
92
10,8
53,9
57
265,1
58
694,1
75
-
19,3
20,0
00
AN
NU
AL
PR
OG
RA
M E
XP
EN
DIT
UR
ES
4,9
33,3
26
15,0
90,9
11
58,0
38,7
35
163,7
08,7
13
210,9
90,7
44
160,8
83,9
21
109,6
45,0
57
50,8
88,9
64
20,3
22,7
56
794,5
03,1
26
CU
RR
ENT
PRO
JEC
TIO
N (C
UM
ULA
TIVE
)4,
933,
326
20,0
24,2
37
78,0
62,9
71
24
1,77
1,68
4
45
2,76
2,42
8
61
3,64
6,34
9
72
3,29
1,40
6
774,
180,
370
79
4,50
3,12
6
TO
TA
L U
NE
XP
EN
DE
D30,2
09,1
87
83,8
18,2
76
157,5
19,0
74
246,9
38,9
53
161,8
14,1
84
107,8
76,8
82
59,4
00,7
76
17,0
35,6
36
-
-
* Fi
nanc
ial D
ata
Subj
ect t
o Pl
ant A
ccou
ntin
g Ve
rific
atio
nP
age 1
1
FY 11
FY 12
FY 13
FY 14
FY 15
FY 16
FY 17
FY 18
FY19
UCH
FUNDS
(INCLUDING PHILANTH
ROPY)
00
08,50
21,62
0,26
83,88
2,74
43,17
8,04
52,94
3,82
43,28
7,12
0AC
C FU
NDS
01,04
9,73
532
,356
,808
78,615
,237
76,238
,493
9,96
8,04
43,63
9,61
831
2,06
50
UC2
1 FU
NDS
4,93
3,32
614
,041
,176
25,681
,927
85,084
,973
133,13
1,98
314
7,03
3,13
310
2,82
7,39
447
,633
,075
17,035
,636
ORIGINAL
PRO
JECT
ION (C
UMULATIVE
)4,75
4,01
027
,569
,603
117,57
2,46
933
8,62
2,25
858
0,60
1,57
375
2,96
2,99
281
7,87
7,71
883
9,80
4,00
083
9,80
4,00
0CU
RREN
T PR
OJECT
ION (C
UMULATIVE
)4,93
3,32
620
,024
,237
78,062
,971
241,77
1,68
445
2,76
2,42
861
3,64
6,34
972
3,29
1,40
677
4,18
0,37
079
4,50
3,12
6
‐ 100,000
,000
200,000
,000
300,000
,000
400,000
,000
500,000
,000
600,000
,000
700,000
,000
800,000
,000
900,000
,000
0
50,000
,000
100,00
0,00
0
150,00
0,00
0
200,00
0,00
0
250,00
0,00
0
Cumulative Expenditures
Expenditures
Plan
ned Project E
xpen
ditures by
Sou
rce
57
Bio
scie
nce C
onnecticut
Capital P
roje
cts
Report
No.
72 -
Apri
l 2018
Pro
gra
m B
udg
et
& F
undin
g S
um
mary
- A
nticip
ate
d C
ost
Co
st
Su
mm
ary
by P
roje
ct
Cu
rre
nt
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pe
nd
ing
Co
mm
itm
en
ts
Pro
jec
ted
Co
sts
Pro
jec
ted
Ove
r/U
nd
er
Ex
pe
nd
itu
re t
o
Da
te%
Ex
pe
nd
ed
AB
CD
E=
B+
C+
DF
=A
-E
Ph
ase
I -
Site
& P
ark
ing
13
,96
9,7
95
13
,96
9,7
95
-
-
13
,96
9,7
95
-
13
,96
9,7
94
10
0%
Ph
ase
II -
Ne
w H
osp
ita
l T
ow
er
(& H
yb
rid
OR
)3
11
,04
6,2
05
31
0,0
79
,09
0
66
9,5
44
29
7,5
71
31
1,0
46
,20
5
-
30
3,2
64
,28
0
97
%
Ph
ase
III -
H B
ldg
Re
no
va
tio
ns -
Sco
pe
Elim
ina
ted
-
-
-
-
-
-
-
0%
To
tal -
Ne
w H
os
pit
al T
ow
er,
Sit
e &
Pa
rkin
g3
25
,01
6,0
00
32
4,0
48
,88
5
66
9,5
44
29
7,5
71
32
5,0
16
,00
0
-
31
7,2
34
,07
5
98
%
Aca
de
mic
Bu
ildin
g A
dd
itio
ns &
Re
no
va
tio
ns
36
,79
5,0
00
36
,52
8,6
71
23
1,3
29
35
,00
0
36
,79
5,0
00
-
35
,40
0,3
34
96
%
Clin
ica
l R
en
ova
tio
ns -
C B
ldg
93
,36
4,6
04
92
,53
8,8
07
46
5,8
37
35
9,9
60
93
,36
4,6
04
-
67
,65
8,9
75
72
%
Ma
in B
uild
ing
La
b (
L)
Re
no
va
tio
ns -
Pro
ject 1
7
7,3
45
,50
3
77
,34
3,5
98
1,9
05
-
77
,34
5,5
03
-
77
,34
3,5
98
10
0%
Ma
in B
uild
ing
La
b (
L)
Re
no
va
tio
ns -
Sw
ing
Sp
ace
59
2,3
48
59
2,3
48
-
-
59
2,3
48
-
59
2,3
48
10
0%
Ma
in B
uild
ing
La
b (
L)
Re
no
va
tio
ns -
Pro
ject 2
39
,88
9,6
71
39
,39
0,0
47
49
9,6
24
-
39
,88
9,6
71
-
38
,56
5,2
50
97
%
Ou
tpa
tie
nt P
avili
on
20
2,1
80
,00
0
20
2,1
50
,05
3
29
,94
7
-
20
2,1
80
,00
0
-
20
2,0
74
,52
9
10
0%
Incu
ba
tor
La
b A
dd
itio
n -
CG
SB
19
,32
0,0
00
18
,89
0,1
03
42
9,8
97
-
19
,32
0,0
00
-
18
,79
6,7
38
97
%
TO
TA
L P
RO
JE
CT
S E
XP
EN
DIT
UR
ES
79
4,5
03
,12
6
79
1,4
82
,51
3
2,3
28
,08
2
69
2,5
31
79
4,5
03
,12
6
-
75
7,6
65
,84
7
95
%
Co
st
Su
mm
ary
by C
ate
go
ry
Cu
rre
nt
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pe
nd
ing
Co
mm
itm
en
ts
Pro
jec
ted
Co
sts
Pro
jec
ted
Ove
r/U
nd
er
Ex
pe
nd
itu
re t
o
Da
te%
Ex
pe
nd
ed
AB
CD
E=
B+
C+
DF
=A
-E
Co
nstr
uctio
n6
12
,11
8,9
13
61
1,3
36
,38
2
90
,00
0
69
2,5
31
61
2,1
18
,91
3
-
58
4,6
16
,71
6
96
%
De
sig
n S
erv
ice
s5
2,4
64
,20
6
52
,40
4,0
06
60
,20
0
-
52
,46
4,2
06
-
50
,76
6,3
14
97
%
Te
leco
mm
15
,33
3,1
94
15
,27
2,9
04
60
,28
9
-
15
,33
3,1
94
-
15
,21
5,7
02
99
%
Fu
rnis
hin
g, F
ixtu
res &
Eq
uip
me
nt
48
,61
1,6
78
48
,37
1,9
90
23
9,6
88
-
48
,61
1,6
78
-
44
,90
7,6
98
92
%
Co
nstr
uctio
n A
dm
inis
tra
tio
n5
,53
0,6
23
5,3
31
,93
0
19
8,6
93
-
5,5
30
,62
3
-
4,9
26
,91
4
89
%
Oth
er
A/E
& C
on
su
ltin
g S
erv
ice
s2
3,6
75
,91
2
23
,64
5,0
32
30
,88
0
-
23
,67
5,9
12
-
23
,06
7,0
98
97
%
Art
wo
rk4
49
,38
7
44
9,3
87
-
-
44
9,3
87
-
44
9,3
87
10
0%
Re
loca
tio
n1
,59
3,1
84
1,5
93
,18
4
-
-
1,5
93
,18
4
-
1,3
42
,05
1
84
%
En
vir
on
me
nta
l1
,09
8,1
43
1,0
98
,14
3
-
-
1,0
98
,14
3
-
1,0
84
,05
1
99
%
Insu
ran
ce
& L
eg
al
12
,72
0,6
04
12
,29
8,0
92
42
2,5
12
-
12
,72
0,6
04
-
11
,81
2,5
38
93
%
Oth
er
Mis
ce
llan
eo
us
19
,74
6,3
77
19
,68
1,4
63
64
,91
5
-
19
,74
6,3
77
-
19
,47
7,3
77
99
%
Su
bto
tal
79
3,3
42
,22
1
79
1,4
82
,51
3
1,1
67
,17
7
69
2,5
31
79
3,3
42
,22
1
-
75
7,6
65
,84
7
96
%
Co
nti
ng
en
cy
1,1
60
,90
5
-
1,1
60
,90
5
-
1,1
60
,90
5
-
-
0%
TO
TA
L7
94
,50
3,1
26
79
1,4
82
,51
3
2,3
28
,08
2
69
2,5
31
79
4,5
03
,12
6
-
75
7,6
65
,84
7
95
%
* Fi
nanc
ial D
ata
Subj
ect t
o Pl
an A
ccou
ntin
g Ve
rific
atio
nP
ag
e 1
2
58
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
Com
ple
te
(Hybrid O
R In C
onstr
uction)
Desig
ner:
SB
A / H
KS
Constr
ucto
r:T
urn
er
Constr
uction
Pro
ject M
anager:
Kevin
Nort
on
Pro
ject N
um
ber:
901590
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
6/3
0/2
010
6/3
0/2
010
0.0
UC
21
317,4
38,0
00
$
310,9
21,3
68
$
98%
Desig
n S
tart
(N
TP
)9/2
/2010
9/2
/2010
0.0
UC
H F
unds
7,5
78,0
00
$
6,3
12,7
07
$
83%
Schem
atic D
esig
n R
eceiv
ed
8/1
9/2
011
8/1
9/2
011
0.0
Schem
atic D
esig
n A
ppro
ved
9/3
0/2
011
9/3
0/2
011
0.0
Desig
n D
ev. / P
hase I C
D's
Receiv
ed
2/1
7/2
012
2/1
0/2
012
0.2
To
tal
325,0
16,0
00
$
317,2
34,0
75
$
98%
Desig
n D
evelo
pm
ent A
ppro
ved
3/3
0/2
012
4/2
4/2
012
(0.8
)
Phase II C
onstr
uction D
ocs R
eceiv
ed
11/2
1/2
012
11/3
0/2
012
(0.3
)
Phase I C
onstr
uction S
tart
(N
TP
)6/1
1/2
012
6/4
/2012
0.2
Metr
icT
arg
et
(To
Date
)C
urr
en
t
Phase I C
onstr
uction C
om
ple
te3/2
9/2
013
3/2
9/2
013
0.0
SB
E P
art
icip
ation
30%
39%
Phase II C
onstr
uction S
tart
(N
TP
)4/1
0/2
013
5/1
3/2
013
(1.1
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
24%
Phase II C
onstr
uction C
om
ple
te1/7
/2016
5/2
/2016
(3.8
)
Ph
ase II F
F&
E / M
ove-I
n C
om
ple
te3/1
7/2
016
5/1
3/2
016
(1.9
)C
ontr
acts
Aw
ard
ed to D
ate
100%
100%
Phase III C
onstr
uction S
tart
(N
TP
)5/5
/2016
TB
DE
arn
ed V
alu
e to D
ate
100%
99%
Phase III C
onstr
uction C
om
ple
te2/1
2/2
017
TB
DE
xpenditure
s to D
ate
100%
97%
Phase III F
F&
E / M
ove-I
n C
om
ple
te3/4
/2017
TB
DC
onstr
uction C
hange O
rders
5%
10%
Pro
ject
Co
mp
leti
on
3/4
/2017
TB
DC
ontingency / R
em
ain
ing C
osts
5%
5%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$248,8
72,6
08
$248,4
85,0
37
$90,0
00
$297,5
71
$248,8
72,6
08
$0
$243,8
19,9
06
Desig
n S
erv
ices
$23,9
25,5
45
$23,9
25,5
45
$0
$0
$23,9
25,5
45
$0
$22,7
54,3
92
Tele
com
m$7,5
14,2
93
$7,5
06,8
47
$7,4
46
$0
$7,5
14,2
93
$0
$7,4
74,6
89
Furn
ishin
g, F
ixtu
res &
Equip
ment
$25,0
59,3
90
$24,9
86,4
47
$72,9
43
$0
$25,0
59,3
90
$0
$24,2
74,3
21
Constr
uction A
dm
inis
tration
$2,8
78,5
31
$2,8
78,5
31
$0
$0
$2,8
78,5
31
$0
$2,8
78,5
30
Oth
er
A/E
& C
onsultin
g S
erv
ices
$8,8
64,4
41
$8,8
64,4
41
$0
$0
$8,8
64,4
41
$0
$8,7
05,3
02
Art
work
$201,0
80
$201,0
80
$0
$0
$201,0
80
$0
$201,0
80
Relo
cation
$491,2
12
$491,2
12
$0
$0
$491,2
12
$0
$460,0
35
Environm
enta
l$241,2
82
$241,2
82
$0
$0
$241,2
82
$0
$241,2
82
Insura
nce &
Legal
$5,2
11,1
41
$5,0
99,7
51
$111,3
90
$0
$5,2
11,1
41
$0
$5,0
95,4
82
Oth
er
Mis
cella
neous
$1,3
87,9
63
$1,3
68,7
12
$19,2
51
$0
$1,3
87,9
63
$0
$1,3
29,0
55
Su
bto
tal
$324,6
47,4
86
$324,0
48,8
85
$301,0
30
$297,5
71
$324,6
47,4
86
$0
$317,2
34,0
75
Co
nti
ng
en
cy
$368,5
14
$368,5
14
$0
$368,5
14
$0
$0
TO
TA
L$325,0
16,0
00
$324,0
48,8
85
$669,5
44
$297,5
71
$325,0
16,0
00
$0
$317,2
34,0
75
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
3
JD
H N
ew
Co
nstr
ucti
on
&
CO
ST
/ F
OR
EC
AS
T *
NO
TE
S
Ren
ovati
on
s (
Ro
ll u
p)
(1)
The p
endin
g c
om
mitm
ent am
ount in
clu
des a
ll pote
ntial costs
for
Turn
er
and their
subcontr
acto
rs.
Ph
ase I -
Park
ing
& S
ite:
Constr
uction o
f a n
ew
403 s
pace p
ublic
gara
ge in t
he e
xis
ting I
lot.
In
additio
n t
o the n
orm
al site w
ork
for
constr
uction, exis
ting s
ite u
tilit
ies inclu
din
g s
anitary
, sto
rm,
wate
r, a
nd
ele
ctr
ical w
ill b
e r
elo
cate
d d
uring t
he initia
l constr
uction p
hase t
o
accom
modate
the c
onstr
uction o
f th
e n
ew
tow
er.
Ph
ase II
-T
he N
ew
Ho
sp
ital
To
wer:
Will
inclu
de e
leven levels
and w
ill
house k
ey p
atient
are
as inclu
din
g t
he e
merg
ency d
epart
ment,
surg
ery
suite,
MR
I suite,
renal dia
lysis
, re
spirato
ry t
hera
py,
inpatient
rehab
(ort
hopedic
s,
rehab g
ym
and w
ork
space),
clin
ical support
, and p
atient
education s
pace. S
upport
serv
ices locate
d in t
he n
ew
tow
er
will
inclu
de
centr
al ste
rile
pro
cessin
g a
nd a
new
main
lobby.
Phase
II a
lso inclu
des a
new
397 s
pace s
taff
gara
ge.
Ph
ase
III
-H
Bu
ild
ing
Ren
ovati
on
: R
epla
cem
ents
and u
pgra
des t
o
syste
ms inclu
din
g h
eating,
air c
onditio
nin
g,
ventila
tion,
plu
mbin
g a
nd
ele
ctr
ical syste
ms.
Renovation
of th
e e
xis
ting J
ohn D
em
psey H
ospital
floors
is n
ot
curr
ently
funded.
SC
OP
E
$0
$50,000,00
0
$100
,000,000
$150
,000,000
$200
,000,000
$250
,000,000
$300
,000,000
$350
,000,000
$400
,000,000
Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
DE
SC
RIP
TIO
N /
TE
AM
SC
HE
DU
LE
FU
ND
ING
*
A A A A A A AM
ET
RIC
S
A A A AA
(1)
59
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
Clo
se O
ut
Desig
ner:
SB
A / H
KS
Constr
ucto
r:T
urn
er
Constr
uction
Pro
ject M
anager:
Kevin
Nort
on
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
6/3
0/2
010
6/3
0/2
010
0.0
UC
21
13,9
69,7
95
$
13,9
69,7
94
$
100%
Desig
n S
tart
(N
TP
)9/2
/2010
9/2
/2010
0.0
Schem
atic D
esig
n R
eceiv
ed
8/1
9/2
011
8/1
9/2
011
0.0
Schem
atic D
esig
n A
ppro
ved
9/3
0/2
011
9/3
0/2
011
0.0
Enablin
g C
D's
Receiv
ed
2/1
7/2
012
2/1
0/2
012
0.2
To
tal
13,9
69,7
95
$
13,9
69,7
94
$
100%
Site &
Park
ing G
MP
5/2
2/2
012
5/2
2/2
012
0.0
Site &
Park
ing C
onstr
uction S
tart
(N
TP
)6/1
1/2
012
6/4
/2012
0.2
Constr
uction S
ubsta
ntial C
om
ple
te3/2
9/2
013
3/2
9/2
013
0.0
Metr
icT
arg
et
(To
Date
)C
urr
en
t
Pro
ject C
om
ple
te6/2
6/2
013
4/3
0/2
013
1.9
SB
E P
art
icip
ation
30%
37%
MB
E/W
BE
/DB
E P
art
icip
ation
10%
13%
Contr
acts
Aw
ard
ed to D
ate
100%
100%
Earn
ed V
alu
e to D
ate
100%
100%
Expenditure
s to D
ate
100%
100%
Constr
uction C
hange O
rders
(1
)6%
0%
Pro
ject
Co
mp
leti
on
6/2
6/2
013
4/3
0/2
013
1.9
Contingency / R
em
ain
ing C
osts
0%
0%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
(1)
Fin
al constr
uction c
ost w
as 2
% less than initia
l constr
uction c
ontr
act
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$13,4
35,9
07
$13,4
35,9
07
$0
$0
$13,4
35,9
07
$0
$13,4
35,9
06
Desig
n S
erv
ices
$0
$0
$0
$0
$0
$0
$0
Tele
com
m$0
$0
$0
$0
$0
$0
$0
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$0
$0
$0
$0
$0
$0
$0
Constr
uction A
dm
inis
tration
$0
$0
$0
$0
$0
$0
$0
Oth
er
A/E
& C
onsultin
g S
erv
ices
$437,7
10
$437,7
10
$0
$0
$437,7
10
$0
$437,7
10
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$0
$0
$0
$0
$0
$0
$0
Environm
enta
l$8,0
00
$8,0
00
$0
$0
$8,0
00
$0
$8,0
00
Insura
nce &
Legal
$25,0
00
$25,0
00
$0
$0
$25,0
00
$0
$25,0
00
Oth
er
Mis
cella
neous
$63,1
78
$63,1
78
$0
$0
$63,1
78
$0
$63,1
78
Su
bto
tal
$13,9
69,7
95
$13,9
69,7
95
$0
$0
$13,9
69,7
95
$0
$13,9
69,7
94
Co
nti
ng
en
cy
$0
$0
$0
$0
$0
$0
$0
TO
TA
L$13,9
69,7
95
$13,9
69,7
95
$0
$0
$13,9
69,7
95
$0
$13,9
69,7
94
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
4
Gara
ge
Ph
ase I -
Sit
e &
East
Park
ing
CO
ST
/ F
OR
EC
AS
T *
Sit
e:
In a
dditio
n t
o t
he n
orm
al site w
ork
for
constr
uction, exis
ting s
ite
utilit
ies inclu
din
g s
anitary
, sto
rm,
wate
r, a
nd e
lectr
ical w
ill b
e r
elo
cate
d
during t
he initia
l constr
uction p
hase t
o a
ccom
modate
the c
onstr
uction o
f th
e n
ew
tow
er
and p
ark
ing f
acili
ties.
Park
ing
: C
onstr
uction o
f a n
ew
403 s
pace p
ublic
gara
ge in t
he e
xis
ting I
lo
t
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A A a A AA AM
ET
RIC
S
$0
$2,000,000
$4,000,000
$6,000,000
$8,000,000
$10,000,00
0
$12,000,00
0
$14,000,00
0
$16,000,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Actual Expen
ditures
Projected Expe
nditu
res
A
60
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
Com
ple
te
(Hybrid O
R In C
onstr
uction)
Desig
ner:
SB
A / H
KS
Constr
ucto
r:T
urn
er
Constr
uction
Pro
ject M
anager:
Kevin
Nort
on
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
6/3
0/2
010
6/3
0/2
010
0.0
UC
21
303,4
68,2
05
$
296,9
51,5
73
$
98%
Desig
n S
tart
(N
TP
)9/2
/2010
9/2
/2010
0.0
UC
H F
unds
7,5
78,0
00
$
6,3
12,7
07
$
83%
Schem
atic D
esig
n R
eceiv
ed
8/1
9/2
011
8/1
9/2
011
0.0
Schem
atic D
esig
n A
ppro
ved
9/3
0/2
011
9/3
0/2
011
0.0
Desig
n D
ev. / E
nablin
g C
D's
Receiv
ed
2/1
7/2
012
2/1
0/2
012
0.2
To
tal
311,0
46,2
05
$
303,2
64,2
80
$
97%
Desig
n D
evelo
pm
ent A
ppro
ved
3/3
0/2
012
3/3
0/2
012
0.0
Constr
uction D
ocum
ents
Receiv
ed
11/9
/2012
11/3
0/2
012
(0.7
)
New
Tow
er
GM
P3/2
9/2
013
5/2
/2013
(1.1
)M
etr
icT
arg
et
(To
Date
)C
urr
en
t
New
Tow
er
Constr
uction S
tart
(N
TP
)4/1
0/2
013
5/1
3/2
013
(1.1
)S
BE
Part
icip
ation
30%
39%
Com
mis
sio
nin
g C
om
ple
te11/1
3/2
015
5/1
1/2
016
(5.9
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
24%
Su
bsta
nti
al C
om
ple
tio
n1/7
/2016
5/2
/2016
(3.8
)
FF
&E
Com
ple
te3/3
/2016
5/1
1/2
016
(2.3
)C
ontr
acts
Aw
ard
ed to D
ate
100%
100%
New
Tow
er
Move-I
n C
om
ple
te3/1
7/2
016
5/1
3/2
016
(1.9
)E
arn
ed V
alu
e to D
ate
100%
99%
Phase 2
b S
itew
ork
Com
ple
te6/1
7/2
016
10/2
5/2
016
(4.3
)E
xpenditure
s to D
ate
100%
97%
Pro
ject C
loseout
8/5
/2016
12/3
1/2
016
(4.9
)C
onstr
uction C
hange O
rders
5%
11%
Pro
ject
Co
mp
leti
on
8/5
/2016
12/3
1/2
016
(4.9
)C
ontingency / R
em
ain
ing C
osts
5%
5%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$235,4
36,7
01
$235,0
49,1
30
$90,0
00
$297,5
71
$235,4
36,7
01
$0
$230,3
84,0
00
Desig
n S
erv
ices
$23,9
25,5
45
$23,9
25,5
45
$0
$0
$23,9
25,5
45
$0
$22,7
54,3
92
Tele
com
m$7,5
14,2
93
$7,5
06,8
47
$7,4
46
$0
$7,5
14,2
93
$0
$7,4
74,6
89
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$25,0
59,3
90
$24,9
86,4
47
$72,9
43
$0
$25,0
59,3
90
$0
$24,2
74,3
21
Constr
uction A
dm
inis
tration
$2,8
78,5
31
$2,8
78,5
31
$0
$0
$2,8
78,5
31
$0
$2,8
78,5
30
Oth
er
A/E
& C
onsultin
g S
erv
ices
$8,4
26,7
31
$8,4
26,7
31
$0
$0
$8,4
26,7
31
$0
$8,2
67,5
92
Art
work
$201,0
80
$201,0
80
$0
$0
$201,0
80
$0
$201,0
80
Relo
cation
$491,2
12
$491,2
12
$0
$0
$491,2
12
$0
$460,0
35
Environm
enta
l$233,2
82
$233,2
82
$0
$0
$233,2
82
$0
$233,2
82
Insura
nce &
Legal
$5,1
86,1
41
$5,0
74,7
51
$111,3
90
$0
$5,1
86,1
41
$0
$5,0
70,4
82
Oth
er
Mis
cella
neous
$1,3
24,7
85
$1,3
05,5
34
$19,2
51
$0
$1,3
24,7
85
$0
$1,2
65,8
77
Su
bto
tal
$310,6
77,6
91
$310,0
79,0
90
$301,0
30
$297,5
71
$310,6
77,6
91
$0
$303,2
64,2
80
Co
nti
ng
en
cy
$368,5
14
$0
$368,5
14
$0
$368,5
14
$0
$0
TO
TA
L$311,0
46,2
05
$310,0
79,0
90
$669,5
44
$297,5
71
$311,0
46,2
05
$0
$303,2
64,2
80
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
5
Ph
ase II -
New
Ho
sp
ital T
ow
er
CO
ST
/ F
OR
EC
AS
T *
& S
taff
Park
ing
Gara
ge
*Phase II: Is s
how
ing a
Pro
ject C
om
ple
tion d
ate
of 8/1
6/1
6. T
his
late
r date
is d
ue to the
Phase 2
b P
ost E
D w
ork
schedule
d to o
ccur
3/2
3/1
6-6
/28/1
6.
Th
e N
ew
Ho
sp
ital
To
wer:
Constr
uction o
f a n
ew
384,0
00 s
quare
foot,
169 b
ed,
ele
ven f
loor
hospital to
wer.
N
ew
Sp
ace:
-E
merg
ency D
epart
ment
-S
urg
ery
Suite
-M
RI S
uite
-R
enal D
ialy
sis
-R
espirato
ry T
hera
py
-In
patient
Rehabili
tation
-C
linic
al
Support
-P
atient
Education
Park
ing
:397 s
pace s
taff
gara
ge.SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A A A A A
ME
TR
ICS
$0
$50,000,00
0
$100
,000,000
$150
,000,000
$200
,000,000
$250
,000,000
$300
,000,000
$350
,000,000
Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Actual Expen
ditures
Projected Expe
nditu
res
AA A AA A
61
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
On H
old
Desig
ner:
SB
A / H
KS
Constr
ucto
r:T
urn
er
Constr
uction
Pro
ject M
anager:
Kevin
Nort
on
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
6/3
0/2
010
6/3
0/2
010
0.0
UC
21
-$
-$
#D
IV/0
!
Desig
n S
tart
(N
TP
)9/2
/2010
9/2
/2010
0.0
UC
H F
unds
-$
Schem
atic D
esig
n R
eceiv
ed
8/1
9/2
011
8/1
9/2
011
0.0
Schem
atic D
esig
n A
ppro
ved
9/3
0/2
011
9/3
0/2
011
0.0
Desig
n D
evelo
pm
ent R
eceiv
ed
2/1
7/2
012
2/1
0/2
012
0.2
To
tal
-$
-$
#D
IV/0
!
Desig
n D
evelo
pm
ent A
ppro
ved
3/3
0/2
012
3/3
0/2
012
0.0
Constr
uction D
ocum
ents
Receiv
ed
11/9
/2012
11/3
0/2
012
(0.7
)
Constr
uction G
MP
1/3
1/2
016
TB
DM
etr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction S
tart
(N
TP
)5/5
/2016
TB
DS
BE
Part
icip
ation
30%
N/A
Constr
uction C
om
ple
te2/1
2/2
017
TB
DM
BE
/WB
E/D
BE
Part
icip
ation
10%
N/A
Com
mis
sio
nin
g C
om
ple
te2/1
2/2
017
TB
D
FF
&E
Com
ple
te3/4
/2017
TB
DC
ontr
acts
Aw
ard
ed to D
ate
N/A
N/A
Move-I
n C
om
ple
te3/4
/2017
TB
DE
arn
ed V
alu
e to D
ate
100%
100%
Expenditure
s to D
ate
100%
100%
Constr
uction C
hange O
rders
N/A
0%
Pro
ject
Co
mp
leti
on
3/4
/2017
TB
DC
ontingency / R
em
ain
ing C
osts
10%
N/A
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
Costs
for
Phase III D
esig
n S
erv
ices a
re inclu
ded in P
hase II R
eport
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$0
$0
$0
$0
$0
$0
$0
Desig
n S
erv
ices
$0
$0
$0
$0
$0
$0
$0
Tele
com
m$0
$0
$0
$0
$0
$0
$0
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$0
$0
$0
$0
$0
$0
$0
Constr
uction A
dm
inis
tration
$0
$0
$0
$0
$0
$0
$0
Oth
er
A/E
& C
onsultin
g S
erv
ices
$0
$0
$0
$0
$0
$0
$0
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$0
$0
$0
$0
$0
$0
$0
Environm
enta
l$0
$0
$0
$0
$0
$0
$0
Insura
nce &
Legal
$0
$0
$0
$0
$0
$0
$0
Oth
er
Mis
cella
neous
$0
$0
$0
$0
$0
$0
$0
Su
bto
tal
$0
$0
$0
$0
$0
$0
$0
Co
nti
ng
en
cy
$0
$0
$0
$0
$0
$0
$0
TO
TA
L$0
$0
$0
$0
$0
$0
$0
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
6
H B
uil
din
g R
en
ova
tio
n CO
ST
/ F
OR
EC
AS
T *
Infr
astr
uctu
re:
Repla
cem
ents
and u
pgra
des t
o s
yste
ms inclu
din
g
heating,
air c
onditio
nin
g,
ventila
tion,
plu
mbin
g a
nd e
lectr
ical syste
ms
Ren
ovati
on
:of
the e
xis
ting J
ohn D
em
psey H
ospital to
allo
w s
evera
l depart
ments
to e
xpand inclu
din
g:
-Clin
ical P
ath
olo
gy L
abs
-Clin
ical P
harm
acy
Th
is S
co
pe
IS N
OT
FU
ND
ED
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
A A A A A A A
$0
$5,000,000
$10,000,00
0
$15,000,00
0
$20,000,00
0
$25,000,00
0
$30,000,00
0
$35,000,00
0
$40,000,00
0
$45,000,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Actual Expen
ditures
Projected Expe
nditu
res
FU
ND
ING
*
ME
TR
ICS
62
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anager
Sta
tus:
Com
ple
te
Desig
ner:
Cente
rbro
ok A
rchitects
& P
lanners
Constr
ucto
r:S
kanska
Pro
ject M
anager:
David
Sem
noski
Pro
ject N
um
ber:
901729
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m S
tart
1/2
3/2
013
1/2
3/2
013
0.0
UC
21
36,0
95,0
00
$
35,1
24,1
87
$
97%
Pro
gra
m A
ppro
val
6/2
4/2
013
7/1
5/2
013
(0.7
)U
CH
Funds
700,0
00
$
276,1
47
$
39%
Schem
atic D
esig
n S
tart
7/1
5/2
013
7/1
5/2
013
0.0
Schem
atic D
esig
n R
eceiv
ed
10/1
7/2
013
10/1
7/2
013
0.0
Schem
atic D
esig
n A
ppro
ved
11/4
/2013
11/2
6/2
013
(0.7
)T
ota
l36,7
95,0
00
$
35,4
00,3
34
$
96%
Desig
n D
evelo
pm
ent R
eceiv
ed
2/2
8/2
014
2/2
6/2
014
0.1
Desig
n D
evelo
pm
ent A
ppro
ved
4/4
/2014
3/2
1/2
014
0.5
Constr
uction D
ocum
ents
Receiv
ed
8/1
4/2
014
11/2
1/2
014
(3.3
)M
etr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction G
MP
11/6
/2014
3/1
7/2
015
(4.3
)S
BE
Part
icip
ation
30%
45%
Constr
uction S
tart
11/2
1/2
014
4/2
0/2
015
(4.9
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
21%
Constr
uction C
om
ple
te9/2
8/2
016
9/1
9/2
017
(11.7
)
FF
&E
Com
ple
te11/8
/2016
9/2
5/2
017
(10.6
)C
ontr
acts
Aw
ard
ed to D
ate
100%
99%
Com
mis
sio
nin
g C
om
ple
te11/8
/2016
9/2
5/2
017
(10.6
)E
arn
ed V
alu
e to D
ate
100%
99%
Move-I
n C
om
ple
te11/8
/2016
10/2
/2017
(10.8
)E
xpenditure
s to D
ate
95%
92%
Constr
uction C
hange O
rders
5%
9%
Pro
ject
Co
mp
leti
on
11/8
/2016
10/2
/2017
(10.8
)C
ontingency / R
em
ain
ing C
osts
5%
13%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$28,4
75,3
45
$28,4
40,3
45
$0
$35,0
00
$28,4
75,3
45
$0
$27,9
09,5
13
Desig
n S
erv
ices
$3,4
94,2
69
$3,4
64,2
69
$30,0
00
$0
$3,4
94,2
69
$0
$3,4
60,9
40
Tele
com
m$567,5
84
$567,5
84
$0
$0
$567,5
84
$0
$560,8
33
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$1,2
49,0
73
$1,2
49,0
73
$0
$0
$1,2
49,0
73
$0
$1,1
85,1
53
Constr
uction A
dm
inis
tration
$205,3
72
$205,3
72
$0
$0
$205,3
72
$0
$125,3
57
Oth
er
A/E
& C
onsultin
g S
erv
ices
$1,4
70,0
78
$1,4
60,0
78
$10,0
00
$0
$1,4
70,0
78
$0
$1,4
53,6
87
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$40,0
00
$40,0
00
$0
$0
$40,0
00
$0
$30,9
58
Environm
enta
l$35,0
00
$35,0
00
$0
$0
$35,0
00
$0
$33,0
29
Insura
nce &
Legal
$942,6
28
$919,7
99
$22,8
29
$0
$942,6
28
$0
$566,1
33
Oth
er
Mis
cella
neous
$156,6
45
$147,1
51
$9,4
94
$0
$156,6
45
$0
$74,7
31
Su
bto
tal
$36,6
35,9
94
$36,5
28,6
71
$72,3
23
$35,0
00
$36,6
35,9
94
$0
$35,4
00,3
34
Co
nti
ng
en
cy
$159,0
06
$0
$159,0
06
$0
$159,0
06
$0
$0
TO
TA
L$36,7
95,0
00
$36,5
28,6
71
$231,3
29
$35,0
00
$36,7
95,0
00
$0
$35,4
00,3
34
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
7
Acad
em
ic B
uild
ing
Ad
dit
ion
&
CO
ST
/ F
OR
EC
AS
T *
(1)
The p
endin
g c
om
mitm
ent am
ount in
clu
des a
ll pote
ntial costs
for
Skanska a
nd their
subcontr
acto
rs.
Constr
uction o
f a
17,6
00 s
.f. additio
n a
nd r
enovations to the
exis
ting A
cadem
ic B
uild
ing t
o p
rovid
e n
ew
cla
ssro
om
space f
or
the m
edic
al and d
enta
l schools
.
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
A A A A A A A A AA
FU
ND
ING
*
$0
$5,000,000
$10,000,00
0
$15,000,00
0
$20,000,00
0
$25,000,00
0
$30,000,00
0
$35,000,00
0
$40,000,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
ME
TR
ICS
(1)
63
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anager
Sta
tus:
In C
onstr
uction
Desig
ner:
Arc
hitectu
ral R
esourc
es C
am
bridge
Constr
ucto
r:F
usco
Pro
ject M
anager:
Kevin
Nort
on
Pro
ject N
um
ber:
901737
Ori
gin
al T
arg
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m S
tart
2/2
5/2
013
2/1
2/2
013
0.4
UC
21
88,5
89,6
04
$
65,7
44,4
72
$
74%
Pro
gra
m A
ppro
val
10/2
4/2
013
10/1
4/2
013
0.3
UC
H F
unds
4,7
75,0
00
$
1,9
14,5
03
$
40%
Schem
atic D
esig
n S
tart
(N
TP
)10/2
5/2
013
10/1
5/2
013
0.3
Schem
atic D
esig
n R
eceiv
ed
1/2
8/2
014
4/2
4/2
014
(2.8
)
Schem
atic D
esig
n A
ppro
ved
2/2
6/2
014
8/1
/2014
(5.1
)T
ota
l93,3
64,6
04
$
67,6
58,9
75
$
72%
Desig
n D
evelo
pm
ent R
eceiv
ed
7/2
3/2
014
1/1
5/2
015
(5.8
)
Desig
n D
evelo
pm
ent A
ppro
ved
8/2
2/2
014
5/8
/2015
(8.5
)
Constr
uction D
ocum
ents
Receiv
ed
1/2
/2015
10/1
5/2
015
(9.4
)M
etr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction D
ocum
ents
Revie
wed
1/3
0/2
015
10/1
5/2
015
(8.5
)S
BE
Part
icip
ation
30%
N/A
Constr
uction G
MP
4/1
0/2
015
3/1
8/2
016
(11.3
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
N/A
Constr
uction S
tart
(N
TP
)4/2
4/2
015
5/2
3/2
016
(13.0
)
Constr
uction C
om
ple
te4/2
7/2
018
2/1
8/2
019
(9.8
)C
ontr
acts
Aw
ard
ed to D
ate
98%
99%
FF
&E
Com
ple
te4/2
7/2
018
2/1
8/2
019
(9.8
)E
arn
ed V
alu
e to D
ate
88%
83%
Com
mis
sio
nin
g C
om
ple
te4/2
7/2
018
2/1
8/2
019
(9.8
)E
xpenditure
s to D
ate
82%
72%
Move-I
n C
om
ple
te4/2
7/2
018
2/2
5/2
019
(10.0
)C
onstr
uction C
hange O
rders
4%
6%
Pro
ject
Co
mp
leti
on
4/2
7/2
018
2/2
5/2
019
(10.0
)C
ontingency / R
em
ain
ing C
osts
5%
2%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$72,4
71,9
84
$72,1
12,0
24
$0
$359,9
60
$72,4
71,9
84
$0
$51,3
88,7
36
Desig
n S
erv
ices
$7,3
99,4
24
$7,3
69,2
24
$30,2
00
$0
$7,3
99,4
24
$0
$6,9
06,0
21
Tele
com
m$986,9
94
$938,4
85
$48,5
08
$0
$986,9
94
$0
$921,4
42
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$5,2
62,9
67
$5,0
96,2
22
$166,7
45
$0
$5,2
62,9
67
$0
$2,4
10,7
23
Constr
uction A
dm
inis
tration
$730,0
94
$730,0
94
$0
$0
$730,0
94
$0
$405,0
94
Oth
er
A/E
& C
onsultin
g S
erv
ices
$4,0
82,9
64
$4,0
82,9
64
$0
$0
$4,0
82,9
64
$0
$3,7
00,8
08
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$280,3
47
$280,3
47
$0
$0
$280,3
47
$0
$103,2
18
Environm
enta
l$248,9
90
$248,9
90
$0
$0
$248,9
90
$0
$237,6
68
Insura
nce &
Legal
$1,5
66,0
62
$1,5
66,0
62
$0
$0
$1,5
66,0
62
$0
$1,4
95,8
72
Oth
er
Mis
cella
neous
$114,3
94
$114,3
94
$0
$0
$114,3
94
$0
$89,3
94
Su
bto
tal
$93,1
44,2
21
$92,5
38,8
07
$245,4
53
$359,9
60
$93,1
44,2
21
$0
$67,6
58,9
75
Co
nti
ng
en
cy
$220,3
83
$0
$220,3
83
$0
$220,3
83
$0
$0
TO
TA
L$93,3
64,6
04
$92,5
38,8
07
$465,8
37
$359,9
60
$93,3
64,6
04
$0
$67,6
58,9
75
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 1
8
Clin
ical R
en
ovati
on
s -
C B
ldg
CO
ST
/ F
OR
EC
AS
T *
Infr
astr
uctu
re R
enovations t
o t
he e
xis
ting C
linic
(C
) build
ing i
nclu
din
g
ME
P s
yste
ms
School of
Denta
l/M
edic
ine E
xpansio
n a
nd R
enovations
Pat
and J
im C
alh
oun C
ard
iolo
gy C
ente
r E
xpansio
n a
nd R
enovations
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A AA
ME
TR
ICS
AA
$0
$10,000,00
0
$20,000,00
0
$30,000,00
0
$40,000,00
0
$50,000,00
0
$60,000,00
0
$70,000,00
0
$80,000,00
0
$90,000,00
0
$100
,000,000
Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8Jul‐1
9
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
A A A
64
Bio
scie
nce
Co
nn
ecticu
t C
ap
ita
l P
roje
cts
Re
po
rt N
o.
72
- A
pri
l 2
01
8
Pro
ject
Re
po
rt
Pro
ject
Title
:
De
live
ry M
eth
od
:C
on
str
uctio
n M
an
ag
em
en
t
Sta
tus:
Co
mp
lete
De
sig
ne
r:S
tan
tec
Co
nstr
ucto
r:T
urn
er
Co
nstr
uctio
n
Pro
ject
Ma
na
ge
r:R
ich
Alle
n
Pro
ject
Nu
mb
er:
90
11
34
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce i
n
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Com
ple
te S
D (
Pre
-Bio
scie
nce P
lannin
g)
5/1
5/2
011
5/1
5/2
011
0.0
UC
21
76,5
30,0
00
$
76,5
28,0
99
$
100%
Revis
ed M
aste
r P
lan A
ppro
val
11/1
1/2
011
11/1
1/2
011
0.0
UC
H F
unds
815,5
03
$
815,4
99
$
100%
NT
P f
or
Revis
ed D
esig
n12/1
6/2
011
12/1
6/2
011
0.0
Revis
ed P
rog
ram
2/8
/2012
2/8
/2012
0.0
Desig
n D
evelo
pm
ent
Receiv
ed
4/6
/2012
3/3
0/2
012
0.2
To
tal
77,3
45,5
03
$
77,3
43,5
98
$
100%
Desig
n D
evelo
pm
ent
Appro
ved
5/2
2/2
012
6/1
/2012
(0.3
)
50%
Constr
uction D
ocum
ents
Receiv
ed
8/1
7/2
012
8/1
7/2
012
0.0
Dem
olit
ion D
ocum
ents
Receiv
ed
9/1
4/2
012
9/1
4/2
012
0.0
Metr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction D
ocum
ents
Receiv
ed
11/9
/2012
11/3
0/2
012
(0.7
)S
BE
Part
icip
ation
30%
48%
Constr
uction G
MP
11/1
6/2
012
12/7
/2012
(0.7
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
29%
Constr
uction S
tart
(N
TP
)11/1
6/2
012
12/7
/2012
(0.7
)
Com
mis
sio
nin
g C
om
ple
te6/1
9/2
015
9/2
1/2
015
(3.1
)C
ontr
acts
Aw
ard
ed t
o D
ate
100%
100%
Constr
uction C
om
ple
te7/1
0/2
015
9/2
1/2
015
(2.4
)E
arn
ed V
alu
e t
o D
ate
100%
100%
FF
&E
Com
ple
te8/7
/2015
10/1
9/2
015
(2.4
)E
xpenditure
s t
o D
ate
100%
100%
Move-I
n C
om
ple
te8/7
/2015
11/3
/2015
(2.9
)C
onstr
uction C
hang
e O
rders
5%
6%
Pro
ject
Co
mp
leti
on
8/7
/2015
11/3
/2015
(2.9
)C
onting
ency /
Rem
ain
ing
Costs
5%
N/A
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$63,3
26,7
01
$63,3
26,7
01
$0
$0
$63,3
26,7
01
$0
$63,3
26,7
01
Desig
n S
erv
ice
$6,7
07,3
62
$6,7
07,3
62
$0
$0
$6,7
07,3
62
$0
$6,7
07,3
63
Tele
com
m$613,9
39
$613,9
39
$0
$0
$613,9
39
$0
$613,9
40
Furn
ishin
g,
Fix
ture
s &
Eq
uip
ment
$1,3
70,2
65
$1,3
70,2
65
$0
$0
$1,3
70,2
65
$0
$1,3
70,2
64
Constr
uction A
dm
inis
tration
$392,3
57
$392,3
57
$0
$0
$392,3
57
$0
$392,3
57
Oth
er
A/E
& C
onsultin
g S
erv
ices
$2,1
37,0
99
$2,1
37,0
99
$0
$0
$2,1
37,0
99
$0
$2,1
37,0
98
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$479,9
69
$479,9
69
$0
$0
$479,9
69
$0
$479,9
69
Environm
enta
l$242,0
38
$242,0
38
$0
$0
$242,0
38
$0
$242,0
39
Insura
nce &
Leg
al
$1,2
57,4
03
$1,2
57,4
03
$0
$0
$1,2
57,4
03
$0
$1,2
57,4
02
Oth
er
Mis
cella
neous
$816,4
65
$816,4
65
$0
$0
$816,4
65
$0
$816,4
65
Su
bto
tal
$77,3
43,5
98
$77,3
43,5
98
$0
$0
$77,3
43,5
98
$0
$77,3
43,5
98
Co
nti
ng
en
cy
$1,9
05
$0
$1,9
05
$0
$1,9
05
$0
$0
TO
TA
L$77,3
45,5
03
$77,3
43,5
98
$1,9
05
$0
$77,3
45,5
03
$0
$77,3
43,5
98
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ifica
tion
Pa
ge
19
Ma
in B
uil
din
g L
ab
(L
) R
en
ova
tio
ns
-
Pro
jec
t 1
CO
ST
/ F
OR
EC
AS
T *
Maste
r P
lan f
or
the c
om
ple
te r
enovation o
f 283,0
00 G
SF
of
space o
n
floors
1-7
of
the L
ab (
L)
build
ing
Renovatio
ns t
o a
ppro
xim
ate
ly 5
0%
of
the 2
83,0
00 G
SF
of
researc
h
and a
dm
in s
pace o
n f
loors
1 –
7 o
f th
e M
ain
Build
ing
Repla
cem
ent
of
the M
EP
infr
astr
uctu
re f
or
the r
enovate
d a
reas
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A A AA A A A AA A
$0
$10,00
0,00
0
$20,00
0,00
0
$30,00
0,00
0
$40,00
0,00
0
$50,00
0,00
0
$60,00
0,00
0
$70,00
0,00
0
$80,00
0,00
0
$90,00
0,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
ME
TR
ICS
A A A
65
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
Com
ple
te
Desig
ner:
Sta
nte
c
Constr
ucto
r:W
hitin
g T
urn
er
Pro
ject M
anager:
Ric
h A
llen
Pro
ject N
um
ber:
901772
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
0.0
UC
21
39,3
87,6
71
$
38,0
63,2
50
$
97%
Desig
n S
tart
(N
TP
)5/1
/2014
9/1
6/2
014
(4.5
)U
CH
Funds
502,0
00
$
502,0
00
$
100%
Schem
atic D
esig
n R
eceiv
ed
9/1
6/2
014
12/1
2/2
015
(14.9
)
Schem
atic D
esig
n A
ppro
ved
10/3
/2014
2/1
3/2
015
(4.4
)
Desig
n D
evelo
pm
ent R
eceiv
ed
12/3
0/2
014
7/2
/2015
(6.0
)T
ota
l39,8
89,6
71
$
38,5
65,2
50
$
97%
Desig
n D
evelo
pm
ent A
ppro
ved
1/2
7/2
015
7/2
/2015
(5.1
)
Constr
uction D
ocum
ents
Receiv
ed
3/2
4/2
015
10/1
6/2
015
(6.8
)
Constr
uction G
MP
5/1
9/2
015
1/2
7/2
016
(8.3
)M
etr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction S
tart
8/1
9/2
015
12/1
4/2
015
(3.8
)S
BE
Part
icip
ation
30%
25%
Constr
uction C
om
ple
te11/2
4/2
017
3/2
9/2
017
7.9
MB
E/W
BE
/DB
E P
art
icip
ation
10%
19%
FF
&E
Com
ple
te12/2
5/2
017
4/1
3/2
017
8.4
Com
mis
sio
nin
g C
om
ple
te12/2
5/2
017
4/1
3/2
017
8.4
Contr
acts
Aw
ard
ed to D
ate
100%
99%
Move-I
n C
om
ple
te12/2
5/2
017
5/1
1/2
017
7.5
Earn
ed V
alu
e to D
ate
100%
99%
Expenditure
s to D
ate
91%
92%
Constr
uction C
hange O
rders
5%
6%
Pro
ject
Co
mp
leti
on
12/2
5/2
017
5/1
1/2
017
7.5
Contingency / R
em
ain
ing C
osts
10%
44%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$33,2
64,5
66
$33,2
64,5
66
$0
$0
$33,2
64,5
66
$0
$32,5
03,0
24
Desig
n S
erv
ices
$2,9
18,1
68
$2,9
18,1
68
$0
$0
$2,9
18,1
68
$0
$2,9
18,1
68
Tele
com
m$416,8
48
$416,8
48
$0
$0
$416,8
48
$0
$415,5
97
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$353,4
63
$353,4
63
$0
$0
$353,4
63
$0
$353,4
63
Constr
uction A
dm
inis
tration
$328,7
93
$328,7
93
$0
$0
$328,7
93
$0
$328,7
93
Oth
er
A/E
& C
onsultin
g S
erv
ices
$1,1
32,1
25
$1,1
32,1
25
$0
$0
$1,1
32,1
25
$0
$1,1
31,8
78
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$55,5
48
$55,5
48
$0
$0
$55,5
48
$0
$21,7
63
Environm
enta
l$37,5
80
$37,5
80
$0
$0
$37,5
80
$0
$36,7
80
Insura
nce &
Legal
$765,6
59
$695,5
20
$70,1
39
$0
$765,6
59
$0
$692,5
84
Oth
er
Mis
cella
neous
$210,1
51
$187,4
36
$22,7
15
$0
$210,1
51
$0
$163,1
99
Su
bto
tal
$39,4
82,9
01
$39,3
90,0
47
$92,8
54
$0
$39,4
82,9
01
$0
$38,5
65,2
50
Co
nti
ng
en
cy
$406,7
70
$0
$406,7
70
$0
$406,7
70
$0
$0
TO
TA
L$39,8
89,6
71
$39,3
90,0
47
$499,6
24
$0
$39,8
89,6
71
$0
$38,5
65,2
50
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 2
0
Main
Bu
ild
ing
Lab
(L
) R
en
ovati
on
s -
Pro
ject
2
CO
ST
/ F
OR
EC
AS
T *
Renovations
to a
ppro
xim
ate
ly 5
0%
of
the 2
83,0
00 G
SF
of
researc
h
and a
dm
in s
pace o
n f
loors
1 –
7 o
f th
e M
ain
Build
ing
Repla
cem
ent
of
the M
EP
infr
astr
uctu
re f
or
the r
enovate
d a
reas
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A A A A A
ME
TR
ICS
$0
$10,000,00
0
$20,000,00
0
$30,000,00
0
$40,000,00
0
$50,000,00
0
$60,000,00
0
$70,000,00
0
$80,000,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
66
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Desig
n/B
uild
(C
ore
& S
hell)
Constr
uction M
anagem
ent (F
it-O
ut)
Sta
tus:
Com
ple
te
D/B
Cri
teri
a A
rchitect:
Fle
tcher
Thom
pson/T
soi K
obus A
ssoc.
Fit-O
ut A
rchitect:
Perk
ins E
astm
an A
rchitects
Desig
n/B
uild
er:
Fusco / C
lark
, A
Join
t V
entu
re
Fit-O
ut C
onstr
uction M
anager:
Dim
eo C
onstr
uction C
om
pany
Pro
ject M
anager:
Robert
Palo
ma
Pro
ject N
um
ber:
11-0
42
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
FO
Constr
uction D
ocum
ents
Receiv
ed
6/3
0/2
013
8/2
8/2
013
(1.9
)C
TL F
unds
203,0
00,0
00
$
202,0
74,5
29
$
100%
FO
GM
P9/5
/2013
11/1
2/2
013
(2.2
)
FO
Constr
uction S
tart
1/6
/2014
1/6
/2014
0.0
Core
&S
hell
Constr
uction C
om
ple
te10/1
5/2
014
10/1
5/2
014
0.0
FO
Constr
uction C
om
ple
te12/3
/2014
4/1
0/2
015
(4.2
)T
ota
l202,1
80,0
00
$
202,0
74,5
29
$
100%
FF
&E
, C
x, M
ove-I
n C
om
ple
te1/2
1/2
015
6/1
5/2
015
(4.8
)
Pro
ject
Co
mp
lete
(N
et
of
8th
Flo
or
East)
1/2
1/2
015
6/1
5/2
015
(4.8
)
Metr
icT
arg
et
(To
Date
)C
urr
en
t
SB
E P
art
icip
ation
30%
36%
MB
E/W
BE
/DB
E P
art
icip
ation
10%
22%
8 E
ast C
onstr
uction D
ocum
ents
Rec
5/2
9/2
015
6/1
/2015
(0.1
)
8 E
ast G
C C
ontr
act E
xecute
d1/2
8/2
016
1/2
8/2
016
0.0
Contr
acts
Aw
ard
ed to D
ate
100%
100%
8 E
ast C
onstr
uction S
tart
1/2
9/2
016
1/2
9/2
016
0.0
Earn
ed V
alu
e to D
ate
100%
100%
8 E
ast C
onstr
uction C
om
ple
te7/1
/2016
7/2
2/2
016
(0.7
)E
xpenditure
s to D
ate
100%
100%
FF
&E
, C
x, M
ove-I
n C
om
ple
te7/8
/2016
7/2
2/2
016
(0.5
)C
onstr
uction C
hange O
rders
5%
7%
8th
Flo
or
East
Pro
ject
Co
mp
lete
7/8
/2016
7/2
5/2
016
(0.6
)C
ontingency / R
em
ain
ing C
osts
5%
0%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$149,3
78,7
92
$149,3
78,7
92
$0
$0
$149,3
78,7
92
$0
$149,3
78,7
92
Desig
n S
erv
ices
$6,4
09,1
08
$6,4
09,1
08
$0
$0
$6,4
09,1
08
$0
$6,4
09,1
00
Tele
com
m$5,0
15,9
26
$5,0
11,5
91
$4,3
35
$0
$5,0
15,9
26
$0
$5,0
11,5
91
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$14,9
26,1
42
$14,9
26,1
42
$0
$0
$14,9
26,1
42
$0
$14,9
23,3
96
Constr
uction A
dm
inis
tration
$745,4
76
$745,4
76
$0
$0
$745,4
76
$0
$745,4
76
Oth
er
A/E
& C
onsultin
g S
erv
ices
$5,5
33,3
61
$5,5
16,2
10
$17,1
51
$0
$5,5
33,3
61
$0
$5,4
86,2
10
Art
work
$248,3
07
$248,3
07
$0
$0
$248,3
07
$0
$248,3
07
Relo
cation
$246,1
08
$246,1
08
$0
$0
$246,1
08
$0
$246,1
08
Environm
enta
l$293,2
53
$293,2
53
$0
$0
$293,2
53
$0
$293,2
53
Insura
nce &
Legal
$2,4
13,5
80
$2,4
13,5
80
$0
$0
$2,4
13,5
80
$0
$2,4
13,5
80
Oth
er
Mis
cella
neous
$16,9
69,9
47
$16,9
61,4
86
$8,4
61
$0
$16,9
69,9
47
$0
$16,9
18,7
16
Su
bto
tal
$202,1
80,0
00
$202,1
50,0
53
$29,9
47
$0
$202,1
80,0
00
$0
$202,0
74,5
29
Co
nti
ng
en
cy
$0
$0
$0
$0
$0
$0
$0
TO
TA
L$202,1
80,0
00
$202,1
50,0
53
$29,9
47
$0
$202,1
80,0
00
$0
$202,0
74,5
29
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 2
1
Ou
tpati
en
t P
avilio
n
CO
ST
/ F
OR
EC
AS
T *
New
Parking
Garage:
1,44
0 spaces
which includ
e 82
handicap spaces.
New
306
,880
squa
re fo
ot Outpa
tient Pavilion
to In
clud
e:
Relocatio
n of m
edical offices th
at are currently hou
sed inou
tdated
and
inadeq
uate m
edical office space in Dow
ling South(85,00
0 square fe
et) a
nd
a po
rtion of Dow
ling North (1
3,50
0square fe
et).
Relocatio
n of th
e Carole and
Ray Neag Co
mpreh
ensive Cancer C
enter
and Ra
diationOncology from
the existin
gmain bu
ilding to th
e Outpatie
nt
Pavilion.
Patie
nt‐cen
tered services such as a café, re
tail space for a
com
mercial
pharmacy and an
optical sho
p.
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A
ME
TR
ICS
A A A A A A
$0
$50,000,00
0
$100
,000,000
$150
,000,000
$200
,000,000
$250
,000,000
Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
AA AA A AA A A A A A A
67
B
ioscie
nce C
onnecticut C
apital P
roje
cts
Report
No. 72 -
Apri
l 2018
Pro
ject R
eport
Pro
ject T
itle
:
Deliv
ery
Meth
od:
Constr
uction M
anagem
ent
Sta
tus:
Com
ple
te
Desig
ner:
Goody C
lancy
Constr
ucto
r:S
tandard
Build
ers
Pro
ject M
anager:
Janic
e H
ill
Pro
ject N
um
ber:
901750
Targ
et
Actu
al/
Pro
jecte
d
Vari
an
ce in
Mo
nth
sS
ou
rce
Bu
dg
et
Co
st
to D
ate
% E
xp
en
ded
Pro
gra
m A
ppro
val
6/2
8/2
013
9/1
2/2
013
(2.5
)U
C21
18,7
70,0
00
$
18,6
62,7
93
$
99%
Schem
atic D
esig
n S
tart
(N
TP
)7/1
/2013
9/1
3/2
013
(2.4
)U
CH
Funds
550,0
00
$
133,9
45
$
24%
Schem
atic D
esig
n R
eceiv
ed
8/1
5/2
013
11/2
1/2
013
(3.2
)
Schem
atic D
esig
n A
ppro
ved
9/1
3/2
013
11/2
1/2
013
(2.3
)
Desig
n D
evelo
pm
ent R
eceiv
ed
12/1
8/2
013
1/3
0/2
014
(1.4
)T
ota
l19,3
20,0
00
$
18,7
96,7
38
$
97%
Desig
n D
evelo
pm
ent A
ppro
ved
1/1
6/2
014
4/1
/2014
(2.5
)
Constr
uction D
ocum
ents
Receiv
ed
6/2
/2014
7/2
4/2
014
(1.7
)
Constr
uction G
MP
& m
obili
zation
8/1
5/2
014
10/6
/2014
(1.7
)M
etr
icT
arg
et
(To
Date
)C
urr
en
t
Constr
uction S
tart
(N
TP
)9/1
/2014
10/6
/2014
(1.2
)S
BE
Part
icip
ation
30%
23%
Constr
uction C
om
ple
te10/9
/2015
10/3
0/2
015
(0.7
)M
BE
/WB
E/D
BE
Part
icip
ation
10%
9%
FF
&E
Com
ple
te10/9
/2015
4/2
9/2
016
(6.7
)
Com
mis
sio
nin
g C
om
ple
te10/9
/2015
5/6
/2016
(6.9
)C
ontr
acts
Aw
ard
ed to D
ate
100%
98%
Move-I
n C
om
ple
te10/9
/2015
4/2
9/2
016
(6.7
)E
arn
ed V
alu
e to D
ate
100%
98%
Expenditure
s to D
ate
100%
96%
Constr
uction C
hange O
rders
6%
4%
Pro
ject
Co
mp
leti
on
10/9
/2015
5/7
/2016
(6.9
)C
ontingency / R
em
ain
ing C
osts
5%
1%
Pro
jecte
d
Bu
dg
et
Co
mm
itte
d
Co
sts
Un
co
mm
itte
d
Co
sts
Pen
din
g
Co
mm
itm
en
tsP
roje
cte
d C
osts
Pro
jecte
d
Over/
Un
der
Co
st
to D
ate
AB
CD
E=
B+
C+
DF
=A
-E
Constr
uction
$15,7
36,5
68
$15,7
36,5
68
$0
$0
$15,7
36,5
68
$0
$15,6
97,6
96
Desig
n S
erv
ices
$1,6
10,3
30
$1,6
10,3
30
$0
$0
$1,6
10,3
30
$0
$1,6
10,3
30
Tele
com
m$217,6
10
$217,6
10
$0
$0
$217,6
10
$0
$217,6
10
Furn
ishin
gs, F
ixtu
res &
Equip
ment
$390,3
78
$390,3
78
$0
$0
$390,3
78
$0
$390,3
78
Constr
uction A
dm
inis
tration
$250,0
00
$51,3
07
$198,6
93
$0
$250,0
00
$0
$51,3
07
Oth
er
A/E
& C
onsultin
g S
erv
ices
$455,8
44
$452,1
15
$3,7
29
$0
$455,8
44
$0
$452,1
15
Art
work
$0
$0
$0
$0
$0
$0
$0
Relo
cation
$0
$0
$0
$0
$0
$0
$0
Environm
enta
l$0
$0
$0
$0
$0
$0
$0
Insura
nce &
Legal
$564,1
31
$345,9
77
$218,1
54
$0
$564,1
31
$0
$291,4
85
Oth
er
Mis
cella
neous
$90,8
12
$85,8
18
$4,9
94
$0
$90,8
12
$0
$85,8
17
Su
bto
tal
$19,3
15,6
73
$18,8
90,1
03
$425,5
70
$0
$19,3
15,6
73
$0
$18,7
96,7
38
Co
nti
ng
en
cy
$4,3
27
$0
$4,3
27
$0
$4,3
27
$0
$0
TO
TA
L$19,3
20,0
00
$18,8
90,1
03
$429,8
97
$0
$19,3
20,0
00
$0
$18,7
96,7
38
* Fi
nanc
ial D
ata
Sub
ject
to P
lant
Acc
ount
ing
Ver
ificat
ion
Page 2
2
Incu
bato
r L
ab
Ad
dit
ion
- C
GS
B
CO
ST
/ F
OR
EC
AS
T *
New
build
ing a
dditio
n t
o t
he e
xis
ting C
ell
and G
enom
e S
cie
nce
Build
ing t
o c
reate
an a
dditio
nal
28,0
00 g
ross s
quare
feet
of
new
in
cubato
r space t
o f
oste
r new
busin
ess s
tart
-ups
and 2
,000 g
ross
square
feet
for
a D
ata
Cente
r D
isaste
r R
ecovery
space.
SC
OP
ED
ES
CR
IPT
ION
/ T
EA
M
SC
HE
DU
LE
FU
ND
ING
*
A A A A A A A A A A
ME
TR
ICS
$0
$5,000,000
$10,000,00
0
$15,000,00
0
$20,000,00
0
$25,000,00
0 Jul‐0
9Jul‐1
0Jul‐1
1Jul‐1
2Jul‐1
3Jul‐1
4Jul‐1
5Jul‐1
6Jul‐1
7Jul‐1
8
Overall Project C
ash Flow
Plan
vs. Actua
l
Orig
inal Plan
Curren
t Plan
Actual Expen
ditures
Projected Expe
nditu
res
A A A A
68
IDT
ask N
am
eD
ura
tio
nS
tart
Fin
ish
1N
ew
Bed
tow
er
& R
en
ovati
on
s76.3
8 m
on
sT
hu
9/2
/10
Tu
e 1
0/2
5/1
6
2D
esig
n S
ite
work
& E
ast
Pa
rkin
g377 d
ays
Thu 9
/2/1
0F
ri 2
/10/1
2
3D
esig
n N
ew
Tow
er
& R
enovations
430 d
ays
Mon 3
/21/1
1F
ri 1
1/9
/12
4S
ite &
East P
ark
ing G
ara
ge C
onstr
uction (
Phase I)
237 d
ays
Mon 6
/4/1
2T
ue 4
/30/1
3
5N
ew
Tow
er
Constr
uction (
Phase II)
790 d
ays
Thu 5
/2/1
3W
ed 5
/11/1
6
6N
ew
Tow
er
FF
&E
84 d
ays
Wed 1
/6/1
6W
ed 5
/11/1
6
7N
ew
Tow
er
Move-I
n2 d
ays
Thu 5
/12/1
6F
ri 5
/13/1
6
8P
hase 2
b -
Post T
urn
over
Work
117 d
ays
Mon 5
/16/1
6T
ue 1
0/2
5/1
6
9A
cad
em
ic A
dd
itio
n &
R
en
ovati
on
58.4
8 m
on
sW
ed
1/2
3/1
3F
ri 1
0/6
/17
10
De
sig
n
468 d
ays
Wed 1
/23/1
3F
ri 1
1/7
/14
11
Site
En
ab
ling
& A
dd
idio
n C
on
str
uctio
n335 d
ays
Mon 4
/20/1
5F
ri 7
/29/1
6
12
A B
uild
ing
Re
no
va
tio
n570 d
ays
Mon 8
/3/1
5F
ri 1
0/6
/17
13
Clin
ical R
en
ovati
on
s75 m
on
sT
ue 2
/12/1
3M
on
2/2
5/1
9
14
De
sig
n C
linic
al R
en
ova
tio
ns
698 d
ays
Tue 2
/12/1
3T
hu 1
0/1
5/1
5
15
Phase 1
Renovation
339 d
ays
Mon 5
/23/1
6F
ri 9
/8/1
7
16
Phase 2
Renovation
142 d
ays
Mon 9
/11/1
7T
ue 3
/27/1
8
17
Phase 3
Renovation
118 d
ays
Wed 3
/28/1
8F
ri 9
/7/1
8
18
Phase 4
Renovation
121 d
ays
Mon 9
/10/1
8M
on 2
/25/1
9
19
Lab
Ren
ovati
on
s P
roje
ct
180.1
mo
ns
Fri
4/1
0/0
9M
on
9/2
1/1
5
20
La
b R
en
ova
tio
n P
lan
nin
g &
De
sig
n936 d
ays
Fri 4
/10/0
9F
ri 1
1/9
/12
21
Ph
ase
1A
Co
nstr
uctio
n340 d
ays
Tue 1
2/1
1/1
2M
on 3
/31/1
4
22
Ph
ase
1B
Co
nstr
uctio
n238 d
ays
Mon 4
/7/1
4W
ed 3
/4/1
5
23
Ph
ase
2A
Co
nstr
uctio
n154 d
ays
Wed 2
/4/1
5M
on 9
/21/1
5
24
Lab
Ren
ovati
on
s P
roje
ct
217.2
4 m
on
sM
on
12/1
4/1
5T
ue 5
/2/1
7
25
Ph
ase
3A
Co
nstr
uctio
n362 d
ays
Mon 1
2/1
4/1
5T
ue 5
/2/1
7
26
Am
bu
lato
ry C
are
Cen
ter
(AC
C)
57.6
2 m
on
sM
on
12/5
/11
Fri
7/2
2/1
6
27
AC
C P
lan
nin
g / C
ore
& S
he
ll D
esig
n460 d
ays
Mon 1
2/5
/11
Fri 9
/6/1
3
28
AC
C P
ark
ing G
ara
ge
210 d
ays
Mon 1
/21/1
3F
ri 1
1/8
/13
29
AC
C C
ore
& S
hell
488 d
ays
Mon 3
/4/1
3W
ed 1
/14/1
5
30
AC
C Inte
riors
- F
it O
ut
310 d
ays
Mon 1
/6/1
4F
ri 3
/13/1
5
31
Do
wlin
g R
elo
ca
tio
ns t
o A
CC
2 d
ays
Fri 1
/30/1
5M
on 2
/2/1
5
32
De
mo
lish
Do
wlin
g N
ort
h &
So
uth
60 d
ays
Mon 3
/2/1
5F
ri 5
/22/1
5
33
8 E
ast C
on
str
uctio
n
126 d
ays
Fri 1
/29/1
6F
ri 7
/22/1
6
34
Ad
dit
ion
to
CG
SB
: In
cu
bato
r L
ab
s28.1
4 m
on
sF
ri 9
/13/1
3F
ri 1
2/1
8/1
5
35
Incubato
r Lab P
lannin
g &
Desig
n207 d
ays
Fri 9
/13/1
3M
on 6
/30/1
4
36
Incubato
r Lab C
onstr
uction
316 d
ays
Fri 1
0/3
/14
Fri 1
2/1
8/1
5
ign
Sit
ew
ork
& E
ast
Park
ing
Desig
n N
ew
To
wer
& R
en
ovati
on
s
Sit
e &
East
Park
ing
Gara
ge C
on
str
ucti
on
(P
hase I)
New
To
wer
Co
nstr
ucti
on
(P
hase II)
New
To
wer
FF
&E
New
To
wer
Mo
ve-I
n
Ph
ase 2
b -
Po
st
Tu
rno
ver
Wo
rk
Desig
n
Sit
e E
nab
lin
g &
Ad
did
ion
Co
nstr
ucti
o
A B
uild
ing
Ren
ovati
on
Desig
n C
lin
ical R
en
ovati
on
s
Ph
ase 1
Ren
ovati
on
Ph
ase 2
Ren
ova
Ph
ase 3
R
Ph
a
Lab
Ren
ovati
on
Pla
nn
ing
& D
esig
n
Ph
ase 1
A C
on
str
ucti
on
Ph
ase 1
B C
on
str
ucti
on
Ph
ase 2
A C
on
str
ucti
on Ph
ase 3
A C
on
str
ucti
on
AC
C P
lan
nin
g / C
ore
& S
hell D
esig
n
AC
C P
ark
ing
Gara
ge
AC
C C
ore
& S
hell
AC
C In
teri
ors
- F
it O
ut
Do
wlin
g R
elo
cati
on
s t
o A
CC
Dem
olish
Do
wlin
g N
ort
h &
So
uth
8 E
ast
Co
nstr
ucti
on
Incu
bato
r L
ab
Pla
nn
ing
& D
esig
n
Incu
bato
r L
ab
Co
nstr
ucti
on
12
2013
2014
2015
2016
2017
2018
201
BIO
SC
IEN
CE
CO
NN
EC
TIC
UT
MA
ST
ER
PL
AN
SC
HE
DU
LE
Tue
5/1/
18
Page 1
of 1
69
Draft Minutes May 21, 2018
ACADEMIC AFFAIRS SUBCOMMITTEE Board of Directors
Time: 10:00 a.m. – 12:00 p.m.
Location: Munson Training Room, 16 Munson Road, Farmington, CT
Present (Voting): Archambault, F; Cloud, S; Duncan, J; Freedman; J; Hansen, M; Hurley, M; Rawlins, W (telephonically); Woods, K Present (Non-Voting): Liang, B; MacNeil, L; Volin, J (telephonically); Henderson, D; Regan, T; Pilbeam, C; Kream, B; Nissen, J; Metz, B; Wetstone, S; Thatcher, C; Hesselbrock, V; Geoghegan, J; Blumenthal, J (telephonically); McKenty, D; Perregaux, R; Andrews, C; Keilty, A; Abu-Hasaballah, K
Excused (Voting): Alleyne, K; Droney, J; Mina, M Excused (Non-Voting): Agwunobi, A; McFadden, D; Lepowsky, S; Nestler, E; Angus, S; Siraco, M; Swiatek, J Meeting commenced at 10:00am
1. Public Comment 2 . Chair’s Remarks
a. Welcome and updatesThe Chair wished Dr. R.L. MacNeil, Dean of the SODM all the best as he moves on from his deanship to teach and work on internationalizing his already national organization.
b. Approval of minutes from January 29, 2018 MeetingMotion to approve the minutes as written. Seconded. Approved 7-0-0.
3. Consent Items a. Approval of School of Medicine Recommendations for Reappointment of
Tenure Track Faculty, Endowed Chair Appointment, Emeritus Appointmentsand Sabbatical Leave (Dr. Bruce T. Liang)
Dr. Bruce Liang, Dean of the SOM, is requesting that the AASBOD approve the faculty being recommended for reappointment of tenure track, as listed on page 10 in the materials. His request includes the recommendation of Dr. David Steffens to be appointment as the Samuel “Sy” Birnbaum/Ida, Louis and Richard Blum Chair in Psychiatry. He is additionally asking that the AASBOD approve the recommendations for emeritus appointments, as listed on page12, as well as Dr. Cato Laurencin’s request for sabbatical leave, as described on page 13. While Dr. Laurencin is on his sabbatical, which will be taken in smaller periods of time, he will stay engaged in both CICATS and the Institute for Regenerative Engineering, as well as appoint a deputy to continue the work being done in these institutes.
Motion to approve the recommendations. Seconded. Approved 6-0-1.
4. Business Items
5 . Informational Items a. School of Medicine Junior Rank Promotions (Dr. Bruce T. Liang)
Dr. Liang presented the names of those receiving junior rank promotion in the SOM, as shown on page 15 in the materials.
70
Draft Minutes May 21, 2018
ACADEMIC AFFAIRS SUBCOMMITTEE Board of Directors
b. Oversight Committee Update – Department and Center Reviews (MarcHansen)
Dr. Mark Hansen reported the status of the department and center reviews. The five reviews scheduled for 2018 are: CT Institute for Clinical and Translational Science, Department of Obstetrics and Gynecology, Department of Pediatrics, Department of Psychiatry, and Institute for Regenerative Engineering. The reviews scheduled for 2019 are: Department of Family Medicine, Departments of Immunology, and Department of Neurology. The completion of these reviews will complete the 7-year cycle of reviews, as mandated by the SOM bylaws.
A type-1 center is a center located within a department and answers to the department. A type-II center is an independent entity and is meant to be outside of the departmental structure. Both are at the discretion of the Dean to appoint, dissolve or consolidate as necessary, in consultation with the Dean’s council.
The board acknowledged this to be Dr. Hansen’s last meeting as a member of the AASBOD, thanked him and his committee for the excellent work done to get the reviews back on track.
c. LCME Exit Report (Dr. David Henderson)The SOM had their LCME site survey on March 4th-7th. A five-person team evaluated the SOM on the basis of 12-standards and 93 constituent elements. The outcome of the review was that five elements were found to be less than outright satisfactory: 1.4 Affiliation Agreements: the agreements have all of the information
that is required but need to be reorganized to meet the LCME’sstandards.
2.4 Sufficiency of Administrative Staff: there were some issues identifiedin the ISA, regarding communication with the students and will requiresome monitoring with the departure of Dr. Rose and the reorganizationof the administrative structure.
3.2 Community Scholars/ Research Opportunities: solutions werealready in place to address the issues noted in scholarship.
3.3 Diversity: the LCME team found issue with the fact that the SOMdoes not have a diversity policy for medical students, separate fromUConn Health. This policy was already written at the time, but had notgone through the approval process. This policy describes how the schooldefines diversity for our students. It was suggested that the policyincorporate verbiage that already exists on the website about the HealthCareer Opportunity Programs (HCOP).
8.8 Monitoring Student Time: a solution was already put into effect with apositive repeat survey, but the LCME felt that additional data collectionwould be appropriate given that it is a new curriculum.
More detail related to the visit can be found on pages19-22 in the materials.
71
Draft Minutes May 21, 2018
ACADEMIC AFFAIRS SUBCOMMITTEE Board of Directors
There is a growing alarm surrounding the decrease in URM students, particularly African American and Latino male students, attending medical school nationally. The issue is rooted in the socioeconomic structure and stems back deep into the educational system early on. Dr. David Henderson has engaged the AAMC consortium and participated in a workshop to develop leadership among minorities; also working with UConn specialties to make an active concerted effort to keep our URM students here after graduation. Maintaining students after graduation would help produce more mentors and create a more inviting environment for incoming students. President Herbst recently signed off on a large proposal submitted to the Dept. of Health and Human Services, which will provide significant resources to improve upon and positon UConn to take a leadership role in addressing this matter.
d. Match Day Statistics (Dr. David Henderson)Dr. Henderson presented the 2018 match day statistics, found on page 23 in the materials. Of note, all 84 students eligible for graduation were placed in residency, not 83/84 as listed in the materials. 25% of the matched students stayed in CT, last year it was 27%, however this number varies from year to year.
e. Admissions Update (Dr. Thomas Regan)Dr. Thomas Regan provided a handout for those in attendance, noting that it was the first time UConn SOM’s acceptance has been overfilled on the day after students were required to make final selections. Of 3,107 applicants, they interviewed 315; 219 of which were CT residents. The LCME has approved the SOM to have a class size of 110, but we are currently at 112. Dr. Regan believes the new curriculum and the learning environment, including new learning areas, are what sold the Medical School to potential applicants. If the school does overenroll, they will need to inform the LCME.
f. MD/PhD Program Update (Dr. Carol Pilbeam)Dr. Carol Pilbeam presented an update on the MD/PhD program, who has a goal of training physician scientists who will devote the majority of their time to research. The information from her presentation can be found on page 24 of the materials. Their program has graduated 79 students, with an 8-year average time of completion, integrating medical and research training. For the 2018 entering class, they received 144 applicants, made 29 offers, and matriculated 7 students; four women, three men. The GPA and MCAT scores of those matriculating are higher than the national average and applications, acceptances, and enrollment have increased with an end goal of 40 students. The Dean has been a great supporter of the program and its collaboration with JAX and new faculty positions only strengthen the program.
72
Draft Minutes May 21, 2018
ACADEMIC AFFAIRS SUBCOMMITTEE Board of Directors
In reviewing applications from URM students, they often do not have enough research experience to make them qualified for admission to the MD/PhD program. The hope is to develop a pipeline where URM students spend time doing research with and getting to know the faculty.
The school does track the graduates to see who indeed devotes their career to biomedical sciences. 45/64 graduates are in an environment where they can do research, but it does not specify whether or not they are in fact doing research. Dr. Pilbeam estimates that approximately 50% of the graduates are indeed engaged in active research.
g. ACGME Update (Dr. Jacqueline “Kiki” Nissen)Dr. Kiki Nissen provided the AASBOD with an ACGME update; her slides are available on pages 25-38 in the materials. The ACGME now has an international accreditation arm since 2010.. There are 128 new international programs and 10,683 US programs accredited by the ACGME. It is the 5th Anniversary of milestones, which are used to enhance the curriculum in each of the residency programs. The ACGME is constantly improving the milestones and using the milestone data to enhance the curriculum.
UConn’s GME has gone through 2-rounds of CLER (Clinical Learning Environment Review), which takes place at the hospitals where the learning happens. The focus of the reviews is on patient safety, healthcare quality/ health disparities, supervision, professionalism, transition in care, and well-being across the clinical care team. A landmark study has shown that the clinical learning environmentin is an important predictor of the quality of care provided long after training. Some overarching themes and findings are listed out on page 29-30 in the materials.
Broad issues affecting GME are the opioid epidemicand, diversity, and physician well-being. Due to the opioid epidemic, the clinical learning environments must use evidence-based medicine in protocols and procedures using opioids; have effective teaching strategies with residents include prevention and recognition of addiction, teach residents how to effectively treatpain syndromesusing non-pharmacological means, and participate in clinical trials of new non-opioid pain relief. The ACGME has convened a taskforce and have new and expanded standards related to diversity and culture. All GME offices will be required to have a diversity statement, mission, and plan for addressing diversity in their own programs. With regard to physician well-being, the ACGME is looking at suicide, clinical depression, and physician burnout. They have sponsored a well-being symposium and since February 2018 there have been ten key papers addressing this topic. The AAMC and National Academy of Medicine are also collaborating to work on this issue. A national suicide hotline has been added to the GME website and a de-identified (by name, not program)
73
Draft Minutes May 21, 2018
ACADEMIC AFFAIRS SUBCOMMITTEE Board of Directors
burnout study is being conducted so that each program will receive this critical data regarding physician burnout.
This however needs to be addressed more broadly and prevention needs to be a greater focus, by improving the workplace environment. Dr. Nissen is working with hospital leadership to develop a wellness committee here at Uconn Health.
Update on the Dean search for the SODM: The search is being coordinated through the Vice Provosts office. There was a robust pool of applicants and is now narrowed down to 4 final candidates:
Sharon M. Gordon, DDS, MPH, PhDo East Carolina University
Michael Glick, DMDo University at Buffalo, SUNY
Russel S. Taichman, DMD, DMSco University of Michigan
Frank A. Scannapieco, DMD, PhDo University of Buffalo
The hope is that a Dean will be named and on site by July 1, 2018.
Motion to adjourn. Approved. 11:54am.
Next Regularly Scheduled Meeting Monday, September 10, 2018 10 a.m. – 12 p.m. Munson Training Room, 16 Munson Road, Farmington, CT
74
Meeting Minutes
May 24, 2018
CLINICAL AFFAIRS SUBCOMMITTEE
Board of Directors
16 Munson Road
1 Cheryl Chase, Chairman, called the meeting to order at 2:04 pm
1.1 No public comment
2 Chair’s remarks 2.1 The Clinical Affairs Subcommittee unanimously approved the motion to accept
the minutes of the subcommittee meeting held on February 22, 2018
3 Chief Executive Officer Report – Dr. Andrew Agwunobi
Dr. Agwunobi provided the following comments:
UCONN Health Finances: UConn Health will be ending the fiscal year at approximately $9m ahead of budget. Year to date we are ahead of budget by $8.26 million. Over the next couple of months some expenses related to EPIC are expected, including the expected productivity of physicians. The group viewed a slide which reviewed the breakdown of the various categories and variance to budget; including clinical which is at $5.148 ahead of budget, research at $1.115 ahead of budget, and the schools of medicine and dental medicine at $1.054 and $2.022 respectfully. Institutional Support is currently showing a deficit due to expenses relating to the transition of Correctional Managed Health Care which have been temporarily categorized in that fund. Anticipation for next year is expected to be a very tough year financially due to required raises, fringe rate increases determined by the State Comptroller, and ongoing expenses related to the EPIC implementation.
Dr. Agwunobi talked briefly on the EPIC (Health One) implementation. Although the go-live did happen as scheduled, some areas, such as the Cancer Center, Dermatology and Ophthalmology, still have work through some issues. Dr. Agwunobi noted that he is very proud of the work done by the hospital and by UMG leadership for the work they continue to do to make sure that this implementation is successful.
4 Quality Reports 4.1 UConn John Dempsey Hospital (JDH) – Dr. Scott Allen
Dr. Allen reported that the hospital’s Leap Frog score dropped from an A to a B for this past quarter. Dr. Allen felt the reasoning for was most likely centered around the increase in CLABSI (central line associated blood stream infections) numbers for the quarter. A plan has been put in place to ensure the cases of CLABSI will be reduced going forward in addition to all other serious infection incidence.
The Serious Safety Event rate maintained through April with a score of 0.7 only one event. There were no serious safety events during the EPIC implementation.
Dr. Allen reviewed the data collected from the HCAHPS (Hospital Consumer Assessment of Hospitals, Providers, and Systems) surveys that are sent to patients following discharge.
Nurse Communication is now well above the targeted goal of 75%.
75
CLINICAL AFFAIRS SUBCOMMITTEE
Meeting Minutes
February 22, 2018
UConn Health
A new program called “No Pass Zone” has been initiated in the hospital. The new program in If you are passing a room where someone needs assistance – go in.
The Doctor communication scored did drop just a little. However the responses are still hovering in the 80% range.
Lastly, the QAPI Committee (Quality Assessment Performance Improvement
Committee) which is chaired by Andy is a group that meets monthly and reviews the
performance improvement and quality metrics throughout the hospital. Going forward as
part of the QAPI Program Dr. Allen will present minutes from the meetings at the
quarterly Clinical Affairs Subcommittee meetings.
4.1.2 Environment of Care - Kevin Higgins Mr. Higgins reported that six months ago the Environment of Care Committee reported about 100 action items that needed attention. To date, the number of items is down to 5 items remaining. A tremendous amount of work has been done. The surveyors are expected soon and at this time the work is winding down and the team will be ready. A company called Joint Commission Readiness will be coming to do a mock survey early in June to ensure that the hospital is prepared.
4.1.3 Joint Commission Clinical Readiness – Deb Abromaitis Last survey was in November 2015, we are on a three year cycle. The surveys begin at 8:00 am and are always unannounced. The steps are first we process an application and then they tell us who the surveyors will be. The processing of the application has been completed. We have been told that our compliment will include a behavioral health care survey which will have a dedicated specialist for one day The second survey will be for the hospital which will include a specialist an ambulatory care specialist for two days, engineer for two days, physician for 4 days, nurse for 4 days and administrator for 3 days. We will be notified at 7:30 the morning of their arrival with the bios of those people coming. The biggest change in the management of the survey is that the findings are not only discussed with the leaders, but put into a matrix that is color coded to designate the severity of the findings. Plans have been put in place to aid in preparation of the Joint Commission visit to ensure that all areas are as ready as possible. These plans include chapter champions, chapter meetings, monthly mock surveys, leadership binders, survey folders and Joint Commission Resources coming back in June to review and run a mock survey.
4.2 UConn Medical Group – Anne Horbatuck, Dr. Denis Lafreniere
Ms. Horbatuck reported some of the key accomplishments from the last quarter. The component preparations for Health One included additional work flow planning, provider scheduling, provider preferences (which allows us to get the right patient to the right provider), making sure patients were seen in a good timeframe, extensive training, hired two new faculty and four APRNs. In addition 199 medical assistants had to be registered. The Putnam site was moved into the multi-specialty area, West Hartford had
76
CLINICAL AFFAIRS SUBCOMMITTEE
Meeting Minutes
February 22, 2018
UConn Health
a lot of physical site improvements done, and ambulatory operations focused on the office assistant and how that person is utilized. Encounters are 5% ahead of prior year and 1.54% ahead budget and the RVU’s are 10’% over last year and just under 1% ahead of budget. There has been an increase in overall doctor rating and also in recommend this provider. Some of the quality updates were:
Population Health – Interviewing for Assistant VP, Nurse Care Manager/Navigator and two Care
Coordinators Chronic Care Management program expansion - New position hired for expansion (grant funded)
• Designed for patients with 2 or more chronic conditions Person Centered Medical Home - Application anticipated to be submitted in July
Quality and Contract Performance - Medicaid Meaningful Use (MU)
• $442,000 total to date in FY18 - Awarded $60,000 from United Medicare Advantage for closing gaps in care for
their members - Anthem – Receiving an additional per member per month (PMPM) payment to
assist with care management for their members • Focus will be on frequent ED users and gaps in care
Dr. Lafreniere reported on the Merit Based Incentive Program (MBIP). The reporting period ended at the end of 2017 and UMG has a score of 100. Anything over 70 indicates the Health Center will receive an increase year in our CMS payment rate over the next fiscal. The amount is not known at this time. The Practice Transformation Network grant is entering its final year. This is a grant to help the Health Center develop a system where we can consistently give patient centered care with increased costs and maximized quality. Part of the mission is to instill this process within UConn Health so it will move forward once the grant is completed. We are working with third party payers (Anthem) to decrease unnecessary ED admissions and working to save money using formulary pharmaceutical costs to ensure what we select is on formulary that will save costs. We are also working with other state agencies in the project, such as the State Comptroller and the new Office of Health Strategy which is helping us to utilize some of the benefits that we can get out of working closer with Medicaid and several other programs within the state
5. EPIC (UConn HealthOne) update – Bruce Metz The HealthOne cut over took place at 5:17 on April 28. Overall the go-live has gone very well. Since the beginning a 24/7 hour support structure has been in place which consisted of a series of command centers, a call center, over 100 EPIC analysts. We brought in about 360 “at the elbow” personnel and we have been depending on a host of after ready clinical ready cycle teams around the clock. The at the elbow personnel work side by side with our end users to help everyone navigate they system and perform the workflows. We have been able to taper down our ATE personnel each week as the end users become more proficient.
77
CLINICAL AFFAIRS SUBCOMMITTEE
Meeting Minutes
February 22, 2018
UConn Health
Summary of Early Successes include:
– On track to meet milestones and metrics established to monitor progress and determine go-live success
– Hospital and inpatient areas as a whole have adapted quicker than expected – Ambulatory clinics that moved from NextGen are reaching pre go-live productivity
levels – For Revenue Cycle billing, cumulative charges are consistent with Epic benchmarks
for this stage of the go-live – Departments, such as Orthopedics and Pharmacy, that took ownership of
operationalizing Epic during implementation are having a smoother transition – Some providers have commented about the benefits of HealthONE (e.g.,
“HealthONE is way better than NextGen for doing orders/charts for the doctor. Takes me a quarter of the time to chart. Vast improvement!” Dr. Craig Rodner)
Summary of Major Concerns and Outstanding Issues include:
– Enterprise-wide adoption of converged and standardized ways of working represents a dramatic change
– Effective and efficient operation of more complex workflows has been challenging for certain clinical areas (e.g., treatment plans in Cancer Center; ordering of procedures in Radiology)
– Ambulatory clinics that moved from paper are experiencing a range of system and process issues (e.g., Dermatology, Cancer Center, Ophthalmology)
– Registration and check-in process is not being completed from start to finish in all cases
– Advanced Epic tools that increase provider productivity and benefit patient care have not been deployed in all clinical areas (e.g., order sets in specialty practices)
– New hardware and device needs have emerged as a result of end-users experiencing the system
– Focused efforts and SWAT teams have been formed to tackle these and other issues
Summary of Key Next Steps include: – Continue to closely monitor the Go-Live, remediate problems and address
challenges – Develop a roadmap for stabilization and plan for shifting to this phase once the go-
live period is complete – Recognize additional successes and the huge effort from thousands of people who
are making change of this magnitude possible School Reports
5.1 School of Dental Medicine – Dr. Steven Lepowsky Dr. Lepowsky shared with the group about his recent care as he was hospitalized here
at the health center. He remarked that all aspects of his care could not have been better from the doctors and nurses to the housekeepers.
The Dental School recently entered the third phase of the renovations. This phase has
created some unique challenges that have not been faced before in the terms of space and space allocation, treatment areas and accessibility to the treatment areas. They
78
CLINICAL AFFAIRS SUBCOMMITTEE
Meeting Minutes
February 22, 2018
UConn Health
started o receive feedback from patients, some of which is negative and related to the construction. Dispute the challenges the clinical operations are doing very well. All of the financial measures across all aspects of the school are doing well. Every financial measure is not only ahead of last year, but also ahead of budget. The net revenue as opposed to gross revenue has improved measurably over last year and budget.
Update on CCMC transition: Although we no longer will have a presence at CCMC we
continue to have ongoing discussions with the leadership of CCMC to ensure that we have a meaningful presence although our outpatient practices will no longer be at CCMC. We are doing quite a bit of work maximizing the utilization of the space at Kane Street to accommodate the activity that used to take place at CCMC.
There being no further business, the meeting was adjourned at 3:04 pm. Respectfully submitted,
Andrew Agwunobi, MD, MBA Chief Executive Officer, John Dempsey Hospital Attendees: Mr. Richard Barry (phone), Ms. Cheryl Chase, Dr. David McFadden, Dr. Wayne Rawlins (phone), Ms. Teresa Ressel (phone), Dr. David Shafer, Dr. Susan Tannenbaum
Next Regularly Scheduled Meeting
Thursday, May 24, 2018 2:00 pm – 4:00 pm
Munson Training Room Munson Road Building
79
CLINICAL AFFAIRS SUBCOMMITTEE PEER REVIEW SESSION
Board of Directors
Location: Munson Training Room, Munson Road Building
The meeting was called to order by Dr. Agwunobi at 3:06 pm
Public Comment There was no public comment
Chairs comments A motion was made, seconded and the minutes of the February 22, 2018 meeting of the Clinical Affairs Peer Review Subcommittee meeting were approved
Executive Session At 3:07 pm, the Committee voted, upon motion made and seconded, to go into Executive Session, pursuant to the General Statutes, to discuss Preliminary notes and drafts that the Health Center has determined that the public interest in withholding such documents and discussions clearly outweighs the public interest in disclosure; and trade secrets that derive independent economic value, actual or potential, from not being generally known, and not being readily ascertainable by proper means by other persons who can obtain economic value from their disclosure of use, and are the subject of efforts that are reasonable under the circumstances to maintain secrecy.
Adjournment At 3:23 pm the Committee went out of Executive Session and upon motion made and seconded, at 3:24 pm voted to adjourn the meeting.
Respectfully submitted,
Andrew Agwunobi, MD, MBA Chief Executive Officer John Dempsey Hospital
Attendance: Mr. Richard Barry (phone), Ms. Cheryl Chase, Dr. David McFadden, Dr. Wayne Rawlins, Dr. David Shafer, Dr. Susan Tannenbaum Guests: Dr. Andrew Agwunobi, Dr. Scott Allen, Dr. Richard Simon, Elizabeth Bjorge, Joanne Boucher, Michelle DeLayo, Anne Niziolek, Caryl Ryan, Jeffrey Blumenthal, Scott Simpson
Meeting Minutes May 24, 2018
80
John
Dem
psey Hospital
Summary of Key Inpatie
nt and
Ancillary Indicators
Mar YTD
FY 18
Key Inpatie
nt Indicators
Mar YTD
FY 18
Prior Y
ear to Da
teVa
riance
% Variance
Admissions
7,48
56,89
559
08.6%
Discharges
7,46
76,88
758
08.4%
Patie
nt Days
31,358
29,056
2,30
27.9%
ALOS
4.1
4.2
‐0.1
‐3.1%
Average Da
ily Cen
sus
114.4
106.0
8.4
7.9%
Key An
cillary Services
Mar YTD
FY 18
Prior Y
ear to Da
teVa
riance
% Variance
ED Visits
26,837
25,166
1,67
16.6%
Surgical Cases (e
xcl pain mgt cases)
7,27
06,80
546
56.8%
UCo
nn M
edical Group
Encou
nters
514,74
749
9,06
015
,687
3.1%
81
